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ABSTRACT 
 
MOLECULAR-GENETIC MECHANISMS OF MEMORY FORMATION IN MOUSE MODELS OF 
NEURODEVELOPMENTAL AND NEUROPSYCHIATRIC DISORDERS 
 
Hannah Schoch 
Ted Abel 
 
Neurodevelopmental and neuropsychiatric disorders are a significant and expanding 
global health crisis.  Many individuals affected by these disorders have social and 
cognitive symptoms represent significant sources of ongoing disability that are refractory 
to available treatment options. The search for cures and therapies for disorders 
fundamentally requires an understanding of the core neuropathology and insight into the 
underlying molecular mechanisms at work.  In this dissertation, I describe experiments 
that we performed to explore molecular and genetic mechanisms underlying memory 
impairment and enhancement in mice.  Synaptic structural proteins form a critical and 
adjustable framework that supports recruitment of neurotransmitter receptors and 
facilitates signal transduction.   In Chapter 2, we explored a role for the autism-related 
gene Protocadherin 10 (Pcdh10) as a key regulator of dendritic spine morphology and 
synapse elimination.  We found that mice with reduced PCDH10 have deficits in 
amygdala function, including impairments in conditioned fear, social interactions and 
gamma synchrony, as well as increased density of immature filopodia-type spines.  In 
the second part of this dissertation, we showed that the co-repressor SIN3A is a 
negative regulator of memory formation.  In Chapter 3, we demonstrated that reducing 
levels of SIN3A enhances in long-term memory and hippocampal synaptic plasticity, and 
v 
 
increases expression of Homer1, a gene encoding a post-synaptic density protein that 
regulates signaling through metabotropic glutamate receptors.   In Chapter 4, we 
identified contextual fear deficits in transgenic mice expressing Cre recombinase in 
forebrain neurons.  These results expand our understanding of molecular mechanisms 
of memory formation, and identify new therapeutic targets for improving cognitive 
function. 
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CHAPTER 1: GENETIC APPROACHES TO MODELING NEURODEVELOPMENTAL 
AND NEUROPSYCHIATRIC DISORDERS 
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Neurodevelopmental and neuropsychiatric disorders are a significant and expanding 
global health crisis.   The Center for Disease Control estimates that 1 in 6 children in the 
US are diagnosed with a developmental disorder, and 1 in 13 children have a learning 
disability (CDC, 2010).  Many individuals affected by neurodevelopmental and 
neuropsychiatric disorders have social and cognitive symptoms that can strongly impact 
their ability to live independently and function in society.  Cognitive deficits, in particular, 
represent significant sources of ongoing disability that are refractory to available 
treatment options.  One significant barrier to development of treatment options is a lack 
of promising therapeutic targets.  The search for cures and therapies for disorders 
fundamentally requires an understanding of the core neuropathology and insight into the 
underlying molecular mechanisms at work.  Many neurodevelopmental disorders have a 
complicated etiology involving a complex combination of environmental contributions, 
developmental insults, and genetic lesions.  The search for molecular mechanisms is no 
simple task, but it has been facilitated by technological advances in genetic research.   
Genetic linkage is one relatively clear-cut way to study disease risk and susceptibility, as 
it is a stable and long-lasting marker.  Unlike environmental exposure and 
developmental events, genetic mutations are stable across the lifespan of the individual 
and can be easily identified through non-invasive genetic screens.  Given the advances 
in gene sequencing technology, the primary challenge lies in identifying risk genes.  
Genome-wide association studies (GWAS) and haplotype mapping have provided a 
wealth of predictive power in linking genes and point mutations to disease susceptibility.  
Researchers are able to break down, isolate, and study the role of identified genes, and 
probe how loss or mutation of these gene products and other interacting factors in the 
pathway may contribute to the disorder.  Through genetic manipulation, model 
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organisms carrying mutations linked to a genetic disorder can be created, allowing for an 
intimate dissection of the contributions of individual genes and providing opportunities for 
screening and testing therapeutic agents. 
1.1. Strategies for modeling neurodevelopmental and neuropsychiatric disorders 
in rodents 
Rodents are a versatile model system for modeling genetic disorders affecting cognition 
and other complex behaviors.  Rodents display a wide variety of complex behaviors, 
both natural and trained, and their rapid generation time and large litters make them 
highly amenable to genetic studies.  Many genetic engineering tools have been 
developed to manipulate the rodent genome to model human genetic lesions, 
particularly in the mouse.  The advent of mouse transgenesis and gene knockout 
technology in the 1980s has led to explosive gains in our understanding of the genetic 
basis of both neurological and somatic disease (Hanahan 2007).  More recently, gene 
knockout and transgenic techniques have been refined in the rat, a model system 
amenable to studies of higher-level cognitive function, social transmission of learned 
behavior, and complex social behaviors (Ko and Evenden 2009, Day et al. 2003, 
Bruchey et al. 2010, Aisner and Terkel 1992, Rutte and Taborsky 2007, Seyfarth and 
Cheney 2013).   
The combination of gene modification in rodents and the advent of human medical 
genetics has paved the way for the development of highly specific genetic models 
designed to closely mimic human genetic disorders.  Patients with neurodevelopmental 
disorders have been widely examined in GWAS, where the genomes of affected 
individuals, and frequently that of siblings and parents, are screened for over-
represented mutations or chromosomal abnormalities that might be linked to the disorder 
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(Talkowski et al. 2012).  The autism spectrum disorder (ASD) field in particular has taken 
a strong interest in identifying genes that might increase susceptibility to developing the 
disorder (State and Sestan 2012, Morrow et al. 2008, Sanders et al. 2012, Michaelson et 
al. 2012).  This has led to the development of multiple lines of genetically modified mice 
carrying mutations in conserved genes and regions identified in GWAS studies.  Studies 
in these animals have greatly enhanced our understanding of the molecular basis of 
ASD, and spawned clinical trials of potential therapeutic agents (Belmonte et al. 2004).  
The two main approaches to study the genetic basis of human neurodevelopmental 
disorders have been gene knockouts, and more recently, epigenetic manipulations. 
1.2. Gene knockout models 
One of the first steps in investigating the function of a gene linked to a 
neurodevelopmental or neuropsychiatric disorder is often experimentally removing it 
from the genome.  Genes can be physically removed from the mouse genome by full or 
partial deletion of the DNA sequence.  Methods for conditionally deleting DNA 
sequences include homologous recombination using a targeted DNA construct, and 
enzyme based conditional deletion systems such as the Cre/LoxP system (Fig. 1.1).  In 
addition to deletion systems, the insertion of novel DNA sequence can also be used to 
disrupt expression at a gene locus, leading to reduced or absent expression of the 
targeted gene.  Mice carrying a gene deletion, “knockout” mice, can then be used to 
study the role of the gene in brain development and organization, neuronal structure and 
function, and cognitive and behavioral phenotypes. 
Studies of gene knockout mice have been very informative in the study of single gene 
disorders.  These are identified in a subset of genetic studies in human subjects in which 
a single common genetic basis for a disorder is found.  Knockout mice are a good model 
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for single gene disorders because the conserved mutation or deletion can be engineered 
in the mouse to create a fairly translational model that can provide further understanding 
of role of the targeted gene in the pathophysiology of the human disorder.  Studies of 
this model not only provide insight into the molecular basis of a disorder, but also 
generate important basic knowledge of the functions of the gene and gene products in 
the animal.  Importantly, basic knowledge of the molecular mechanisms underlying a 
neural disorder is critical for identifying drug targets and designing therapeutic 
approaches. 
1.2.1. Advances in genetic models of neurodevelopmental disorders 
Identifying the genetic basis of neurodevelopmental disorders has been successful in 
certain monogenic disorders.  Mutations and copy number variants affecting the gene 
encoding the liver enzyme phenylalanine hydroxylase lead to neurological symptoms 
including seizures, social impairment and intellectual disability, as well as other medical 
issues (Gentile et al. 2010, Rolle-Daya et al. 1975, Lenke et al. 1980).  Genetic 
screening combined with an understanding of the underlying biological pathways 
involved has led to a steep drop in neurological effects.  Affected infants who are 
diagnosed early and adhere to a diet low in phenylalanine show near-normal brain 
development and cognitive ability (Smith and Knowles 2000, Janzen and Nguyen 2010, 
Pietz et al. 1998).   Neurological conditions arising from metabolic or peripheral (rather 
than central) nervous system dysfunction can be more amenable to therapeutic 
approaches, particularly in the case of dietary causes.  
1.2.2. Significant challenges remain 
Unfortunately, most neurodevelopmental disorders lack effective therapeutic options, 
even in cases where the genetic and molecular basis of a disorder is known.  Many 
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monogenic neurological disorders with a clearly defined neuronal and molecular 
pathology lack effective treatment options.  The following overview of therapeutic 
challenges focuses on two neurodevelopmental disorders with well-defined genetic 
components but very limited therapeutic promise to date: schizophrenia and Fragile X 
disorder. 
Schizophrenia is typically labeled a psychiatric rather than a neurodevelopmental 
disorder, but longitudinal studies have unmasked a set of early cognitive and behavioral 
symptoms in prodromal children who go on to get diagnosed as young adults 
(Reichenberg et al. 2010, Fuller et al. 2002).  A complex and heterogeneous disorder, 
schizophrenia is typically diagnosed with the emergence in adolescence and early 
adulthood of positive psychotic symptoms such as hallucinations, delusions, and 
paranoid ideation, as well as motor effects including stereotypy or catatonia.  Negative 
symptoms such as abnormal social behavior and cognitive impairments in verbal and 
working memory appear much earlier (Fuller et al. 2002, Reichenberg et al. 2010). 
Studies in young children affected by ASD suggest that intensive behavioral therapy 
early in life can improve cognitive and social functioning (Dawson et al. 2010, Warren et 
al. 2011).  The presence of progressive white matter loss, behavior issues, and early 
verbal IQ deficits in children and adolescents who eventually receive a diagnosis of 
schizophrenia highlights the need for early detection and intervention (Fuller et al. 2002, 
Reichenberg et al. 2010, Ho et al. 2007, Jones et al. 1997).    
A high degree of heritability is observed with schizophrenia, with an increased risk of as 
much as 64% observed in siblings of affected individuals that points to a strong genetic 
component (Lichtenstein 2009).  Mutations in the transmembrane protein Neuregulin1 
(NRG1) and its receptor ERBB4 have been linked to schizophrenia in multiple human 
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genetic linkage studies (Li et al. 2006, Walsh et al. 2008, Law et al. 2006).  A synaptic 
protein involved in brain development and synaptic function, NRG1 in mice regulates 
synapse formation and maintenance, neurotransmitter receptor expression, and 
neuronal firing patterns and oscillations in the brain (Ehrlichman et al. 2009, Barz et al. 
2014, Chen 2008, Xie et al. 2004, Gu et al. 2005).  Loss or reduction of NRG1 leads to 
cognitive, social, and communication deficits in both humans and in mouse models 
(Ehrlichman et al. 2009, Barz et al. 2014, Chen et al. 2008, Egan et al. 2001, Kircher et 
al. 2009, Krug et al. 2010), supporting a strong link between disruption of NRG1 
signaling and endophenotypes of schizophrenia.   
Despite advances in clinical genotyping and gene sequencing technologies and 
extensive studies in pre-clinical rodent models, no specific treatment solutions are 
available to schizophrenia patients found to be carrying disease-associated 
polymorphisms in the Nrg1 gene.  Available therapies for schizophrenia include typical 
and atypical antipsychotics that largely address positive symptoms (Elis et al. 2013).  
Although addressing positive symptoms is critically important, the remaining negative 
symptoms are often a significant source of ongoing disability for patients for which no 
therapeutic options exist.  Recombinant NRG1 peptides had been used to manipulate 
neurotransmitter receptor expression and firing patterns of cultured neurons almost a 
decade ago and have since been used in clinical studies for cardiac injury and cancer 
treatment, but moving therapeutic agents across the blood-brain barrier is a significant 
obstacle to both peptide and small-molecule based therapies in the CNS (Gao et al. 
2010, Britten et al. 2004, Xie et al. 2004, Gu et al. 2005).  Oddly, there is no evidence 
that existing NRG1 compounds are being considered as a therapeutic option for 
schizophrenia patients carrying Nrg1 mutations.  In 10 years of published pre-clinical 
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studies of these compounds, no studies have investigated CNS function.  Improved 
communication between basic and clinical researchers and across research fields is 
critical in order to develop targeted therapies for genetic disorders. 
In ASD, significant advances have been made in the quest for treatment options in 
Fragile X syndrome, a single gene disorder characterized by intellectual disability, 
seizure, withdrawal, altered motor coordination and repetitive behaviors, and connective 
tissue abnormalities (Rodgers et al. 2001, Kidd et al. 2013).  Anatomical differences in 
the brains of FX patients include increases in white matter density in cortical and 
hippocampal regions as well as the corpus callosum, as well as defects in cortical 
dendritic spine morphology including increased spine density and elevated prevalence of 
immature long, filopodia-like spines (Hallahan et al. 2011, Irwin et al. 2000).  An 
overwhelming majority of FX patients carry mutations in coding or regulatory regions 
associated with the X chromosomal gene locus Fmr1, which encodes the Fragile X 
mental retardation protein (FMRP) (Crawford et al. 2001, Section 1.3.1).  Knockout mice 
lacking Fmr1 show behavioral and structural changes similar to phenotypes observed in 
FX individuals, including impairments in cognitive and motor tasks, defects in dendritic 
spines, and impaired synaptic plasticity (Bernardet and Crusio 2006, Boda et al. 2014, 
Comery et al. 1997, Huber et al. 2002, Zhao et al. 2005).  A high degree of phenotypic 
similarity between human probands and mouse models has facilitated detailed 
mechanistic studies of FMRP in the brain.  FMRP is an mRNA binding protein that 
mediates transport and translational regulation of synaptic activity-regulated mRNA 
transcripts.  Loss of FMRP is associated with over-production of synaptic proteins 
(including ARC/ARG3, PSD-95, CAMKIIα, PCDH10, and MAP1B), a mechanism that is 
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thought to underlie synaptic defects observed in Fmr1 KO mice (Bassell and Warren 
2008).   
Activity-dependent translation of synaptic mRNA transcripts is regulated in part by 
signaling pathways downstream of metabotropic glutamate receptors, particularly 
mGluR5 (Bhakar et al. 2012).  Pharmacological inhibition or genetic knockdown of 
mGluR5 rescues behavioral, synaptic plasticity, and spine structural phenotypes in Fmr1 
KO mice, supporting a dominant role of aberrant mGluR5 activity in the pathophysiology 
of Fragile X (deVrij et al. 2008, Levenga et al 2011, Bhakar et al. 2012).  Interestingly, 
other pharmacological interventions aimed more specifically at reducing protein 
synthesis show mixed success in normalizing synaptic plasticity in Fmr1 KO mice, an 
outcome that hints at additional roles for mGluR5 in FX besides regulation of protein 
synthesis (Osterweil et al. 2012, Nosyreva et al. 2006).  Clinical trials are currently 
underway to test efficacy of mGluR5 antagonist compounds as potential therapeutic 
agents for improving symptoms of FX, but outcomes have been variable (Berry-Kravis 
2014, Jacquemont et al. 2014). 
In addition to difficulties with developing novel targeted therapeutics, the timing of 
therapeutic intervention may be critically important.  Genetic disorders can derail critical 
developmental processes occurring within discrete windows of time.  Environmental 
manipulations such as maternal immune activation or acute lead exposure starkly 
illustrate the long-lasting effects of brief exposure of the developing brain to injurious 
conditions (Lanphear et al. 2005, Patterson et al. 2010, Brown and Derkits 2010).  Social 
and intellectual changes associated with neurodevelopmental and neuropsychiatric 
disorders can occur quite early in childhood, and imaging studies suggest that 
neurostructural changes that accompany disorders such as ASD and schizophrenia are 
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present early in life during critical periods of verbal and social development 
(Reichenberg et al. 2010, Fuller et al. 2002, Wolff et al. 2012, Ho et al. 2007, Landa et 
al. 2007).  Studies in a schizophrenia model mouse carrying an inducible genetic 
manipulation suggest that even with full suppression of a genetic defect, adult animals 
may experience an incomplete recovery and retain certain types of cognitive deficits 
(Fig. 1.2, Kelly et al. 2008).  These studies highlight the need to expand studies of 
rodent models to expand our understanding of early neurodevelopmental processes and 
how disruption of these processes may be a critical and treatment-refractory source of 
behavioral and cognitive changes observed in adult animals.   
1.2.3.  Multi-gene disorders and gene-environment interactions 
One significant challenge in the study of genetic disorders is the presence of multiple 
genetic and non-genetic risk factors present in many disorders.  Many individuals with 
neurodevelopmental disorders are described as having ‘idiopathic’ disorders where a 
clear cause cannot be identified.  Our inability to understand the pathogenesis of these 
disorders likely reflects a complicated disease mechanism involving interaction of 
environmental factors combined with multiple rare alleles.  This “perfect storm” type of 
disease risk is very difficult to predict using GWAS and epidemiological studies because 
individual risk genes and factors do not confer susceptibility to the general population.  
Exploration of multi-gene and gene-environment interactions in model systems is only 
starting to be explored in basic research.  Complex genetic models will be a difficult 
challenge for neuroscience research in the upcoming decades, but is certain to provide 
important new insights into mitigating risk and severity of genetic disorders, and open 
new avenues of research into the ultimate cure: prevention. 
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1.3. Epigenetic models 
A second category of genetic disorders are not driven by mutations within the gene 
coding sequence, rather they affect regulatory sequences that affect expression, 
processing or stability of the gene transcript.  Regulatory regions of the genome are a 
substrate for a wide variety of covalent ‘epigenetic’ modifications of both DNA and the 
associated histone proteins.  Epigenetic modifications form a stable code that can exert 
a strong influence on the expression of the genome by regulating the biochemical and 
structural properties of chromatin.  Epigenetic modifications are most often studied in the 
context of DNA methylation and post-translational modification of histones, but can 
include nucleosome remodeling and incorporation of histone variants (Kouzarides, 2007; 
Maze et al., 2013).  Post-translational modification of histone N-terminal tails is a 
complex and tightly regulated process that has been linked to regulation of key aspects 
of gene expression including timing and levels of transcriptional activation, mRNA 
splicing, and poly-A site selection (Kouzarides, 2007; Maze et al., 2013; Sims et al., 
2007; Zhou et al., 2012).  Epigenetic modifications are a central mechanism for 
regulating chromatin structure and gene expression in the brain.   
1.3.1 Epigenetic regulatory mechanisms in neurodevelopmental disorders 
Disruption of epigenetic regulation has been implicated in multiple neurodevelopmental, 
neuropsychiatric and neurodegenerative disorders (Abel and Zukin, 2008; Fischer et al., 
2010; Peixoto and Abel, 2013).  Mutation, insertion, or deletion events in regulatory 
regions of genes can strongly affect recruitment of regulatory proteins, type and amount 
of epigenetic modifications in these regions, and ultimately transcriptional activation at 
the affected locus.  Expansion of a nearby CpG island, a regulatory DNA sequence that 
can be methylated, has been linked to decreased expression at the Fmr1 gene locus, 
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the causative gene in the autism-spectrum disorder Fragile X syndrome.  Reduced or 
absent Fragile X mental retardation protein (FMRP) expression in the brain results in 
cognitive deficits, altered social behavior, and aberrant dendritic spine morphology in 
both human patients and mouse models (Comery 1997, Bernardet and Crusio 2006). 
Abnormal DNA methylation patterns have also been found in individuals with ASD and 
other neurological disorders, particularly affecting the promoter region of the gene for 
methyl-CpG binding protein 2 (MECP2).  MECP2 is the causative gene in Rett 
Syndrome, a neurodevelopmental disorder affecting motor function, social behavior, and 
cognition.   MECP2 itself is not a synaptic protein, rather it functions in the nucleus as a 
transcription factor and epigenetic regulator, binding methylated DNA and recruiting co-
repressor complexes to regulate transcription of genes involved in neuronal 
development and function (Yasui et al. 2007, Hite et al. 2009).  Indeed, numerous 
transcriptional and epigenetic regulatory proteins have been identified in gene linkage 
studies for neurodevelopmental and neuropsychiatric disorders, a fact that emphasizes 
the need to identify and understand the contributions of epigenetic mechanisms in 
neuronal function (Schoch and Abel, 2014).  Many gene linkage studies have identified 
disease-linked haplotypes residing outside of coding regions, supporting the idea that 
regulatory DNA sequences may provide critical new insight into the basis of genetic 
disorders (Nica et al. 2010). Epigenetic regulation in the brain is only beginning to be 
explored in basic research, and the clinical implications of these findings for neurological 
disease have yet to be fully realized.  
A wide array of histone- and DNA-modifying enzymes have been identified as critical 
regulators of neuronal function, memory formation, and as causative agents in 
neurodevelopmental and neuropsychiatric disorders.  Much of the research in epigenetic 
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regulation of cognition has focused on the regulation of co-activator complexes and 
histone acetyltransferase (HAT) enzymes involved in increasing acetylation of histone 
lysine residues including H3K9, H3K14, H3K27 and H4K8, marks often associated with 
increased chromatin accessibility and active gene expression (Abel and Zukin, 2008; 
Borrelli et al., 2008; Fischer et al., 2007; Peixoto and Abel, 2013). Fewer studies address 
positive and negative regulation of gene expression by lysine methylation of histones; a 
modification that functions as a binding surface for protein interactions (Bannister and 
Kouzarides, 2011).  Overall, little is known in the brain about how changes in histone 
acetylation and methylation mediate negative regulation of gene expression and 
silencing by co-repressor complexes. 
1.3.2. Co-repressors regulate cognitive processes 
Co-repressors assemble multi-protein complexes containing structural, chromatin-
binding, and DNA- and histone-modifying enzymes that suppress transcription.  Catalytic 
components are assembled around structural proteins, and bound to DNA or histones by 
chromatin-binding proteins (Fig 1.3A).  Gene silencing is associated with the removal of 
activating epigenetic marks, such as acetylation or H3K4 methylation of histones; or 
through addition of repressive epigenetic marks including DNA methylation and histone 
methylation at H3K9, H3K27, and H3K36 (Bannister and Kouzarides, 2011).  Co-
repressor complexes frequently contain multiple catalytic components involved in both 
addition and removal of epigenetic modifications, suggesting that gene silencing may 
involve combinatorial or serial effects on modifications across multiple residues and 
substrates (Fig. 1.3B) (Bannister and Kouzarides, 2011; Kouzarides, 2007; Maze et al., 
2013).  Studies of histone modifications indicate that the presence of certain marks can 
regulate the modification of other residues, even across histones (Kouzarides, 2007).  
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Thus, the diversity of catalytic activities within individual co-repressor complexes is likely 
a critical aspect of their function. 
Early studies of co-repressor function in yeast and cell culture models found that co-
repressors regulate critical cellular functions from cell growth to differentiation, signal 
transduction and apoptosis, but the functions of many co-repressors in the brain are very 
poorly understood (Kato et al., 2011; McDonel et al., 2009).  Few biochemical studies of 
co-repressor complexes have been conducted in neuronal cells.  Much of our knowledge 
regarding the functional properties of co-repressors in mammalian systems has come 
from the fields of cancer research and developmental biology, where alterations in the 
function or localization of co-repressors were linked to aberrant regulation of growth, cell 
morphology, and tissue organization (Kumar et al., 2005; Lai and Wade, 2011; McDonel 
et al., 2009).  In the adult brain, which is primarily populated with post-mitotic, terminally 
differentiated cells, we are only beginning to appreciate the important roles co-
repressors play in signal transduction, plasticity, and cellular memory.  Epigenetic 
mechanisms are engaged by and critically important for mnemonic and cognitive 
functions in the brain (Peixoto et al. 2013; Schoch et al. 2014; Mahan et al. 2012).  In the 
context of these uniquely neuronal processes, the function and composition of co-
repressors in the brain may not be equivalent to those of non-neuronal tissues.  
Additionally, the expression of neuron-specific components of co-repressor complexes 
strongly hints at the existence of specialized functions for these complexes in the brain 
(Palm et al., 1998; Potts et al., 2011; Vogel-Ciernia et al., 2013). Multiple co-repressors 
have been linked to dynamic changes in gene expression and neuronal activity-
dependent regulation, but the specific roles co-repressors play in the brain are only 
starting to be uncovered (Chen et al., 2003; Ebert et al., 2013; Youn and Liu, 2000a).  
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Further studies of co-repressors and their function in neuronal tissue are needed to 
ascertain whether unique functions for these complexes exist within the nervous system, 
especially with regard to dynamic mechanisms of transcriptional repression/de-
repression following neuronal activity. 
Many core and accessory components of co-repressor complexes have been linked 
through genomic studies to neurodevelopmental and neurological disorders, but there is 
an overall lack of functional studies directly addressing the role of co-repressors in 
cognitive processes (Peixoto et al. 2013; Schoch et al. 2014).  Future studies of the 
composition and function of co-repressors in the brain are likely to provide powerful 
insights into gene regulation and how its disruption can lead to neurological and 
cognitive disorders.   
1.3.3.  Co-repressors and their function in the brain 
NCOR  The nuclear receptor co-repressor NCOR plays critical roles both in neural 
development and in cognitive processes in the adult brain.  NCOR assembles a multi-
protein co-repressor complex (Fig. 1.3B) that interacts with nuclear receptor 
transcription factors and represses expression of their target genes (Fig. 1.4A).  NCOR 
and its sister repressor, silencing mediator of retinoic acid and thyroid hormone 
receptors (SMRT/NCOR2), were discovered as reversible repressors that interact with 
the ligand-binding domain of T3 thyroid hormone receptors and are released by T3 (Fig. 
1.5A).These co-repressors have been shown to bind to a wide range of nuclear 
receptors (NR) including the retinoid receptors and NR4A family of orphan nuclear 
receptors, and the methyl CpG binding protein MeCP2 (Codina et al., 2004; Ebert et al., 
2013; Hörlein et al., 1995; Kato et al., 2011).  NCOR forms a complex that binds 
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HDAC3, the SIN3A co-repressor (discussed below), and the H3K9/H3K36 demethylase 
JMJD2A (Ishizuka and Lazar, 2005; Nagy et al., 1997; Zhang et al., 2005).  
Repression by NCOR is necessary for both neural development and memory storage in 
the adult brain. Regulation of neuronal genes through the retinoid receptors (RAR/RXR) 
by NCOR is a critical component of neuronal function from the earliest stages of 
development (Gilbert and Lasley, 2013).  In the mature brain, disruption of NCOR-
regulated TR- and NR4A-dependent gene expression has been linked to cognitive 
dysfunction and memory impairment in human disorders and rodent models (Bono et al., 
2004; Gilbert and Lasley, 2013; Hawk et al., 2012; Hawk and Abel, 2011; Xing et al., 
2006).  A recent study identified an NCOR-binding domain on MeCP2 that is affected by 
multiple mutations linked to Rett syndrome, a neurodevelopmental disorder 
characterized by severe motor and cognitive disability (Lyst et al., 2013).  Elimination of 
a critical phosphorylation site within the NCOR-binding domain of MECP2 recapitulates 
motor and lethality endophenotypes associated with loss of MECP2 function, but the 
impact of this mutation in cognitive functioning is not known (Ebert et al., 2013; Lyst et 
al., 2013).Mutation analysis of NCOR identifies HDAC3 as a critical component of the 
NCOR complex in the brain (McQuown et al., 2011).  Mice carrying a point mutation in 
the HDAC3-interaction domain of NCOR show enhanced hippocampus-dependent 
object location memory, indicating that histone deacetylation by the NCOR complex is a 
key negative regulator of hippocampal gene expression during memory consolidation 
(Fig. 1.4) (McQuown et al., 2011).   
In addition to HDAC3, NCOR recruits epigenetic regulators SIN3A and JMJD2A, but the 
roles of these regulators in the NCOR complex are not well understood.  SIN3A and 
JMJD2A both bind to the N-terminal RD1 repression domain of NCOR and exhibit 
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repressor activity in reporter assays, but it is not clear whether these interactions are co-
occurring or mutually exclusive (Nagy et al., 1997; Zhang et al., 2005).  JMJD2A 
appears to play a complex role in transcriptional regulation as a remover of both 
repressive H3K9me and permissive H3K36me modifications via its dual Jumonji 
demethylase domains.   The SIN3A co-repressor has also been linked to both activating 
and repressive functions through its many catalytic binding partners (discussed 
below)(Silverstein and Ekwall, 2005).  Without knowing which enzymatic components of 
the SIN3A-HDAC complex are present in association with NCOR, it is difficult to guess 
what impact the complex may have on the regulation of NCOR target genes.  Future 
studies of NCOR and SIN3A co-repressors will provide important insights into 
mechanisms of gene repression in the brain, and the roles it plays in both development 
and cognition. 
NuRD In addition to histone modifications, nucleosome repositioning is linked to gene 
regulation thought regulation of chromatin structure and DNA accessibility. Recent 
studies of chromatin remodeling complexes have uncovered a complex ATP- dependent 
mechanism by which these complexes uncouple the DNA from the histone surface to 
allow for looping of DNA and mono-directional sliding of the nucleosome along the DNA 
(Allen et al., 2013; Tang et al., 2010).  One nucleosome repositioning complex involved 
chromatin compaction is the NuRD complex.  A multi-functional complex containing both 
chromatin remodeling and histone modifying activities, the NuRD complex has been 
linked to rapid heterochromatin formation by nucleosome compaction via the MI-
2/CHD3/4 ATPase/helicase, and histone deacetylation by HDAC1/HDAC2 (Fig. 
1.3B)(Allen et al., 2013).  The catalytic activity of the NuRD complex is directed to 
chromatin by H3K9me-binding plant homology domain s (PHD) on MI-2, the transcription 
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factor binding metastasis-associated gene family (MTA1-3), and by methyl CpG binding 
domain proteins MBD2 and MBD3, which bind methylated and hydroxyl-methylated DNA 
respectively (Allen et al., 2013; Yildirim et al., 2011).  Depletion of MI-2 increases 
chromatin accessibility and induces DNA demethylation, demonstrating a role for the 
NuRD complex as a critical component of heterochromatin maintenance (Gao et al., 
2009). 
The role of the NuRD complex in the brain is not well studied, but it has recently been 
indirectly linked to regulation of neuronal gene expression and cognitive function 
(Schoch et al. 2014).  A novel CHD ATPase/helicase family member CDH5 is highly 
enriched in the brain, where it forms a NuRD-like complex that includes HDAC1/HDAC2 
and MBD3 and regulates the expression of neuronal genes in cultured neurons (Potts et 
al., 2011).  Mutations in members of the MBD gene family (including MBD2 and MBD3) 
have been identified in individuals with ASD, suggesting that NuRD complex association 
with methylated DNA is important for neural development (Cukier et al., 2012, 2010; 
Murgatroyd and Spengler, 2012).  Genetic deletion studies of MBD family members in 
mice have identified autism-related behavioral phenotypes in mice lacking MBD1, but 
MBD2 and MBD3 KO mice have not been behaviorally characterized (Allan et al., 2008; 
Allen et al., 2013; Hendrich et al., 2001).  Although the role NuRD-mediated chromatin 
compaction in memory formation is unclear, chromatin opening by the nucleosome 
repositioning Brg1-associated factor (BAF) complex (mammalian SWI/SNF) is critically 
important for memory formation. Loss of neuron-specific BAF complex subunit BAF53b 
impairs synaptic plasticity and long-term memory consolidation in the hippocampus 
(Vogel-Ciernia et al., 2013b).Further studies of the NuRD complex in neuronal function 
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and in behaving animals are needed to gain a more thorough understanding of its role in 
neural development and cognition. 
SIN3A The Switch-insensitive 3a (SIN3A) co-repressor complex is a massive 1.5-2 MDa 
transcriptional regulatory complex that interacts with a wide array of epigenetic 
regulatory proteins with critical roles in brain development and cognition.  Originally 
discovered as a suppressor of mating-type switching in yeast, SIN3A is a scaffold 
protein with multiple protein interaction domains through which it binds a core group of 
structural proteins along with HDAC1 and HDAC2, and a number of DNA- and protein-
modifying enzymes (Fig. 1.3B) (Nasmyth et al., 1987; Silverstein and Ekwall, 2005; 
Williams et al., 2011).  SIN3A is critically important for embryonic development, and 
constitutive loss of Sin3a leads to peri-implantation lethality (Dannenberg et al., 2005).  
There is a dearth of studies of SIN3A in the brain; however, we show in Chapter 3 that 
SIN3A is a negative regulator of both memory formation and synaptic plasticity. 
SIN3A recruits a wide array of epigenetic modifiers that have been linked to memory and 
cognition both in human genetic disorders and rodent models.  The classic role for the 
Sin3a complex is transcriptional silencing through the deacetylation of histones mediated 
by HDAC1/2.  Blockade of HDAC activity and loss of HDAC2 (but not HDAC1) both 
increase synaptic connectivity and enhance long-term memory in rodents (Guan et al., 
2009).In addition to transient repression by deacetylase activity, Sin3a co-repressor 
complexes have also been linked to long-term silencing and heterochromatin formation 
through Sin3a-HDAC structural protein SDS3, and the H3K9 methyltransferase 
SETDB1(David et al., 2003; Yang et al., 2003).  SETDB1 activity is implicated in the 
neuropathology of rodent models of Huntington’s disease and Rett syndrome, and 
mutations in SETDB1 have been linked to ASD (Akbarian and Huang, 2009; Cukier et 
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al., 2012; Jiang et al., 2011; Ryu et al., 2006). Mice conditionally over-expressing 
SETDB1 in the forebrain have altered emotional responses, but perform normally in 
cognitive tasks (Jiang et al., 2010). A unique addition to the Sin3a co-repressor complex, 
OGT, catalyzes serine and threonine N-acetyl O-glycosylation, a reversible 
monosaccharide post-translational modification that is abundant in the brain (Khidekel et 
al., 2007). O-glycosylation has been linked to structural and functional changes in key 
transcriptional proteins, including RNA polymerase II and cyclic AMP response element 
binding protein CREB (Ranuncolo et al., 2012; Rexach et al., 2012; Wells et al., 2003).  
In addition to its roles in gene silencing, Sin3a core complex interacts with factors that 
have been linked to positive transcriptional regulation during memory formation.  The 
SET1/MLL family of histone methyltransferase stably associate with the Sin3a complex 
via host cell factor 1 (HCF1) and catalyzes H3K4 tri-methylation, an activating mark that 
acts as a binding surface for methyl-lysine binding proteins involved in the assembly of 
the pre-initiation complex and mRNA splicing machinery at the promoter, and the 
maintenance of active gene expression (Sims and Reinberg, 2006; Sims et al., 2007; 
Wysocka et al., 2003; Yokoyama and Wang, 2004).  In addition to binding positive 
transcriptional regulators, methylation at H3K4 also blocks recruitment of the H3K9me-
binding MI-2 subunit of the NuRD chromatin remodeling complex (Allen et al., 2013; 
Nishioka et al., 2002). Changes in H3K4 histone methylation have also been linked to 
activity dependent DNA demethylation and release of methyl-CpG binding protein 
MECP2 from the promoter CpG islands of memory-related genes Zif268 and Bdnf 
(Gupta et al., 2010).  The MLL family of H3K4 methyltransferases has been directly 
linked to intellectual disability in multiple human genetic disorders (Murgatroyd and 
Spengler, 2012; Ng et al., 2010).  Mice with reduced MLL have less H3K4 methylation in 
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the hippocampus and impaired long-term memory (Gupta et al., 2010).  A role for SIN3A 
in both positive and negative transcriptional regulation is supported by genome-wide 
expression studies showing that loss of SIN3A is associated with bidirectional changes 
in expression of its target genes (Cowley et al., 2005; Dannenberg et al., 2005; van 
Oevelen et al., 2010). 
A recently discovered epigenetic modification of DNA involves hydroxylation of 5-methyl-
cytosineto5-hydroxy-methyl-cytosine (hmC), a reaction catalyzed by the TET family of 
hydroxylases (Zhang et al., 2010).Studies of methyl-binding proteins suggest that hmC 
may fulfill a role that is analogous but distinct to that of mC, as a substrate for hmC-
binding proteins including MBD3 of the NuRD complex(Allen et al., 2013; Yildirim et al., 
2011).  Over-expression studies of TET1 reduces DNA methylation, but the relationship 
between hmC and DNA demethylation has not been determined (Zhang et al., 2010).  
Recent studies identified TET1 as a SIN3A binding partner, suggesting that hydroxyl-
methylation may be yet another way that the Sin3a complex is able to influence the 
association of epigenetic and transcriptional regulators with DNA(Williams et al., 2011).  
The function of TET1 in DNA demethylation and chromatin remodeling in the brain 
remains an open question.  Future studies of TET1 in behavioral and cognitive 
functioning are a crucial next step in understanding the role of TET1 and hmC in the 
brain. 
The Sin3a-HDAC co-repressor complex is recruited to chromatin through association 
with its transcription factor binding partners, many of which have been linked to 
neurodevelopmental disorders with cognitive symptoms.  SIN3A interacts with a variety 
of transcription factors, including neural-restrictive silencing factor (REST/NRSF), 
MECP2, and myocyte enhancer factor 2(MEF2).  Constitutive silencing by REST is 
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critical for suppressing expression of neuronal genes in non-neuronal tissues, but the 
role of SIN3A as a co-repressor of REST in the brain is not understood (Ballas et al., 
2005).  The methyl-CpG binding protein MECP2 is well studied as a repressor of 
memory-related genes including Bdnf and Zif268 in the brain (Chen et al., 2003; Gupta 
et al., 2010).  Loss of activity-dependent repression by MECP2 in rodent models is also 
associated with deficits in memory, motor behavior, and in the structure and function of 
synapses, but the roles of MECP2 in cognition and transcriptional regulation are 
complex and not entirely clear (Collins et al., 2004; Li et al., 2011; Moretti et al., 2006; 
Nelson et al., 2011, 2006).  The transcription factor MEF2 interacts with SIN3A in an 
activity-regulated manner, and bi-directionally regulates the expression of genes 
involved in memory and synaptic plasticity (Fig. 1.5B) (Cole et al., 2012; Flavell et al., 
2008).  Expression of a constitutively-active form of MEF2 that lacks the SIN3A 
interaction domain impairs memory and dendritic spine growth, supporting a role for 
SIN3A-MEF2 in memory formation (Cole et al., 2012). Though SIN3A associates with a 
wide diversity of transcription factors and epigenetic modifiers implicated in neuronal 
function, the role of SIN3A in the brain is only beginning to be explored. 
CoREST  A relative newcomer to the co-repressor family of transcriptional regulators is 
CoREST. CoREST (KIAA0071) was discovered by two groups screening for repressors 
that interact with HDAC2 and REST (Andrés et al., 1999; Humphrey et al., 2001).  
CoREST is best known as a complex that mediates deacetylation by HDAC1 and 
HDAC2, but more recently, H3K4 demethylation activity was discovered in the CoREST 
complex via lysine specific demethylase 1 (LSD1) (Fig. 1.3B)(Hakimi et al., 2002; Lee et 
al., 2005).  The DNA-binding co-factor BRCA2-associated factor 35 (BRAF35), regulates 
repression activities of the CoREST complex by directly binding to RE1 elements. 
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(Hakimi et al., 2002).  In contrast to the co-repressor complexes with dual regulatory 
activities discussed previously, CoREST appears to have only silencing activity. 
CoREST is a versatile repressor linked to both chronic and transient repression of 
neuronal genes. In non-neuronal cells with high REST expression, CoREST and the 
SIN3A-HDAC complex bind to paired repressor domains on REST and stably silence the 
expression of neuronal genes (Lakowski et al., 2006a).  Gene knockdown studies of 
CoREST in the developing mouse brain highlight a critical role for this co-repressor 
complex in the development of cortical pyramidal neurons, and in the maintenance of 
cortical neuronal precursors (Fuentes et al., 2012).  Depletion of CoREST or SIN3A in 
non-neuronal cells increases expression of neuron-specific genes (Dannenberg et al., 
2005; Lee et al., 2005; van Oevelen et al., 2010).  Interestingly, activity-dependent 
expression of REST isoforms was found in post-mitotic neurons in the adult brain, but 
the function of REST/CoREST in the mature brain is not known (Palm et al., 1998).  In 
the absence of REST, CoREST is still able to bind RE-1 elements through the HMG 
DNA binding domain of BRAF35, but SIN3A recruitment is lost (Hakimi et al., 2002; 
Lakowski et al., 2006b).  In addition to REST, CoREST interacts with the methyl CpG 
binding protein MECP2, where it has been linked to activity-dependent regulation of 
gene expression during memory consolidation (Fig. 1.5C, Section 1.3.6) (Chen et al., 
2003; Guy et al., 2011; Kavalali et al., 2011).  Additional studies of CoREST and its 
associated factors are needed to understand the role of this co-repressor in the brain. 
 
1.3.4. Complexity and synergism within co-repressor complexes 
Co-repressor complexes recruit a wide variety of epigenetic modifiers, and the impact of 
this diversity on the function of the complexes is frequently not clear.  Much of the 
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literature on co-repressors focuses on identifying catalytic and transcription factor 
binding partners (Allen et al., 2013; Silverstein and Ekwall, 2005). Simply identifying 
proteins that can interact with a co-repressor provides limited information about the 
function of the complex.  Very little work has been done to determine whether a co-factor 
is constitutively present or conditionally recruited to a complex.  Knowledge of the 
composition of a complex is critical to the understanding of its function because transient 
accessory components can impart significant variation in the function of the complex.  
For example, the presence of both activating and repressive epigenetic modulators 
NCOR and SIN3A calls into question the ‘repressor’ status of these complexes, and 
hints at the existence of multiple subtypes of these complexes with different regulatory 
outcomes.  Detailed structural and functional studies of co-repressor complexes and 
their interacting proteins are sorely needed to gain an accurate understanding of how 
these complexes can influence the expression of their target genes. 
Studies of histone modification patterns suggest that certain marks are highly dependent 
on the presence or absence of other modifications, but the role of co-repressors in 
synergistic coordination of histone modifying enzymes has not yet been explored 
(Bannister and Kouzarides, 2011).  The modification of lysine 9 of H3 is one example of 
how coordination of multiple epigenetic regulatory enzymes within a single complex 
could have important implications for the regulatory outcome.  Coupling HDAC1/2 with 
the histone methyltransferase SETDB1 in the Sin3a complex would allow for efficient 
H3K9 deacetylation to expose the lysine residue for subsequent methylation by 
SETDB1.  On the other hand, methylation of H3K4 by SIN3A-associated SET1 is 
functionally antagonistic to H3K9meand blocks recruitment of H3K9me-binding proteins. 
It is likely that SETDB1 and SET1 are found in distinct subtypes of the Sin3a complex; 
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however, the existence of functional variants of the Sin3a complex has yet to be 
demonstrated.  It is imperative to expand the focus of future studies of epigenetic 
regulation beyond individual enzymes and single modifications into the larger context of 
multi-protein complexes regulating chromatin accessibility and protein recruitment. 
1.3.5.  Not just silencing: co-repressors as dynamic regulators of gene expression 
Gene promoters typically contain multiple conserved sequence elements bound by 
transcriptional regulators to collectively influence expression levels at the locus.  Genetic 
studies of conserved regulatory sequences suggest that multiple transcription factors 
can mediate highly divergent patterns of expression at a promoter.  Especially striking is 
the recruitment of common repressors to mediate two distinct patterns of silencing at a 
single gene locus.  CoREST/SIN3A regulation has been linked to both constitutive 
silencing (REST) and activity-regulated repression (MECP2) at the Bdnf and Zif268 loci 
(Ballas et al., 2005; Chen et al., 2003; Gupta et al., 2010).  Both repressor complexes 
were found at two distinct regulatory sites, a REST-bound repressor element 1 (RE1) 
site and a MECP2-bound CpG island (Ballas et al., 2005). In non-neuronal cells, 
repressor complexes were found at both sites and expression was strongly inhibited 
(Ballas et al., 2005). In neurons, constitutive silencing by REST was relieved, leaving 
plastic repression through the activity-regulated MECP2 (Ballas et al., 2005).    These 
studies suggest that repressor complexes may function as adaptable silencing modules 
that fulfill a wide range of roles depending on the transcription factors with which they 
associate.  
1.3.6.  Activity-dependent gene regulation by co-repressors 
Activity-induced activation of gene expression in neurons is best understood in the 
context of regulation of HATs and histone acetylation; however, studies of HDAC 
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inhibitor compounds and activity-regulated repressor proteins suggest that relief of 
repression is a critical component of gene regulation in the brain.  The nuclear receptor 
field has thoroughly demonstrated that co-repressor complexes can be responsive to 
signal transduction pathways.  Ligand-mediated release of NCOR co-repressor from 
nuclear hormone receptors is required to expose the transactivation domain of the 
receptor to co-activator binding (Fig. 1.5A).  In neurons, signaling is frequently 
propagated to the nucleus via the effects of calcium influx on calcium-binding proteins 
and kinase activity. The activity-regulated transcription factor MEF2 regulates in turn the 
expression of numerous neuronal genes, including Bdnf, Homer1, Egr1, and Nurr1 
(Flavell et al., 2008).  MEF2 alternates between recruitment of either the SIN3A-HDAC 
co-repressor or the co-activator p300 via a calcium dependent switching mechanism 
(Fig. 1.5B).  At rest, MEF2 transactivation is inhibited by the binding of CABIN1, a 
molecular switch that recruits the SIN3A-HDAC complex (Youn and Liu, 2000a).  In the 
presence of calcium, calmodulin binds to CABIN1 and dissociates it from MEF2, 
alleviating repression by SIN3A, and freeing the MEF2 domain to bind the co-activator/ 
HAT p300 (Youn and Liu, 2000b).  In addition to calcium-binding proteins, co-repressor 
activity can also be regulated by phosphorylation, as is the case for MECP2. 
MEPC2 has long been associated with chronic repression and maintenance of 
methylated DNA, but recent discoveries strongly suggest that both DNA methylation and 
MECP2 are dynamically regulated (Adachi and Monteggia 2014).   Recent studies 
suggest that the activity of repressor protein MECP2 is regulated by neuronal activity 
and calcium signaling (Guy et al., 2011).  At promoters with methylated CpG islands, 
MECP2 has been associated with histone deacetylation and transcriptional silencing, 
presumably through interactions with repressive SIN3A, NCOR and CoREST complexes 
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(Fig 1.5C).  Phosphorylation of MECP2 is associated with bi-directional changes in 
affinity of MECP2 for methyl-cytosine, and is reported to occur following neuronal activity 
(Chen et al., 2003; Ebert et al., 2013; Guy et al., 2011; Li et al., 2011; Tao et al., 2009).   
Interestingly, gain- and loss-of-function studies support a role for MECP2 in 
transcriptional activation at promoters lacking methylated CpG islands as a binding 
partner for cyclic AMP response element binding protein CREB; however, the function of 
MeCP2-CREB interactions in gene regulation has not yet been elucidated (Chahrour et 
al., 2008).   One could speculate about a possible role for MECP2 in recruiting an 
activating SIN3A/HDAC/SET1 complex to locally increase H3K4 methylation, but this 
hypothesis has yet to be tested (Fig. 1.5C).  Further studies of the dual roles of MEF2, 
MeCP2, and the Sin3a-HDAC complex as bidirectional regulators of transcription will 
yield important new insights into activity-dependent gene regulation, and its dysfunction 
in neurodevelopmental disorders. 
1.3.7. Co-repressors: looking forward 
Co-repressor complexes regulate chromatin structure and transcriptional regulation with 
a wide array of epigenetic modifications.  In the brain, epigenetic modifications and 
chromatin dynamics are highly plastic, and are an integral and fundamental component 
of neuronal responses to developmental and environmental signals.  Studies of 
transcription factors and regulatory factors associated with co-repressor complexes have 
uncovered evidence of highly dynamic regulation of repression by SIN3A and CoREST 
complexes in response to calcium influx, a mechanism long associated with positive 
regulators, but only recently linked to repression.   Evidence that individual co-repressors 
can fulfill a range of roles from activity-regulated repression to long-term stable silencing 
is opening up exciting new avenues for discovery.   
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Although co-repressors themselves are relatively poorly studied in the brain, many 
transcription factors and catalytic enzymes associated with co-repressor complexes 
have strong connections to neuronal function, and neurodevelopmental and cognitive 
disorders.  A recurring theme in disease models with co-repressor dysfunction is altered 
recruitment of proteins to chromatin.  All of the complexes discussed herein are involved 
in either regulation of histone or DNA methylation (NCOR, SIN3A, CoREST) or contain 
components that bind to methylated histones (NuRD) or methylated or hydroxyl-
methylated DNA (NuRD, SIN3A, CoREST).  Surprisingly, the role of these complexes as 
regulators of chromatin-binding proteins has not been well studied.   Much of what is 
known about transcriptional regulation by histone- and DNA-binding proteins came from 
studies of tumor suppressors in cancer research, but many of these same molecules are 
being identified as causative agents in neurodevelopmental disorders.  Increased 
dialogue and collaboration between the fields of neuroscience and cancer biology could 
be highly beneficial to the study of epigenetic basis of memory and synaptic function. 
 1.4.  Summary and future directions 
Cognitive deficits are a disabling feature of many neurodevelopmental and 
neuropsychiatric disorders, and are refractory to many of the available treatment options.  
Here, we discussed rodent genetic models as a key tool to uncover molecular 
mechanisms underlying cognitive deficits, and identify novel targets and strategies for 
drug discovery.  In Chapter 2, I use a gene knockout model to examine behavioral, 
cognitive and synaptic functioning in mice lacking a copy of ASD candidate gene 
Pcdh10.  One promising avenue for cognitive enhancement lies in the contributions of 
epigenetic regulatory complexes, particularly silencing complexes, as both causative 
agents and potential therapeutic targets for neurodevelopmental and neuropsychiatric 
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disorders.  In Chapter 3, I use a gene knockdown model to show that the co-repressor 
Sin3a is a negative regulator of memory formation and synaptic plasticity in mice.  
Finally, in Chapter 4, I identify limitations to a currently available conditional gene 
deletion system in rodents.  Together, these studies expand our knowledge of synaptic 
and epigenetic mechanism of memory formation, and highlight the role of synaptic 
structural proteins as key targets of genetic regulation in memory formation. 
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Chapter 1 Figure legends 
 
Figure 1.1.  Conditional targeted recombination using the Cre-loxP system.  A. 
Gene knock-in of loxP recognition sites flank the exon targeted for deletion (red).  B.  
During Cre-mediated recombination, the intervening sequence between the two loxP 
sites is arranged into a crossover configuration.  C.  Recombination event results in 
excision and repair of parent strand, and creation of a circular loop of DNA containing 
the targeted sequence. 
Figure 1.2.  Cognitive and neurostructural phenotypes in a schizophrenia mouse 
model depend on temporal pattern of transgene expression.  In mice conditionally 
overexpressing the G protein alpha S subunit, contextual memory, PPI and brain volume 
phenotypes depend on what stage of life overexpression occurred.  Contextual memory 
deficits result from developmental changes associated with overexpression in juvenile 
animals, and these deficits are stable through adulthood despite transgene suppression.  
PPI deficits persist with constitutive overexpression, but can be rescued by transient 
suppression during either development or adulthood.  Volumetric differences in the 
striatum are readily produced in animals that overexpress in adulthood.  Interestingly, 
striatal volume changes induced during overexpression in juvenile animals fail to recover 
following transgene suppression in adulthood. (adapted from Kelly et al. 2008) 
Figure 1.3.  Structure and composition of co-repressor complexes. A. Co-repressor 
complexes are composed of structural co-repressor backbones bound to epigenetic 
modifier effector proteins, and recruited to chromatin by DNA- or histone-binding 
proteins.  B.  Factors associated with NCOR, NuRD, SIN3A, and CoREST co-repressor 
complexes, including both core components and accessory co-factors. 
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Figure 1.4.  NCOR regulates long-term memory consolidation via HDAC3.  A.  Wild-
type NCOR complex binds HDAC3 and SIN3A co-repressor, and represses transcription 
of genes regulated by nuclear receptors.  B.  Mutant NCOR carries a single point 
mutation in the deacetylase activating domain (DADm) that blocks HDAC3 binding.  C.  
DADm mutant mice exhibit enhanced memory in the hippocampus-dependent object 
location memory task.  DADm mice display robust discrimination under sub-threshold 
training conditions that do not induce long-term memory in wild-type animals.  (adapted 
from McQuown et al. 2011.) 
Figure 1.5. Predicted roles for co-repressor complexes in dynamic gene 
regulation.  A.  NCOR recruits HDAC activity both directly and indirectly through 
association with the SIN3A co-repressor.  Unliganded nuclear receptors are 
transcriptionally silent, and are associated with elevate H3K9 methylation and reduced 
H3K4me and AcH3.  Ligand binding induces dissociation of NCOR and recruitment of 
the histone acetyltransferase p300.  B.  MEF2 alternates between co-repressor 
recruitment and co-activator recruitment in an activity-dependent manner.  The calcium-
responsive co-factor CABIN1 binds both MEF2 and SIN3A under basal conditions.  C.  
Methyl-DNA bound MECP2 associates with multiple co-repressors, including CoREST 
and SIN3A.  Neuronal activity-dependent phosphorylation of multiple residues on 
MECP2 alters its affinity for mC.  MECP2 can interact with CREB at promoters lacking 
DNA methylation, but positive transcriptional regulation by MECP2 has not been 
demonstrated.  One potential mechanism for positive regulation could involve SIN3A and 
the H3K4 methyltransferase SET1. 
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CHAPTER 2: MALE-SPECIFIC SOCIAL AND COGNITIVE DEFICITS IN MICE 
HAPLOINSUFFICIENT FOR PCDH10 
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Abstract  
 
Behavioral and cognitive impairments in individuals with autism spectrum disorder (ASD) 
have been attributed to abnormal neuronal connectivity in the developing brain, but the 
molecular basis of these deficits is largely unknown.  Human genetic studies have 
implicated several members of the cadherin / protocadherin superfamily of genes in 
autism spectrum disorders (ASD), including Protocadherin 10 (PCDH10), a member of 
the δ2 subfamily of non-clustered protocadherin genes.  Previous reports indicate that 
Pcdh10 plays a role in prenatal axon outgrowth, as well as synapse elimination, but its 
effects on social behavior and cognitive function, phenotypes highly relevant to ASD, are 
unknown.  Here we show that male mice lacking one copy of Pcdh10 (male Pcdh10+/- 
mice) have behavioral deficits in social approach and conditioned fear, and have 
abnormal spine morphology and impaired gamma activity in the amygdala.  Social 
deficits in Pcdh10+/- males can be rescued with acute treatment with the NMDAR partial 
agonist d-cycloserine.  Our studies reveal that Pcdh10+/- mice have male-specific 
synaptic and behavioral deficits consistent with amygdala dysfunction, and establish 
Pcdh10+/- mice as a novel genetic model for investigating structural and behavioral 
changes relevant to ASD.  
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2.1 Introduction 
 
Reduced tendency to seek out and engage in social interactions is a highly disabling and 
treatment refractory core feature of autism spectrum disorders (ASD) that disrupts 
growth of social cognition and social skills during the sensitive developmental period of 
childhood (Dawson et al., 2002; Jones et al., 2008; Chevallier et al., 2012).  The genetic 
and neurobiological bases of impaired sociability in ASD are both diverse and poorly 
understood, but multiple lines of evidence from structural imaging, post-mortem brain 
analysis, and genetic risk genes point to abnormal synaptic connectivity as a key 
neurobiological feature of ASD that may underlie both social and cognitive impairments 
(Bakhtiari et al 2012, Wolff et al. 2012, Irwin et al. 2001, Gilman et al. 2011).  Human 
linkage studies have identified multiple ASD-associated genes that are implicated in the 
structure and function of neuronal synapses (Toro et al. 2010, Gilman et al. 2011, 
Morrow et al. 2008).  Accumulating evidence has strongly implicated variants in the 
cadherin and protocadherin superfamily of calcium-dependent neural cell adhesion 
molecules genes in ASD (O'Roak, 2012, Camacho, 2012).  Deletions affection the 
protocadherin 10 gene Pcdh10 and the regulatory region near Pcdh10 have been 
associated with ASD, suggesting that it may play a role in the pathophysiology of the 
disorder (Morrow et al., 2008; Bucan et al., 2009).   
 
PCDH10, also known as OL-protocadherin, is a member of the δ2 subfamily of non-
clustered protocadherins is highly expressed in the brain (Kim et al. 2011, Hirano et al. 
1999).  Pcdh10 is an activity-regulated gene expressed throughout much of the 
postnatal mouse brain, with high levels of expression in olfactory and limbic regions,  
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including the basolateral amygdala (Hirano et al., 1999; Aoki et al., 2003).  In neurons, 
PCDH10 functions in a molecular pathway with Fragile X mental retardation protein 
(FMRP) and myocyte enhancer factor 2 (MEF2), to regulate the stability of the post-
synaptic density following neuronal activity (Tsai et al 2012).  FMRP binds Pcdh10 
mRNA transcripts and transports them to the synapse (Dictenberg et al. 2008, Tsai et al. 
2012).  At the synapse, PCDH10 has been linked to both spinogenesis and synapse 
elimination.  A synaptic transmembrane protein, PCDH10 interacts with Nck-associated 
protein 1 (Nap1) to recruit the WAVE actin polymerization complex, a mechanism that 
has been linked to lamellipodia extension and spinogenesis in neurons (Nakao Takeichi 
2010 and Pilpel and Segal 2005).  Following neuronal activity, PCDH10 facilitates 
proteosomal degradation of postsynaptic density protein 95 (PSD-95) and is required for 
MEF2-induced synapse elimination (Tsai et al., 2012).  The role of PCDH10 in regulating 
spine dynamics downstream of FMRP supports the intriguing idea that synaptic 
abnormalities observed in Fragile X syndrome, which often has an ASD-like phenotype, 
might be attributed in part to effects of FMRP loss on the trafficking and regulation of 
PCDH10.   
 
Here we use a gene knockout mouse model to investigate the role of Pcdh10 in 
modulating social behavior, cognition, and connectivity phenotypes relevant to ASD.  We 
demonstrate a role for Pcdh10 as a regulator of social and cognitive functioning, which 
likely exerts its effects through modulation of synaptic connectivity in the amygdala.  
2.2 Methods 
Animal Housing 
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All mice were cared for in accordance with the National Academy of Sciences Guide for 
the Care and Use of Laboratory Animals and all animal procedures were approved by 
the University of Pennsylvania Institutional Animal Care and Use Committee 
(IACUC).Pcdh10+/-mice in which the first exon of Pcdh10 had been replaced with a lacZ-
neo selection cassette were obtained from Shinji Hirano and Masatoshi Takeichi (Kochi 
Medical School and RIKEN Center for Developmental Biology, Japan) (Uemura et al., 
2007).  The mice had been backcrossed to a C57BL/6N genetic background for more 
than 15 generations (personal communication from Shinji Hirano).  Male Pcdh10+/- mice 
were crossed with female C57BL/6J (B6) mice, to generate wild-type (Pcdh10+/+) or 
heterozygous null (Pcdh10+/-) offspring.  The mouse line was maintained by consecutive 
generations of crossing Pcdh10+/- males with B6 females.  The mice that underwent 
behavioral testing were the offspring of at least two consecutive backcrosses to 
C57BL/6J.  Same-sex littermates were weaned into group-housing with 2 - 5 per cage in 
a temperature and humidity controlled environment in a 12-hour light-dark cycle.  All 
mice had access to food and water ad libitum.  Behavioral testing and tissue collection 
were conducted during the light phase.  
Behavior  
Social Approach Test (SAT).  Naïve mice underwent the SAT, a test of sociability 
(tendency to seek social interaction) in a 3-chambered apparatus in a darkened 
behavioral testing room, using methods described previously (Fairless et al., 2012). The 
two end chambers of the testing apparatus, separated by a middle chamber, each 
contained an empty, transparent, perforated Plexiglas cylinder. For the initial 10 minutes 
of the SAT, each Pcdh10+/- or wild-type test mouse was allowed to freely explore the 
three chambered apparatus (Phase 1).  Following this habituation phase, a non-social 
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stimulus (paperweight) was placed into one cylinder and a social stimulus mouse (an 
adult male A/J that had been gonadectomized prior to 4 weeks of age and had been 
habituated to being in the cylinders on 3 previous, consecutive days) was placed 
simultaneously in the other cylinder and the test mouse was allowed to explore the 
apparatus and cylinders for the next 10 minutes (Phase 2). Immediately following Phase 
2, the cylinders were removed so that the test mouse could freely interact with the 
stimulus mouse and the paperweight for 10 minutes (Phase 3).  The time that each test 
mouse spent in each chamber and spent in sniffing each cylinder, as well as the 
distance each mouse traveled was scored in each Phase, using the automated 
behavioral analysis system, TopScan (CleverSysInc, Reston, VA, USA) (Fairless et al., 
2011).  Within each sex, time spent sniffing the cylinders was compared using repeated 
measures analysis of variance (rmANOVA).  ANOVA interactions that were p < 0.05 
underwent post hoc tests (Bonferroni-Dunn).   
 
Olfactory habituation-dishabituation. This test of ability to detect and differentiate odors 
(Yang and Crawley, 2009) was performed under infrared lighting in an otherwise 
darkened room.  Mice were allowed to acclimate for 30 minutes to a clean testing cage, 
and then were presented with a sequence of different odorant-dipped cotton swabs that 
were lowered into the cage for 2 min each, with 1 min intervals between presentations of 
swabs.  The order of odorants presented--each presented 3 consecutive times--was the 
following:  water, almond, vanilla, soiled mouse bedding from an unfamiliar same-sex 
mouse, soiled mouse bedding from an unfamiliar opposite sex mouse.  The time that the 
test mouse spent sniffing each swab was measured. 
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Fear conditioning.  Animals were singly housed one week prior to training, and 
conditioned as previously described (Hawk et al., 2011).  Briefly, animals were handled 2 
min per day for three consecutive days, followed by a single training session in enclosed 
rectangular conditioning chambers.  Contextually conditioned animals were exposed to 
the conditioning context for 148 s, followed by a 2 s 1.5mA footshock.  Cue conditioned 
animals were exposed to the context for 120s, a 60 dB tone was presented for 30s, 
which co-terminated with a 2 s 1.5mA footshock.  Animals were removed from the 
chambers 30s after receiving the footshock, and tested for memory retention after 24 
hrs.  Contextually conditioned animals were returned to the training context for a single 5 
min context test.  Cue conditioned animals were tested in a new room and were placed 
in a novel round or triangular chambers with solid floors and a novel odorant (lemon dish 
soap) for 3 min of exploration (pre-CS) followed immediately by 3 min conditioned cue 
presentation (CS).  Training and test sessions were recorded and freezing behavior was 
measured using automated scoring software (Clever Systems, Reston, VA, USA). 
 
Open field.  Naïve group housed mice were exposed to a 41 x 41 cm white open field 
(San Diego Instruments, San Diego, CA, USA) for 30 min as previously described (Kelly 
et al., 2008).  Horizontal ambulatory activity was calculated for center (greater than 5cm 
from apparatus wall) and peripheral (within 5cm of apparatus wall) zones.  For center, 
periphery and total movement, each sex was separately compare by genotype using an 
unpaired two-tailed t-test. 
 
Elevated zero maze test.  The Plexiglas zero maze had a width of 2 inches and outside 
circumference of 79 inches.  It consisted of open quadrants and two closed quadrants.  
In this test of anxiety-like behavior (Tarantino et al., 2000), each mouse was allowed to 
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investigate the apparatus for 5 minutes.  The Viewpoint Tracking System was used to 
calculate time spent in the open quadrants vs. in the closed quadrants and numbers of 
transitions between the quadrants.  Genotypes were compared using one-way ANOVA. 
 
Accelerating rotarod. To assess motor coordination and balance, mice were placed on a 
turning rotarod that accelerated from 0 to 40 revolutions per minute over the course of 5 
minutes (Crawley, 2007).  Each trial ended when the mouse fell off of the rotarod to a 
table top several inches below or when 5 minutes elapsed.  There were 10 consecutive 
trials, with 5 minute inter-trial intervals.  Time that each mouse remained on the rotarod 
in each trial was measured.  Genotypes were compared across training using repeated 
measures ANOVA. 
 
Novel object recognition.  Group housed mice were trained and tested as previously 
reported (Oliviera et al, 2010).  Briefly, mice were handled for 2 min per day for 3 
consecutive days, followed by five consecutive days of 5 min habituation sessions in the 
empty experimental arena.  On training day, animals were exposed to two identical 
objects placed near the center of the arena and allowed to freely explore the objects for 
15 min.  Twenty-four hours after training, one familiar object explored during training and 
one novel object was placed in the arena and animals were allowed to explore the 
objects for a single 15 min test session. Test sessions were scored by a trained observer 
blind to the genotypes of the animals for exploratory sniffing in which the animal’s snout 
is within approximately 4mm of an object.  Preference for the novel object was 
expressed as the fraction of the total exploration time an animal spent sniffing the novel 
object.  Genotype effects for each sex were calculated using unpaired two-tailed t-tests. 
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Neuronal reconstruction and spine counts 
Male mice were sacrificed and whole brains were removed, rinsed in PBS, and Golgi 
impregnation was conducted using the FD Rapid GolgiStain kit (FD Neurotechnologies, 
Columbia, MD, USA) according to manufacturer’s instructions.  After 5 days of 
impregnation in kit solution A/B, brains were placed in solution C twice for 24hrs each.   
Brains were frozen and 100um coronal sections were taken on a cryostat.  Sections 
were mounted on gelatin coated slides and were protected from light and thoroughly 
dried at room temperature over 7 or more days.  Slides were developed according to the 
manufacturer’s instructions, and coverslipped using Permount mounting medium 
(Thermo-Fisher).   Clearly-stained amygdala neurons with visible spines were manually 
reconstructed using Neurolucida neuron tracing software (MBF Bioscience, Williston, 
VT).  Traced neurons with multiple dendrites over 140 µm in length were selected for 
spine counts.  Proximal (within 100 µm of the soma) and distal (within 100 µm of the 
terminus) dendritic regions (50 µm length) were identified on long dendrites, and all 
visible spines within the 50 µm region were manually identified and counted by type 
(Hering and Sheng 2001, Yuste and Bonhoeffer 2004).  A maximum of two dendrites 
each with proximal and distal regions were counted on each neuron.  Average spine 
counts of each type per 50 µm were calculated for each genotype.  Percent filopodial 
type was calculated as filopodial spines / total spines for each region.  
 
Electrophysiology 
VSD experiments were performed according to previous studies (Carlson and Coulter, 
2008). Following isoflurane anesthesia, mice were decapitated. The brain was extracted 
and coronal amygdalar slices 350 µm thick were cut using an Integraslice 7550 PSDS 
vibrating microtome (Campden Instruments, Lafayette, IN) in ice-cold sucrose artificial 
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cerebrospinal fluid (ACSF), in which NaCl was replaced with an equiosmolar 
concentration of sucrose.  ACSF consisted of 130 mM NaCl, 3 mM KCl, 1.25 mM 
NaH2PO4, 26 mM NaHCO3, 10 mM glucose, 1 mM MgCl2, and 2 mM CaCl2 (pH 7.2-
7.4 when saturated with 95% O2 and 5% CO2). Slices were then transferred to a static 
interface chamber (34°C) for 30 min and kept at 22- 25°C thereafter. The osmolarity of all 
solutions was 305-315 mOsm. 
 
Slices were stained for 15 min with 0.125 mg/ml (in ACSF) of the voltage sensitive dye 
di-3-ANEPPDHQ (D36801, Invitogen), and imaged in an oxygenated interface chamber 
using an 80 x 80 CCD camera recording at a 1 kHz frame rate (NeuroCCD: 
RedShirtImaging, Decatur, GA). Epi-illumination was provided by a custom LED 
illuminator. Slices were continuously bathed in ACSF. Amygdalar stimulation using burst 
of 4-40-mA, 200-ms pulses were administered with the electrode placed in the most 
dorsal region of the lateral amygdala (LA). After initial electrode placement and 
establishment of slice viability, baseline responses with control ASCF were elicited by 
either 12 burst stimulus trials, each separated by 40 s. 
 
To analyze VSD data, a data processing program was created in IGOR (Wavemetrics, 
Lake Oswego, OR). Regions of Interest (ROI) were chosen according to a standardized 
anatomy of the amygdala. The lateral amygdala (LA) was chosen to be the dorsal most 
region of the structure. This region, however, did not include the area where the 
electrode was placed to avoid including direct stimulation into the analysis. The 
basolateral amygdala (BLA) was chosen to be ventral medial to the LA. The striatum 
was chosen to be dorsal medial to the LA. Fluorescence-changes are calculated as the 
percent change in fluorescence divided by the resting fluorescence (%dF/F0). Colored 
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images were generated in IGOR on 12-trial-averages. For gamma power analysis data 
was imported into Matlab (Mathworks), and processed with the open source tool box 
(Oostenveld, Fries, Maris, & Schoffelen, 2011). Time-locked averaged data were 
transformed to time frequency space using Morlet wavelets previously used in in-vivo 
electrophysiology experiments (Gandal et al., 2010) to allow calculation of evoked 
power. To quantify changes in power, the region of the steady-state GAMMA was 
observed on the time-frequency plot, and the integral calculated of the response using in 
house scripts. 
Data analysis 
The behavioral data and structural are presented as mean ±SEM.  Statistical tests were 
conducted using SPSS (IBM, Armonk, NY) software.   
 
2.3 Results 
2.3.1  Pcdh10+/- males exhibit reduced sociability.   
To determine whether social behavior is altered in Pcdh10+/- mice, we tested male and 
female juvenile Pcdh10+/- mice and wildtype (WT) littermates in the three-chambered 
social approach task (Sankoorikal et al. 2006, Fairless et al. 2013).  Relative to male WT 
littermates, male Pcdh10+/- mice spent less time sniffing the social cylinder in the 
presence of the stimulus mouse in Phase 2 (Fig. 2.1A; rmANOVA: phase F1,26= 34.8, 
p<0.0001; genotype F1,26=8.4, p<0.01, and phase*genotype F1,26=10.4, p<0.01; 
Bonferroni post hoc wild-type by phase p<0.05, phase 2 by genotype p<0.01).  There 
were no differences in exploration of the non-social cylinder during Phase 1 or 2 by male 
mice (Fig. 2.1B; rmANOVA: phase F(1,26)=0.38 p>0.05, genotype F(1,26)=3.37, 
p>0.05).  Interestingly, there was no significant difference between female WT 
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littermates and female Pcdh10+/- mice in sniffing the social cylinder or in Phase 2 (Fig. 
2.1C, rmANOVA: genotype F(1,23)=4.2 p>0.05), nor were differences found in non-
social exploration in female mice (Fig. 2.1D; rmANOVA F(1,23)= 24.55, p<0.0001, 
Bonferroni post hoc wild-type by phase p<0.05, Pcdh10+/- by phase p<0.05).  Because 
olfactory function is critically important for social investigation in this task and Pcdh10 is 
highly expressed in the olfactory bulb, male and female Pcdh10 mice were tested for 
anosmia using the olfactory habituation-dishabituation task.  Males and females of both 
genotypes showed robust exploration in response to presentation of social and non-
social odors, and similar rates of habituation to repeated presentations (Fig.2.2, 
rmANOVA: male genotype F(1,14)=0.765 p>0.05; female genotype F(1,14)=1.8 p>0.05).  
This pattern of responses indicates that basic olfactory acuity and discrimination is intact 
in Pcdh10+/- mice.  Altogether, these data show reduced social approach and social 
sniffing behavior specifically in male Pcdh10+/- mice that is not attributable to an olfactory 
deficit. 
 
2.3.2  Impaired fear memory in Pcdh10+/- males.   
Intellectual disability affects approximately 40% of individuals with ASD and is a core 
phenotype of Fragile X syndrome particularly in males with Fragile X syndrome 
(AADDMN, Pederson et al. 2012, Brodkin 2008).  To investigate the role of Pcdh10 in 
associative learning, we tested adult Pcdh10+/- mice and WT littermates for conditioned 
fear memory.  Processing of contextual and auditory cue stimuli rely on anatomically 
distinct pathways (hippocampal, and auditory/thalamic respectively), but associative 
pairing of cue stimuli to a footshock experience requires amygdala circuitry (Phillips and 
LeDoux 1992, Muller LeDoux 1997, Marschner 2008, Goosens Maren 2001, Newton et 
al. 2004).  
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Contextual fear memory relies on both hippocampus and amygdala circuits (Phillips and 
LeDoux 1992, Kim Faneslow 1993).  When we conditioned mice to contextual cues, 
Pcdh10+/- males showed reduced freezing behavior basally prior to footshock, as well as 
upon exposure to the conditioned context (Fig.2.3A.  two-way ANOVA: phase F(1, 22)= 
99.82, p<0.001; genotype F(1,22)= 13.21, p<0.001).  By contrast, no difference in 
freezing behavior was observed in Pcdh10+/- females (Fig.2.3B.  two-way ANOVA: 
phase F(1,19)=  51.75, p<0.001).  
 
 Auditory tone cued fear memory relies on inputs from cortical/thalamic and brainstem 
auditory nuclei to the amygdala (Muller and LeDoux 1997, Rogan LeDoux 1997, Newton 
et al. 2004).  During the cued fear test, Pcdh10+/- males respond to the tone 
presentation, but have reduced freezing responses compared to wild type animals 
(Fig.2.3C.  two-way ANOVA: phase F(2,18)= 43.58, p<0.001; genotype F(1,19)= 10.13, 
p<0.01); genotype*phase F(2,18)= 3.27, p<0.05).  Pcdh10+/- females show a generalized 
reduction in freezing behavior compared to wild-type females that is not specific to tone 
presentation (Fig.2.3D.  two-way ANOVA: phase F(2,20)= 78.61, p<0.001; genotype 
F(1, 21)= 6.75, p<05; phase*genotype F(2, 20)= 1.67, p<0.2).  These results indicate 
that male Pcdh10+/- mice have impairments in cued conditioned fear that are likely to 
reflect alternations in amygdala function, given the known role of amygdala circuits in 
this learning paradigm. 
 
2.3.3  No alteration in anxiety-related behaviors or motor coordination.   
Social behavior and conditioned fear performance can be influenced by changes in 
motor function or anxiety-like behavior.  When adult Pcdh10+/-  mice were tested for 
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anxiety-like behavior and locomotor activity in the open field test, no significant genotype 
differences were observed in center or peripheral exploration, nor were differences in 
total ambulatory movements found for either sex (Fig. 2.4. unpaired t-test: center p<0.2, 
periphery p<0.3, total p<0.6).  Similarly, no differences were observed in anxiety-like 
behavior in the elevated zero maze test (Fig. 2.5A, B. one-way ANOVA: genotype males 
F(1,24)=0.275 p>0.05, females F(1,16)=0.003 p>0.05), or motor function in the 
accelerating rotarod test (Fig. 2.5C, D. rmANOVA: genotype males F(1,24)=3.4 p>0.05, 
females F(1,16)=0.404 p>0.05) in juvenile Pcdh10+/-  males or females.  Together, these 
results show a lack of basal changes in locomotor or anxiety-like behaviors in Pcdh10+/- 
mice. 
 
2.3.4  Object recognition memory is intact in Pcdh10+/- mice.   
Because the conditioned fear deficits displayed by male Pcdh10+/- mice suggest specific 
impairment in fear memory, we next explored whether the mice were impaired in a non-
fear based memory task. Object recognition memory is a relatively non-aversive 
cognitive task in which animals are allowed to explore two identical objects, followed by 
a discrimination test with one familiar object and one novel object (Oliviera, 2010).  This 
task engages perirhinal cortical circuits involved in discriminating objects using sensory 
features (Norman and Eacott, 2004; Winters and Bussey, 2005).  In this task, both male 
and female Pcdh10+/- mice were able to discriminate between novel and familiar objects 
(Fig.2.6. t-test: males p<0.8, females p<0.93).  Pcdh10+/- males and females were also 
tested in the hippocampus-dependent spatial version of the Morris water maze 
(Broadbent et al. 2006, Lattal et al. 2001).  No genotype differences were found in 
latency to find the hidden platform either during acquisition or in the probe trial, 
suggesting that hippocampal function is intact (Fig. 2.7, t-test: male wild-type p<0.03, 
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male Pcdh10+/- p<0.05; female wild type p<0.001, female Pcdh10+/- p<0.001).  These 
data suggest that Pcdh10+/- males have specific cognitive deficits affecting amygdala-
dependent fear memory circuits but not affecting hippocampal spatial memory, cortical 
recognition memory, novelty detection, or interaction with non-social objects.  
 
2.3.5  Abnormal dendritic spines in amygdala of Pcdh10+/- males. 
Both social approach and cued fear tasks strongly engage amygdala circuits, and are 
impaired in Pcdh10+/- males (Rogan LeDoux 1997, Felix-Ortiz and Tye 2014, Marschner 
2008).  Because Pcdh10 has been linked to spine elimination, we hypothesized that the 
behavioral deficits we observe may be related to changes in spine density in the 
amygdala of Pcdh10+/- mice.  To visualize amygdala dendrites and spines, brains from 
wild-type and Pcdh10+/- males were stained using Golgi impregnation.  When dendritic 
arbors were reconstructed (Fig. 2.8A) and spines counted (Fig. 2.8B), there was no 
significant genotype effects on the number of dendrites or branch points (Fig. 2.8C. 
unpaired t-test: dendrites p<0.24, branches p<0.79), but spine density was increased in 
Pcdh10+/- dendrites (Fig. 2.8D. unpaired t-test: p<0.03).  When we separated spines into 
categories by morphological characteristics (Hering and Sheng 2001, Yuste and 
Bonhoeffer 2004), we found that Pcdh10+/- dendrites contain a higher percentage of thin, 
elongated filopodia-like spines compared to wild-type dendrites (Fig. 2.8E. unpaired t-
test: p<0.04).  The change in spine density in Pcdh10+/- dendrites appears to be driven 
primarily by the increased number of filopodial-type spines, an immature spine 
morphology (Ziv and Smith 1996, Petrak et al. 2006) and to a lesser extent by increased 
mushroom-type spines (Fig. 2.9. unpaired t-test: filopodia p<0.003, mushroom p<0.05).   
 
2.3.6  Reduced LA-BLA transmission of gamma coherence in Pcdh10+/- slices. 
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White matter structural changes observed in schizophrenia and ASD are thought to 
underlie changes in functional connectivity and temporal binding of regional brain 
activity, particularly in the gamma frequency range (Ye et al. 2014, Wolff et al. 2012, 
Wilson et al. 2007, Gandal et al. 2010, Khan et al. 2013).  Alterations in gamma activity 
in the amygdala have been linked to impairments in social cognition and fear processing 
(Das et al. 2007, Williams et al. 2009). To determine whether functional connectivity is 
altered in Pcdh10+/- amygdala circuitry, voltage sensitive dye was used to optically 
record the transmission of stimulation-evoked activity from lateral amygdala to its 
functional targets.  The lateral amygdala was stimulated at gamma frequency and 
spread of evoked response, or changes in fluorescence, to neighboring basolateral 
amygdala (BLA) and ventral caudate (STR) was imaged (Fig. 2.10A).  Peak evoked 
responses and gamma-band activity in the BLA and STR were analyzed.  Evoked 
responses in BLA and STR regions of interest (Fig. 2.10B) were analyzed for peak 
response amplitude, and gamma-band activity.  No differences were found in the 
amplitude of responses in amygdala or striatal regions (Fig. 2.10C); however, Pcdh10+/- 
slices showed significant reduction in BLA high-frequency gamma power (Fig. 2.10D, E).  
Interestingly, the impairment in gamma transmission was limited to LA-BLA connections, 
and no differences were found in gamma responses in the striatum.  These results 
provide further evidence suggesting that abnormal synaptic and network connectivity 
amygdala circuits involving the basolateral amygdala underlie the impairments in social 
behavior and fear learning observed in Pcdh10+/- males. 
 
2.3.7  Rescue of social deficits in Pcdh10+/- males with NMDAR activation. 
Impaired social behavior and reduced gamma frequency responses have been 
described in mouse models with reduced NMDAR expression (Meilnik et al. 2014, 
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Gandal et al. 2012). One therapeutic agent that has shown promise in improving 
sociability in both animal models and human individuals with ASD is the NMDAR partial 
agonist d-cycloserine (dCs) (Posey et al. 2004, Burket et al. 2013, Deutsch et al. 2012).  
To determine this NMDAR partial agonist could rescue sociability in Pcdh10+/- mice and 
WT littermates were treated with an acute, systemic injection of saline or dCs 30 min 
prior to social approach testing. Treatment with dCs rescued the deficit in social sniffing 
seen in Pcdh10+/- males (Fig. 2.11A), but had no effect on social sniffing in wild-type 
littermates.  Exploration of the non-social cylinder (Fig. 2.11B) and locomotor activity 
(Fig. 2.11C) were not affected by dCs in Pcdh10+/- mice and WT littermates, indicating 
that dCS treatment did not elicit non-specific changes in exploratory behavior or 
locomotor output. 
 
2.4  Discussion  
Social and cognitive deficits are major behavioral phenotypes of autism spectrum 
disorder as well as Fragile X syndrome but the neural circuitry and molecular changes 
underlying these phenotypes are not fully understood. Reduced expression of Fragile X 
protein FMRP disrupts trafficking and translation of mRNAs encoding multiple synaptic 
structural and functional proteins, including Protocadherin 10.  Here we showed that 
male mice lacking a single copy of Pcdh10 exhibit reduced social approach behavior and 
associative fear learning, as well as altered structure and function of synaptic 
connections in the amygdala.   
2.4.1  Behavioral deficits in Pcdh10+/- males implicate amygdala dysfunction 
Behavior and cognitive phenotypes in Pcdh10+/- males are remarkably limited to reduced 
social approach and investigation, as well as deficit in cued fear conditioning. Male 
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Pcdh10+/- mice exhibit profound impairments in the social choice task, showing similar 
exploratory behavior toward empty cylinders compared to cylinders containing a live 
mouse. Reduced social approach behavior has been observed in multiple genetic and 
environmental models of ASD (Peca et al. 2011, Penagarikano et al. 2011, Ehninger et 
al. 2010, Kirsten et al. 2010), but interpretation of this behavior has frequently been 
complicated by accompanying changes in locomotor activity (Penagarikano et al. 2011) 
and anxiety-like behaviors (Peca et al. 2011).  Despite robust expression of Pcdh10 in 
striatal and BLA regions, locomotor activity, anxiety like behavior are not altered in 
Pcdh10+/- males.  Inputs from the BLA to ventral hippocampus and from VTA to Nucleus 
accumbens (N.Acc) have been proposed as a key pathways likely mediating negative 
and positive modulation of social behaviors in mice respectively (Felix-Ortiz and Tye 
2013, Gunaydin et al. 2014).  Inputs from NAcc to BLA have been identified as key 
modulators of reward seeking behavior (Ciano and Everitt 2004), supporting the role of 
the BLA as a central regulator of emotional valence during social interactions.  Further 
dissection of the functional circuitry underlying amygdala and striatal regulation of social 
approach behavior is needed to gain a more complete understanding of the roles these 
regions play in social motivation and social avoidance behaviors. 
Intellectual disability is a principal feature of Fragile X syndrome, and is often present in 
individuals with ASD (AADDMN, Pederson et al. 2012, Brodkin 2008).  Pcdh10+/- males 
exhibit memory impairments that are strikingly specific to associative fear conditioning.  
Both cued and contextual fear conditioning tasks rely on BLA integration of aversive 
stimuli with predictive cues (contextual features, auditory tone, odors) for associative 
learning (Phillips and LeDoux 1992, Muller et al.1997, Marschner 2008, Goosens et al. 
2001).  The presence of male specific deficits in both types of associative fear learning 
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strongly implicates BLA dysfunction, as it is a common neuroanatomical substrate for 
both tasks.  The absence of impairment in object recognition and spatial water maze 
tasks furnish additional support for regional specificity of the cognitive deficits. 
 
2.4.2  Structural and functional connectivity impaired in the amygdala. 
Alterations in maturation of synaptic connections and organization of major white matter 
tracts have been observed in the brains of individuals with ASD both developmentally 
and in adulthood (Bakthiari et al. 2012, Wolff et al. 2012, Hutsler et al. 2010).  Dendritic 
spine processes are dynamic, highly plastic structures with structural and functional 
properties that are highly dependent on neuronal activity (Leuner and Shors 2004, 
Matsuzaki et al. 2004).   We show that amygdala neurons from adult male Pcdh10+/- 
mice have increased spine density, and that this effect largely reflects an increase in 
long filamentous spines.  Dendrites with a dense covering of long, thin filopodia-type 
spines have been described in adult neurons from individuals with Fragile X syndrome 
and Fmr1 KO mice (Irwin et al. 2001, Comery et al. 1997), but it is unclear whether 
increases in spine density and immature filopodia-type spines seen in adults reflect 
lingering circuit-level effects of aberrant spine maturation and pruning during 
development, or are driven by ongoing disruption of homeostatic regulation of spine 
function.  Future studies of the role of Fmr1 and Pcdh10 in regulation of synaptic 
structure and function in adult neurons are needed to address these open questions. 
 
Increased spine density and extension of filopodial processes has been observed with 
pharmacological and genetic manipulations that impair synaptic plasticity, synaptic 
transmission, or acutely block NMDAR activity (Chen et al. 2014, Petrak et al. 2005, Lin 
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and Constantine-Paton. 1998).   Elongation of spine necks is correlated with reduced 
charge transfer between spine head and the parent dendrite (Harris and Stevens 1989), 
suggesting that long filamentous spines are less effective at synaptic transmission.  In 
amygdala slices from Pcdh10+/- males, we observed impaired transmission of the high-
frequency gamma activity from LA to BLA.  EEG and MEG studies in human subjects 
have linked deficits in evoked amygdala gamma oscillations to impaired social cognition 
and fear association (Das et al. 2007, Williams et al. 2009).  Reduced evoked gamma 
activity has been observed along with social and cognitive deficits in mice with reduced 
NMDAR activity (Gandal et al. 2012).  In Pcdh10 males, enhancing activation of 
NMDARs with the glycine site agonist dCS rescued the social approach deficit observed 
in juvenile mice.  Together, these results suggest that reduced synaptic efficacy, 
particularly in the amygdala, underlie the behavioral deficits we observe in Pcdh10+/- 
males. 
 
2.4.3  Sex differences are an important feature of ASD models. 
A striking feature of this study is the stark sex difference observed in social and cognitive 
functioning. ASD is more common in males than females, but the basis of this sex 
difference in susceptibility is poorly understood (Werling and Geschwind 2013, Baron-
Cohen et al. 2011).  X-linked disorders, such as Fragile X, predictably show strong sex 
differences, but the majority of ASD-associated genes, including Pcdh10, are autosomal 
(Morrow et al.2008, State and Sestan 2012).  These differences raise intriguing 
questions about the nature of sex differences, particularly in disorders with early, pre-
pubertal onset (Wolff et al. 2012, Hartley and Sikora 2009).  Two prevailing theories for 
molecular sources of sex differences (sex-linked genes and exposure to sex hormones) 
represent related but distinct opportunities for gene x gene and gene x environment 
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(hormone) interactions.  Organizational effects of the pre-natal testosterone surge on the 
brains of male fetuses represent an early window for neuroendocrine effects on neural 
development (Lutchmaya et al. 2002, Knickmeyer and Baron-Cohen 2006).  In rodents, 
male pups undergo a surge in testosterone around birth that organizes sexually 
dimorphic effects on both behavior and brain structures (Isgor and Sengelaub 1998, 
Olioff and Stewart 1978, Handa et al. 1985).  Despite the prominent sex differences in 
ASD incidence and the large body of knowledge on sex differences in neuronal structure 
and behavior in rodent models, studies of sex differences in rodent ASD models are 
surprisingly limited.  Exploration the existence of sex differences in ASD models along 
with studies of their molecular and genetic underpinnings, will be critical steps toward 
understanding of the nature and source of the male predominance ASD, and ultimately 
provide clues to a powerful source of resilience.   
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Chapter 2 Figure Legends 
 
Figure 2.1.  Male-specific reduction in social approach behavior in juvenile 
Pcdh10+/- mice.   A. Social exploration is impaired in juvenile male Pcdh10+/- mice and 
wildtype (WT) littermates (rmANOVA: Phase- F(1,26)= 34.8, p<0.0001; Genotype 
F(1,26)=8.4, p<0.01, and phase*genotype F (1,26)=10.4, p<0.01). Wild-type males, but 
not Pcdh10+/- males, spent more time sniffing the social cylinder containing the novel 
mouse in Phase 2 than the empty cylinder in Phase 1 (*Bonferroni post hoc:  p<0.05). 
Pcdh10+/- males spent less time sniffing the social cylinder during Phase 2 than wild-type 
males (+Bonferroni post hoc p<0.01).  B. No difference in exploration of a novel object by 
wild-type and Pcdh10+/- males during either Phase 1 or Phase 2 (rmANOVA, no main 
effect of time F(1,26)=0.38 p>0.05, no main effect of genotype F(1,26)=3.37, p>0.05).  
C. No difference in social exploration in juvenile wild-type and Pcdh10+/- females. Both 
genotypes display increased exploration of the social cylinder in Phase 2 compared to 
Phase 1 (rmANOVA F(1,23)= 24.55, p<0.0001, * Bonferroni post hoc p<0.05).  D. No 
difference in exploration of a novel object by wild-type and Pcdh10+/- females during 
either Phase 1 or Phase 2 (rmANOVA, no main effect of genotype F(1,23)=4.2 p>0.05). 
Figure 2.2.  Olfactory habituation dishabituation in juvenile Pcdh10+/- and WT mice. 
A. Juvenile male wild-type (n=13) mice do not show a significant difference in sniffing 
times when compared with Pcdh10+/-  (n=13) males (rmANOVA: trial F(1,14 = 52.9,  
p>0.05), nor they do not show a significant difference between groups when exposed to 
the odor stimuli (rmANOVA: genotype F(1,14)=0.765 p>0.05 not significant).  B.  Both 
juvenile female WT (n=9) and Pcdh10+/- (n=9) mice show an overall change in sniffing 
times (rmANOVA: trial F(1,14 = 26.7, p<0.001); however they do not show a significant 
60 
 
difference between groups when exposed to the odor stimuli (rmANOVA: genotype 
F(1,14)=1.8 p>0.05 not significant). 
Figure 2.3.  Male-specific deficits in conditioned fear memory in Pcdh10+/- mice.  
A. Pcdh10+/- males exhibited reduced freezing when tested 24hrs after contextual fear 
conditioning (two-way ANOVA: phase F(1, 22)= 99.82, p<0.001; genotype F(1,22)= 
13.21, p<0.001).  B.  Both WT and Pcdh10+/- females exhibited high levels of freezing 
when tested in the conditioned context (two-way ANOVA: phase F(1,19)=  51.75, 
p<0.001).  C. Pcdh10+/- males showed reduced freezing to the tone compared to wild-
type littermates when tested for tone cued fear 24hrs after conditioning (two-way 
ANOVA: phase F(2,18)= 43.58, p<0.001; genotype F(1,19)= 10.13, p<0.01); 
genotype*phase F(2,18)= 3.27, p<0.05).  D.  Pcdh10+/- females exhibit a general 
reduction in freezing in the cued fear task (two-way ANOVA: phase F(2,20)= 78.61, 
p<0.001; genotype F(1, 21)= 6.75, p<05; phase*genotype F(2, 20)= 1.67, p<0.2). 
Figure 2.4.  No differences in anxiety or locomotor behaviors in Pcdh10+/- mice.   
A. No differences in spontaneous locomotor activity, or in exploration of center and 
peripheral regions of the open field by adult Pcdh10+/- males (t-test: center p<0.2, 
periphery p<0.3, total p<0.6).  B.  No difference in locomotor activity or center or 
peripheral exploration by adult Pcdh10+/- females (t-test: center p<0.2, periphery p<0.9, 
total p<0.5) 
Figure 2.5.  Juvenile Pcdh10+/- mice show no differences in anxiety-like behavior 
or motor function.  A. Elevated Zero maze. There is no significant difference in the 
percent of time juvenile male WT (n=13) or Pcdh10+/-  (n=13) spent in closed or open 
arms in the elevated zero maze (one-way ANOVA (1,24)=0.275 p>0.05 not significant).  
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B. There is no significant difference in the percent of time juvenile female WT (n=9) or 
Pcdh10+/-  (n=9) spent in closed or open arms in the elevated zero maze (one-way 
ANOVA (1,16)=0.003 p>0.05).  C. No significant differences in performance of male 
juveniles on the accelerating rotarod (rmANOVA: genotype F(1,24)=3.4 p>0.05).  D. 
There is no significant difference between juvenile female WT (n=9) and Pcdh10+/- 
(n=9) mice in latency to fall from the rotarod (rmANOVA: genotype F(1,16)=0.404 
p>0.05). 
Figure 2.6.  Object recognition memory is intact in Pcdh10+/- mice.  A. No 
difference in novel object recognition in male Pcdh10+/- mice (t-test: p<0.8).  B.  No 
difference in object recognition memory in female Pcdh10+/- mice (t-test: p<0.93).  
Figure 2.7.  Spatial navigation memory in the water maze is intact.  No differences 
in latency to locate the hidden platform in male (A) or female (B) Pcdh10+/-  mice during 
acquisition of the spatial water maze.  Both male (C) and female (D) Pcdh10+/-  mice 
show significant preference for the target quadrant (formerly containing the platform) and 
reduced preference for the quadrant opposite the target during the probe trial (t-test: 
male wild-type p<0.03, male Pcdh10+/- p<0.05; female wild type p<0.001, female 
Pcdh10+/- p<0.001). 
Figure 2.8.  Increased filopodia-type spines on amygdala neurons of Pcdh10+/- 
males.  A. Representative dendritic reconstructions from amygdala neurons from wild-
type and Pcdh10+/- males.  B. Representative dendritic lengths from BLA neurons from 
wild-type and Pcdh10+/- males.  C.  No difference in number of dendrites or dendritic 
branch points in Pcdh10+/- neurons (t-test: dendrites p<0.24, branches p<0.79).  D. 
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Increased spine density in Pcdh10+/- dendrites (t-test: p<0.03).  E.  Increased filopodia-
type spines in Pcdh10+/- dendrites (t-test: p<0.04).  
Figure 2.9.  Change in spine density is driven by increases in filopodia and 
mushroom type spines. A. Average number of spines counted in each morphological 
category in 50um regions of wild-type and Pcdh10+/- amygdala neurons.  Significant 
increases in mushroom type (ttest: p<0.05) and filopodia type (ttest: p<0.003) spines 
were detected in Pcdh10+/- dendrites. 
Figure 2.10. Pcdh10+/- mice exhibit BLA-specific impairment for the transmission 
of gamma-band power, but not amplitude of EPSP.   A) Grey scale image of 
amygdala coronal slice showing the lateral amygdala (LA), basolateral amygdala (BLA) 
and striatum (STR), electrode placement and regions of interest. Color images show 
peak VSDi responses following direct stimulation of the LA amygdala in slices from wild-
type and Pcdh10+/- males. B) Kinetics of fluorescence changes in response to 4 stimuli 
at 40Hz over time are shown from ROIs in the BLA and STR. Traces from wild-type mice 
are shown in black and Pcdh10+/- are shown in red. C) The lack of peak differences in 
these representative traces are reflected in the group data (n=5).  D) In contrast, taking 
the integral of the gamma-band response (30-50Hz) over time in both BLA and STR, 
showed specific reduction in the ability of the BLA to mount a gamma-band response to 
high frequency LA activity. E) This is specific to the LA -> BLA circuit, as functional 
connectivity to the striatum remains unaffected (bottom). 
Figure 2.11.  NMDAR agonist d-cycloserine rescues social impairment in Pcdh10+/- 
males.  A. Social exploration is improved in juvenile Pcdh10+/- males after acute d-
cycloserine (dCS, 32mg/kg) treatment. Both genotypes show a significant increase in 
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exploration of the social cylinder during Phase 2 when it contains a novel mouse, 
compared Phase 1 when it is empty (rmANOVA, main effect of phase F(1,34= 186.2, 
p<0.0001). During Phase 2, acute dCS treatment increases social exploration in 
Pcdh10+/- males (Pcdh10+/- saline n= 9 vs. Pcdh10+/-  dCS n=9, Bonferroni Dunn post hoc 
p=0.01) but does not alter exploration in wild-type males.  B. Treatment with dCS does 
not alter exploration of the non-social cylinder.  C. Locomotor activity is not altered by 
dCS treatment.  During Phase 2, exposure to the social and non-social stimuli reduces 
locomotor activity in both wild-type and Pcdh10+/-  males (rmANOVA, significant main 
effect of phase, F (1,34)=82.9, p<0.001). However, there is no significant difference in 
locomotor activity between juvenile wild-type and Pcdh10+/-   males treated with saline or 
dCS 32mg/kg (rmANOVA, main effect of genotype F (1,34)=6.5 p=0.02, no significant 
interaction genotype*treatment (F1,34)=1.3, p>0.05). 
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CHAPTER 3: THE TRANSCRIPTIONAL CO-REPRESSOR SIN3A REGULATES 
HIPPOCAMPAL SYNAPTIC PLASTICITY VIA HOMER1/MGLUR5 SIGNALING 
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Abstract 
Long-term memory depends on the control of activity-dependent neuronal gene 
expression, which is regulated by epigenetic modifications.  The epigenetic modification 
of histones is orchestrated by the opposing activities of two classes of regulatory 
complexes: permissive co-activators and silencing co-repressors.  Much work has 
focused on co-activator complexes, but little is known about the co-repressor complexes 
that suppress the expression of plasticity-related genes.  Here, we define a critical role 
for the co-repressor SIN3A in memory and synaptic plasticity showing that post-natal 
neuronal deletion of Sin3a enhances hippocampal long-term potentiation and long-term 
contextual fear memory. SIN3A regulates the expression of a specific set of genes 
encoding proteins in the post-synaptic density.  Loss of SIN3A increases expression of 
the synaptic scaffold Homer1, alters the mGluR1α- and mGluR5-dependence of long-
term potentiation, and increases activation of extracellular signal regulated kinase (ERK) 
in the hippocampus after learning.  Our studies define a critical role for co-repressors in 
modulating neural plasticity and memory consolidation and reveal that Homer1/mGluR 
signaling pathways are central molecular mechanisms for memory enhancement. 
3.1 Introduction 
Long-term memory consolidation and hippocampal long-term potentiation depend on 
activity-dependent neuronal gene expression, which is in turn regulated by epigenetic 
mechanisms such as post-translational histone modification (Fischer, Sananbenesi, 
Mungenast, & Tsai, 2010; Peixoto & Abel, 2013). Histone acetylation is associated with 
transcriptional activation, and both histone acetylation and expression of acetylation-
regulated genes are increased during memory consolidation (Levenson et al., 2004; 
Mahan et al., 2012; Maze, Noh, & Allis, 2013; Peixoto & Abel, 2013). Acetylation levels 
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are determined by the activity of histone acetyltransferase (HAT) and histone 
deacetylase (HDAC) enzymes, which are recruited to chromatin by association with co-
activator and co-repressor proteins (Guan et al., 2009; McQuown et al., 2011; Vecsey et 
al., 2007). For example, HATs such as CBP and p300 are recruited by the transcription 
factor and co-activator protein CREB in response to signaling cascades triggered by 
synaptic activity (Vo & Goodman, 2001). The CREB-CBP/p300 complex can regulate 
transcription through HAT activity as well as association with other plasticity-related 
transcription factors , and genetic studies have demonstrated critical roles for CREB, 
CBP, and p300 in memory and synaptic plasticity (Alarcón et al., 2004; Oliveira, Wood, 
McDonough, & Abel, 2007; Vecsey et al., 2007). On the other hand, HDACs and other 
histone-modifying effector enzymes are recruited by co-repressor proteins such as 
NCoR, SIN3A, MI-2 (NuRD), and CoREST (Schoch & Abel, 2014, Chapter 1.3.3). In 
neurons, co-repressors have been linked to dynamic and activity-dependent regulation 
of gene expression  and neuron-specific components of co-repressor complexes have 
also been described (Schoch & Abel, 2014), suggesting that these proteins may play a 
large role in regulating transcription-dependent plasticity. However, few studies have 
directly addressed the function of the co-repressor proteins in memory and plasticity. 
 
SIN3A is a highly-conserved co-repressor protein that is expressed throughout the brain, 
both in neuronal and in non-neuronal cells. Through its histone-interacting domain (HID), 
SIN3A recruits a core complex that includes the histone binding proteins RBAP46/48, 
stabilizing proteins SAP18/20 and SDS3, and the Class I HDAC enzymes HDAC1 and 
HDAC2 (Grzenda, Lomberk, Zhang, & Urrutia, 2009; Silverstein & Ekwall, 2005) 
(Fig.1.3). Four paired-amphipathic helix (PAH) domains mediate the binding of the 
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SIN3A-HDAC complex to numerous transcription factors, DNA binding factors, and other 
co-repressor proteins, facilitating the dynamic recruitment of SIN3A to chromatin 
(Grzenda et al., 2009; Silverstein & Ekwall, 2005). The binding partners of the SIN3A-
HDAC complex include several factors linked to neuronal function and cognition, 
including MEF2, MECP2, NCoR, REST, and CoREST(Schoch & Abel, 2014; Silverstein 
& Ekwall, 2005).  Members of the core SIN3A complex, especially HDAC2, have also 
been shown to regulate memory and plasticity (Bahari-Javan et al., 2012; Guan et al., 
2009).  These findings suggest that the SIN3A co-repressor complex is in a position to 
act as a critical regulator of neuronal function and cognition, but this co-repressor and its 
function in the mature nervous system have not been studied. 
Pharmacological inhibition of HDAC enzymes has been shown to facilitate robust 
enhancements in long-term memory  as well as in long-term potentiation(Alarcón et al., 
2004; Levenson et al., 2004; Vecsey et al., 2007). Although a number of acetylation-
regulated genes have been identified in these studies, it remains to be defined what 
downstream mechanisms mediate the enhancement of LTP and memory at the level of 
synaptic function. Similarly, while HDAC2 has been identified as a negative regulator of 
memory and plasticity in the hippocampus(Guan et al., 2009), the mechanisms by which 
it is recruited to its regulatory targets and ultimately leads to changes in synaptic function 
has received little attention. Interestingly, blocking the HDAC binding site on the co-
repressor NCOR recapitulates the effect of HDAC inhibitor drugs on object memory, 
highlighting the critical role for co-repressors in bringing epigenetic regulators to gene 
loci (McQuown et al., 2011).  Here, we address the function of co-repressors in memory 
storage and synaptic plasticity by conditionally deleting the co-repressor SIN3A in 
excitatory neurons, demonstrating a role for the SIN3A-HDAC co-repressor complex as 
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a negative regulator of memory and plasticity that exerts its downstream effects through 
the synaptic scaffold protein Homer1 and the Group I metabotropic glutamate receptors. 
3.2 Methods  
Mice 
Mutant mice with a forebrain-specific deletion of Sin3a were generated by crossing mice 
homozygous for a loxP-flanked exon 4 of the Sin3a gene (Sin3aL/L)(Dannenberg et al., 
2005) with mice carrying the CaMKIIα-Cre transgene (L7ag#13) (Dragatsis & Zeitlin, 
2000) and heterozygous for a loxP-flanked exon 4 of Sin3a (CaMKIIα-Cre; Sin3a+/L) to 
produce CaMKIIα-Cre; Sin3aL/L (Sin3aNH) mice and control littermates. Deletion and 
premature stop codons were confirmed in cDNA from Sin3aNH hippocampus by PCR 
across the deletion site using the following primers- Exon 2 F: 
CAGCAGTTTCAGAGGCTCAAG and Exon 6 R: GGGCATACACCTCTTGCTCA.  
Amplified products were separated by gel electrophoresis, purified, and sequenced.  In 
Sin3aNH, a full length Sin3a product and a single recombined Sin3a product were 
identified (data not shown).   All genotypes produced from this mating were examined in 
fear conditioning. No differences were observed among genotypes with the exception of 
Sin3aNH mice, so all other genotypes were grouped for controls in the presented data. 
Experimenters were blind to the genotypes of the mice during collection of behavioral 
and electrophysiological data. CaMKIIα-Cre line L7ag#13 expresses Cre recombinase 
throughout the forebrain including the hippocampus, cortex, and amygdala with the 
majority of recombination occurring postnatally(Dragatsis & Zeitlin, 2000). These 
Sin3aNH mice were produced after more than 6 generations of backcrossing of the loxP-
flanked Sin3a allele and more than 9 generations of backcrossing the CaMKIIα-Cre 
transgene into C57BL/6J. 
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Genotyping was performed using PCR with allele-specific primers. To identify mice 
bearing floxed alleles of the Sin3a gene, PCR was performed with the following primers: 
3A-4 5’-AGC CAG CCC TGA GAC TAG TGA TAA AC-3’, 3A-6: 5’-GGG GGA ATG CTG 
TGT TTT AGG TAT G-3’. PCR reactions were performed using RedExtract-N-Amp 
(Sigma, R4775) with the following thermal cycles parameters: 94° C for 15 min, [94° C 
for 30 s, 55° C for 30 s, 72° C for 30 s] x 50 cycl es, 72° C for 10 min. For CaMKII-Cre 
genotyping, PCR was performed with the following primers: Cre1 5’-CTG CCA CGA 
CCA AGT GAC AGC-3’, Cre2 5’-CTT CTC TAC ACC TGC GGT GCT-3’, Bglob1 5’-CCA 
ATC TCC TCA CAC AGG ATA GAG AGG GCA GG-3’, Bglob2 5’-CCT TGA GGC TGT 
CCA AGT GAT TCA GGC CAT CG-3’. Thermal cycling parameters were as follows: 94° 
C for 3 min, [94° C for 45 s, 61° C for 45 s, 72° C  for 60 s] x 30 cycles, 72° C for 10 min. 
 
Mice were maintained under standard conditions consistent with National Institute of 
Health guidelines for animal care and use, and were approved by the Institutional Animal 
Care and Use Committee of the University of Pennsylvania.  Mice were maintained on a 
12 hr light-dark cycle and provided with food and water in their home cages ad libitum.  
Animals were group housed in cages of 2-5 littermates except for fear conditioning 
experiments.  For fear conditioning, animals were moved from group housing to single 
housing 1 week prior to training.  Behavioral testing, tissue collection, and 
electrophysiology were conducted on 2-6 month old male and female animals during the 
light portion of the cycle.  
Immunoblots 
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Hippocampal lysation and immunoblotting were conducted as previously described 
(Hawk et al., 2012).  Mice were cervically dislocated, and hippocampi were quickly 
dissected and flash frozen on dry ice.  Hippocampi were homogenized at 4° C in 500 µL 
of cell lysis solution (10 mM HEPES pH 7.9, 1 mM EDTA, 1.5 mM MgCl2, 10 mM KCl, 
1% protease inhibitor cocktail (Sigma), 1 mM DTT), and nuclei were pelleted by 20 min 
centrifugation at 1000 x g at 4° C.  Nuclear pellet s were resuspended in 100 µL of 
nuclear lysis buffer (20 mM HEPES pH 7.9, 0.2 mM EDTA, 1.5 mM MgCl2, 400 mM KCl, 
25% glycerol, 1% protease inhibitor cocktail (Sigma), 1mM DTT).  After 30 min 
incubation on ice, samples were centrifuged at 4° C  for 20 min at 1000 x g.  Protein 
concentrations of the supernatants were quantified by the Bradford method (Biorad).  
Nuclear protein samples were prepared using 20 µg fractionated protein combined with 
NuPage LDS sample buffer and 2-mercaptoethanol (Invitrogen) and incubated for 5 min 
at 100° C.  Proteins were separated on a 3-8% Bis-T ris gel (Novex, Life Technologies) 
for 1 hr and transferred to a PVDF membrane for immunoblotting.  Membrane was 
blocked with 5% milk/PBST for 2 hrs at room temperature (RT), and incubated with anti-
SIN3A (Sigma,S6695) 1:500 in 2% milk/PBST at 4° C o vernight.  Membrane was 
washed three times in PBST for 10 min and incubated with anti-rabbit HRP conjugated 
secondary antibody (sc-2004, Santa Cruz Biotechnology) 1:1000 in 2% milk/PBST for 2 
hr at RT.  After three 10 min washes in PBST, the membrane was incubated for 1 min in 
ECL  Western Blotting Detection Reagent (GE Healthcare) and developed on film.  For 
detection of β tubulin control band, antibody was removed from the blot using Restore 
Western Blot Stripping Buffer (Thermo Scientific) according to the manufacturer’s 
instructions.  The membrane was re-blocked and re-probed with anti- β tubulin antibody 
(Sigma, T4026) using the same blotting protocol. 
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Gene expression 
Hippocampal RNA was purified and cDNA was prepared as previously described (Hawk 
et al., 2012).  Following contextual conditioning, hippocampal dissections were 
performed on ice, and tissue stored in RNA Later (Qiagen) at -80° C until RNA 
extraction.  RNA was isolated by Trizol extraction and purified using an RNeasy kit 
(Qiagen) according to the manufacturer’s instructions.  RNA concentration was 
measured using a NanoDrop spectrophotometer (ThermoFisher Scientific).  Template 
cDNA was synthesized from 1 µg total RNA using the RETROscript kit (Ambion).  
Reactions were conducted at 44° C for 1 hr, heat in activated at 100° C for 10min, and 
the final products were diluted in water to a final concentration of 2 ng/µL.   Real time 
qPCR was performed on the Viia7 Real Time PCR platform (Applied Biosystems) in 5uL 
reactions consisting of 4.5 ng cDNA, 2.5 µL Fast SYBR Green master mix (Applied 
Biosystems), and 250nM forward and reverse primers.  Samples that did not amplify 
were excluded from analysis.  Values were normalized to three housekeeper genes 
(Gapdh, ActB, ActG), and relative quantification was calculated using a ∆∆Ct method as 
described previously (Vecsey et al., 2007).  Relative gene expression is reported as the 
fold difference in mean values for distinct biological replicates. 
Behavior 
Fear conditioning was conducted as previously described (Hawk et al., 2012).  For 
contextual conditioning, naïve 2- to 6-month old male and female Sin3a NH (CaMKIIα-
Cre; Sin3aL/L ) and control (CaMKIIα-Cre; Sin3aL/+ , and Sin3aL/L )  mice were placed in a 
novel training chamber for 180 s and a single 2 s, 0.75 mA foot shock was administered 
after 148 s. Contextual fear testing was conducted 1 hr or 24 hrs after training, by re-
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exposing the animals to the trained context for 5 min.  Cued fear conditioning was 
conducted using a similar training procedure as contextual fear, with the addition of a 30 
s tone presentation starting at 120 s. Cued fear testing was conducted in a novel 
conditioning chamber with altered floor covering, odor, and dimensions. Mice were 
exposed to the novel context for 3 min, followed immediately by 3 min of tone 
presentation. Freezing behavior during contextual and cued testing was scored by 
computer using FreezeScan software (Clever Systems). Freezing levels for all groups 
was examined for normality using Shapiro-Wilk test.  Normally distributed data sets were 
compared using two-way ANOVA, with significance levels of p < 0.05.  Non-parametric 
data were compared using independent samples Kruskal-Wallis test, with p value 
significance level of 0.05.  For all conditioning experiments, animals with responses two 
standard deviations above or below the group mean were excluded from the analysis as 
outliers.  Mice were tested in the elevated zero maze with a single 5 min exposure in 
which the animals were allowed to freely explore the maze.  Time spent in open and 
closed quadrants of the maze were scored manually by a trained observer blind to the 
genotypes of the animals.  A two-tailed independent samples t-test was used to compare 
genotypes for open and closed areas. For all behavioral tasks, testing order was 
designed so that mice of different sexes were not in the testing room at the same time.  
Testing chambers were thoroughly cleaned between each session to minimize odor 
cues.   
Immunohistochemistry 
Transcardial perfusions and immunohistochemical stainings were conducted as 
previously described (Havekes et al., 2012). Sections incubated rabbit anti-phopsho-
ERK1/2 (Cell Signaling, AB9101). Phosphatase inhibitors were included in the fixative 
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and all buffers (Havekes et al., 2012). Cell counts were conducted as described 
(Havekes et al., 2012) by a trained observer blind to grouping.  Groups were compared 
using a one-tailed independent samples t-test. 
Electrophysiology 
Recordings: To assess the effects of conditional Sin3a mutation on LTP, 2- to 6-month 
old male and female Sin3a NH (CaMKIIα-Cre; Sin3aL/L ) and control (Sin3aL/L ) mice we 
killed by cervical dislocation and their hippocampi quickly dissected out into ice-cold 
oxygenated artificial CSF (aCSF;124 mM NaCl, 4.4 mM KCl, 1.3 mM MgSO4•7H2O, 1 
mM NaH2PO4•H2O, 26.2  mM NaHCO3, 2.5 mM CaCl2•2H2O, 10 mM D-glucose). 
Transverse hippocampal slices were cut 400µm thick using a tissue chopper (Stoelting 
Co., Wood Dale, IL), placed in an interface chamber, and perfused with oxygenated 
aCSF at 28.0°C at a flow rate of 1 mL/min. Slices w ere allowed to recover for at least 2 
hours before beginning electrophysiological recordings. Single-pathway recordings were 
made using a single bipolar stimulating electrode made from nichrome wire (A-M 
Systems, Sequim, WA) placed in the stratum radiatum and used to elicit action 
potentials in the axons of CA3 pyramidal neurons. Field potentials (fEPSPs) were 
recorded using an aCSF-filled glass microelectrode (A-M Systems) with a resistance 
between 1 and 5 MΩ placed in the stratum radiatum region of CA1.  Data collection was 
handled by Clampex software (Molecular Devices, Palo Alto, CA) and was analyzed 
using Clampfit software (Molecular Devices). The peak fEPSP amplitude induced by the 
stimulating electrode was required to be at least 5 mV, and stimulus intensity during the 
recording was set to produce a response of 40% of the maximum fEPSP amplitude. Test 
stimulation occurred once every minute. Baseline responses were recorded for 20 
minutes before LTP induction or drug application. To examine early-phase LTP (E-LTP) 
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one 1-second, 100 Hz train of stimuli was applied through the stimulating electrode. To 
examine late-phase LTP (L-LTP) four 1-second, 100 Hz trains of stimuli were delivered 5 
min apart. Recordings continued for at least 160 min after LTP induction. The initial 
slope of the recorded fEPSPs were normalized to the average of the 20 baseline traces 
and expressed as percentages of this baseline value. 
 
Drugs: All drugs used in the electrophysiology experiments were mixed as stock 
solutions and stored as individual aliquots at -20° C. The HDAC inhibitor Trichostatin A 
(TSA; AG Scientific) was mixed as a 16.5 mM stock solution in 50% ethanol (Vecsey et 
al., 2007), and diluted to a final concentration of 1.65 µM in aCSF. The mGluR5 
antagonist MPEP and the mGluR1α antagonist LY367385 were purchased from AbCam. 
MPEP was mixed as a 5 mM stock solution in ddH2O and diluted to a final concentration 
of 40 µM in aCSF. LY367385 was mixed as a 50 mM stock solution in equimolar NaOH, 
and diluted to a final concentration of 100 µM in aCSF. The RNA synthesis inhibitor 
actinomycin D was dissolved in DMSO at a stock concentration of 50 mM, and was 
diluted to a final concentration of 25 µM in aCSF(Vecsey et al., 2007). Drug application 
was initiated 20 min prior to induction and lasted for 10 min (mGLuR antagonists) or for 
the duration of the recording (TSA and Actinomycin-D). 
 
Statistical analyses: Initial slope of the fEPSP was used to quantify synaptic potentiation, 
normalized to the averaged value of the 20-minute baseline. Only one slice per animal 
was included in any treatment condition. Within each LTP experiment, recordings were 
made from multiple slices from each mouse whenever possible to reduce the number of 
animals used. The order of treatment was determined randomly on each day of 
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recording. Sample sizes were not predetermined using statistical methods, but the 
sample sizes in our experiments are similar to those reported in similar previously 
published research from our lab and others(Havekes et al., 2012; Vecsey et al., 2007). 
To evaluate potential differences in paired-pulse facilitation a repeated measures 
ANOVA was used with genotype and inter-stimulus interval as factors and the facilitation 
ratio as the dependent variable. For evaluation of input–output characteristics, an 
independent samples t-test was performed comparing the average linear regression 
slopes for control mice and Sin3aNH mice. Potential differences in the maximum fEPSP 
slope were evaluated using an independent samples t-test. Between-group differences 
in LTP maintenance were determined using a repeated measures ANOVA on the final 
20 minutes of the recordings, followed by Tukey’s post-hoc test when 
appropriate(Vecsey et al., 2007). Normality and variance of LTP data were checked to 
determine suitability for analysis by ANOVA. Normality of the data was evaluated by 
Shapiro-Wilk tests and examination of normal probability plots of the residuals. Variance 
was evaluated by examination of residual plots of observed versus fitted values. All 
statistical analyses were performed using STATISTICA software (StatSoft Inc.; Tulsa, 
OK). Significance for all tests was set at p < 0.05. In all related figures, significance is 
indicated by *p < 0.05, **p < 0.01, and ***p < 0.001. 
3.3 Results 
3.3.1 Deletion of Sin3a from forebrain excitatory neurons enhances long-term 
potentiation 
To explore the role of SIN3A in synaptic plasticity and memory consolidation, we used 
the Cre-loxP system to conditionally delete the Sin3a gene in forebrain excitatory 
neurons (Fig. 3.1A).  SIN3A protein levels are reduced by approximately 50% in the 
88 
 
hippocampus of Sin3a neuronal hypomorphs (Sin3aNH) relative to control animals 
(ANOVA: F(1,10)= 32.74, p < 0.001) (Fig. 3.1B,C).  SIN3A binds HDAC1 and HDAC2, and 
mediates transcriptional repression through interactions with multiple transcription 
factors and epigenetic regulatory proteins that have been linked to both positive and 
negative regulation of gene transcription (Fig. 3.1D).  
 
HDAC inhibition enhances hippocampal long-term potentiation (LTP), transforming 
short-term LTP into long-lasting, transcription-dependent LTP (Levenson et al., 2004; 
McQuown et al., 2011).  Because SIN3A is a scaffold protein that recruits both HDAC1 
and HDAC2 to sites of transcriptional regulation, we hypothesized that reduced neuronal 
Sin3a would mimic the effects of HDAC inhibition and enhance hippocampal LTP.  
Initially, we tested basal synaptic properties, paired-pulse facilitation, and synaptic 
stability at the Schaffer collateral synapses of area CA1. We found that these 
electrophysiological properties were unchanged in the Sin3aNH mice, indicating that 
synaptic transmission and the stability and health of slices are not affected by reduced 
neuronal Sin3a (Fig. 3.2). In hippocampal slices from wild-type control mice, a single 
tetanus (1 sec, 100 Hz) induces short-lasting LTP that typically returns to baseline levels 
within one or two hours after stimulation(Havekes et al., 2012; Vecsey et al., 2007). In 
slices from Sin3aNH mice, the same weak stimulus produces sustained potentiation that 
is significantly higher than in controls (controls, n = 6, avg. of fEPSP slope over final 20 
min = 101.25 ± 2.03 %; Sin3aNH, n = 6, avg. of fEPSP slope over final 20 min = 151.72 
± 10.88 %; repeated measures ANOVA: genotype, F(1,10) = 7.713, p = 0.0195; Fig. 3.3A). 
Further, this LTP enhancement in Sin3aNH slices is blocked by the transcription inhibitor 
Actinomycin D (Fig. 3.4). Given the enhancement in hippocampal LTP by Sin3a 
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deletion, we next investigated the ability of an HDAC inhibitor to further enhance LTP in 
Sin3aNH mice. As has been demonstrated previously(Vecsey et al., 2007), the 
combination of a single tetanus and administration of the HDAC inhibitor Trichostatin A 
(TSA) enhances LTP in wild-type control slices (controls + veh, n = 4, avg. fEPSP slope 
= 99.71 ± 7.24%; controls + TSA, n = 6, avg. fEPSP slope = 155.01 ± 9.47%; repeated 
measures ANOVA: genotype, F(1,16) = 10.604, p = 0.005; treatment, F(1,16) = 5.111, p = 
0.038; genotype × treatment interaction, F(1,16) = 5.151,  p = 0.037; Tukey’s post-hoc, 
controls + veh vs. controls + TSA, p = 0.026; Fig. 3.3B). However, in Sin3aNH mice, 
TSA administration did not enhance LTP compared to vehicle-treated slices (Sin3aNH + 
veh, n = 4, avg. fEPSP slope = 168.82 ± 2.05%; Sin3aNH + TSA, n = 6, avg. fEPSP 
slope = 169.34 ± 17.4%; Tukey’s post-hoc, Sin3aNH + veh vs. Sin3aNH + TSA, p = 
0.999; Fig. 3.3C). Further, LTP in Sin3aNH slices was significantly greater than in 
vehicle-treated control slices but was similar to TSA-treated control slices (repeated 
measures ANOVA with Tukey’s post-hoc test: control + veh vs. Sin3aNH + veh, p = 
0.012; control + veh vs. Sin3aNH + TSA, p = 0.006; control + TSA vs. Sin3aNH + veh, p 
= 0.894; control + TSA vs. Sin3aNH + TSA, p = 0.862; Fig. 3.3D). The occlusion of the 
effects of TSA on LTP in Sin3aNH mice and the similarity of LTP enhancement by Sin3a 
deletion to LTP enhancement by HDAC inhibitor treatment suggest that the changes we 
observe here in synaptic plasticity are a phenocopy of HDAC inhibition, and that the 
enhanced LTP phenotypes share a common underlying mechanism. 
3.3.2  Reduced Sin3a in forebrain excitatory neurons enhances hippocampal long-
term memory 
To determine whether reduction of neuronal Sin3a impacts memory consolidation, we 
tested associative memory in Sin3aNH animals using the contextual fear conditioning 
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paradigm.  First, we tested long-term memory in Sin3aNH and wild type control animals 
in the foreground contextual fear paradigm, a cognitive task that engages the 
hippocampus(Maren & Fanselow, 1997; Trifilieff et al., 2006). Sin3aNH animals show 
enhanced long-term memory compared to controls when tested 24 hrs after conditioning 
(independent samples Kruskal-Wallis, effect of genotype: pre-shock, p < 0.13; 24 hr test, 
p < 0.008; Fig. 3.5A). Consolidation of long-term (24 hr) hippocampal fear memory 
requires transcriptional activation and translation of new proteins, but 1 hr short-term 
memory does not(Bourtchouladze et al., 1998; Igaz, Vianna, Medina, & Izquierdo, 2002). 
When we tested a second naïve cohort of animals for short-term contextual fear memory 
1 hr after training, we found no differences in the freezing responses of Sin3aNH and 
control animals to the training context (two-way ANOVA; genotype F(1,44) = 0.05, p < 
0.83; phase F(1,44) = 94.1, p < 0.001; Fig. 3.5B). Previous studies of fear learning circuitry 
suggest that associative fear conditioning to a tone cue is dependent on the amygdala, 
but not on the hippocampus (Maren, 2005; Phillips & LeDoux, 1992). When we 
conditioned a third cohort of Sin3aNH animals in the tone cued fear task, no differences 
were seen in either baseline freezing pre-CS, or during CS tone presentation (two-way 
ANOVA: genotype F(1,22) = 0.1, p < 0.77; phase F(1,22) = 21.0, p < 0.001); Fig. 3.5C). This 
finding suggests that the memory enhancements observed are specifically due to 
changes in hippocampal function. As a next step, we examined mice for anxiety-related 
behaviors in the elevated zero maze. Sin3aNH mice show increased time spent in the 
open sections (independent samples t-test, p < 0.01) compared to controls, a result 
suggestive of decreased anxiety in the Sin3aNH animals (Fig. 3.5D).  The low levels of 
anxiety-like behaviors in the Sin3aNH mice together with the absence of changes in both 
1hr contextual and cued fear responses strongly argue against general fear 
abnormalities in these animals. Rather, these results indicate that reducing the function 
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of the SIN3A co-repressor in excitatory neurons enhances hippocampal long-term 
memory. 
3.3.3  Reduction of neuronal SIN3A changes memory-related gene expression and 
synaptic signaling.  
The effects of SIN3A depletion on transcription-dependent forms of long-term memory 
and synaptic plasticity support a role for the SIN3A-HDAC complex in regulating the 
expression of genes involved in neuronal plasticity. We focused our studies on specific 
gene loci linked to memory and synaptic plasticity that were shown by others to be 
regulated by both HDAC2 and SIN3A (NHGRI ENCODE)(Guan et al., 2009; Kundaje et 
al., 2012). To investigate whether expression of these candidate target genes is altered 
in Sin3aNH mice, we collected hippocampal tissue from Sin3aNH and control animals 1 
hr after contextual fear conditioning and measured mRNA transcript levels by 
quantitative RT-PCR.  Neuronal depletion of SIN3A alters mRNA expression of a subset 
of HDAC2-regulated synaptic genes, increasing levels of transcripts encoding synaptic 
scaffold Homer1 and cyclin-dependent kinase Cdk5 (Student’s t-test: Homer,1 p < 0.001; 
Cdk5, p < 0.02; Gria1, p < 0.26; Grin2a,  p < 0.61; Grin2b, p < 0.02; CaMKIIα, p < 0.34; 
Fig. 3.6A). Homer1 and Cdk5 are implicated in memory consolidation and both proteins 
function in a common pathway regulating the localization and function of type I mGluRs, 
so we further investigated the role of HOMER1 and mGluR signaling in the Sin3aNH 
animals (Mahan et al., 2012; Orlando et al., 2009). Two classes of HOMER1 isoforms 
modulate mGluR signaling at the synapse (Shiraishi-Yamaguchi & Furuichi, 2007). Long 
Homer1 isoforms promote mGluR signaling and recruit mGluRs to the post-synaptic 
density (Mao et al., 2005; Tu et al., 1999; Xiao et al., 1998). Short isoforms of Homer1 
act in a dominant negative manner to uncouple mGluRs from the post-synaptic density 
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and from downstream effector molecules (Bottai et al., 2002; Kammermeier & Worley, 
2007). A more detailed examination of Homer1 mRNA expression in Sin3aNH animals 
revealed an increase in expression across the Homer1 locus, including regions specific 
to both short isoforms (Homer1a-specific UTR following exon 5, and Ania-3 specific exon 
A) and long isoforms (exon 10) (Student’s t test: exon 1, p < 0.02; Homer1a, p < 0.01; 
Ania-3, p < 0.08; exon10, p < 0.01; Fig. 3.6B and Fig. 3.7C and D).  These data provide 
evidence of synaptic changes that accompany Sin3a deletion, and suggested a 
mechanism that could support the memory and plasticity phenotype observed in 
Sin3aNH mice through changes in Group I mGluR function. 
The Group I mGluRs (mGluR1α and mGluR5), have been shown to play important roles 
in several forms of memory and synaptic plasticity (Jia et al., 1998; Manahan-Vaughan & 
Braunewell, 2005; Ménard & Quirion, 2012; Neyman & Manahan-Vaughan, 2008), and 
are upstream of a number of signaling pathways that contribute to plastic processes 
(Fig. 3.8A), including intracellular Ca2+ release, IP3/DAG signaling and PKC activation, 
ultimately leading to the phosphorylation and activation of ERK1/2(Anwyl, 2009; Piers et 
al., 2012).  Compounds that facilitate activation of mGluR5 enhance performance in 
rodent learning paradigms(Ayala et al., 2009; Balschun, Zuschratter, & Wetzel, 2006; 
Uslaner et al., 2009). Because the reduction of forebrain SIN3A was accompanied by 
the enhancement of long-term memory and long-term potentiation, as well as the 
upregulation of both Homer1 and Cdk5 mRNA levels, we hypothesized that the 
observed memory and LTP enhancements could be attributed to increased function of 
synaptic Type 1 mGluRs. We chose to assay levels of ERK1/2 phosphorylation after 
contextual fear conditioning as an initial test of the memory-related signaling cascades 
downstream of the Group I mGluRs. ERK phosphorylation is essential for memory 
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formation and synaptic plasticity (Thomas & Huganir, 2004; Trifilieff et al., 2006), is 
regulated by mGluR1α/5 activity (Mao et al., 2005), and is necessary for 
Homer1/mGluR-mediated enhancement of LTP (O’Riordan, Gerstein, Hullinger, & 
Burger, 2014). We measured activation of ERK signaling pathways in hippocampal 
neurons one hour after contextual fear conditioning using immunostaining for 
phosphorylated ERK1/2 in sections from both Sin3aNH and control mice (Fig. 3.6C and 
Fig. 3.9). Quantification of the immunostained cells revealed a higher number of 
phospho-ERK1/2 positive cells in area CA1, but not in area CA3 or in the dentate gyrus 
(DG), of Sin3aNH mice compared to control littermates (n =10 for each group; CA1 t-
test, p = 0.0296; CA3 t-test, p = 0.46; DG, t-test, p = 0.0864; Fig. 3.6 D). These results 
suggest that a reduction in neuronal Sin3a leads to elevated expression of the mGluR 
scaffold Homer1, and increased activity in mGluR signaling pathways. 
3.3.4 Reduction of neuronal Sin3a changes mGluR contributions to long term 
potentiation   
Changes in Homer1 expression have been linked to changes in synaptic plasticity, and 
previous studies have shown that increasing the expression of long-form Homer1 alters 
signaling through mGluR1α/mGluR5 in long-lasting forms of synaptic plasticity (Gerstein, 
O’Riordan, Osting, Schwarz, & Burger, 2012; Klugmann et al., 2005). Late phase LTP in 
wild-type hippocampal slices requires activity of both mGluR1 and mGluR5, but slices 
expressing long isoform Homer1c exhibited a form of LTP that did not require mGluR1 
signaling(Gerstein et al., 2012).  To investigate whether the changes we observed in 
Homer1 expression in the Sin3aNH mice affect the contributions of mGluR1α and 
mGluR5 to synaptic plasticity, we induced L-LTP using spaced 4-train stimulation in the 
presence of either the mGluR1α antagonist LY367385 or the mGluR5 antagonist 
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MPEP(Neyman & Manahan-Vaughan, 2008). When slices from wild type control mice 
and Sin3aNH mice were stimulated with this protocol in the absence of drug treatment 
no differences in LTP were observed, indicating L-LTP maintenance is not changed by 
Sin3a depletion (Fig. 3.10). In slices from wild type control mice, antagonizing either of 
the Type I mGluRs reduced LTP compared to vehicle-treated slices (controls + veh, n=6, 
avg. fEPSP slope = 182.24 ± 4.67%; controls + LY367385, n = 5, avg. fEPSP slope = 
121.82 ± 20.67%; controls + MPEP, n = 5, avg. fEPSP slope = 120.96 ± 6.56%; 
repeated measures ANOVA: genotype, F(1,28) = 17.894, p = 0.00023; treatment, F(2,28) = 
20.453, p = 0.000003; genotype × treatment interaction, F(2,28) = 7.924, p = 0.0019; 
Tukey’s post-hoc test, controls + vehicle vs. controls + MPEP, p = 0.018; controls + 
vehicle vs. controls + LY367385, p = 0.008; Fig. 3.11A). In slices from Sin3aNH mice, 
the administration of MPEP significantly reduced LTP, while antagonism of mGluR1α 
with LY367385 did not have a significant effect on potentiation (Sin3aNH + veh, n = 5, 
avg. fEPSP slope = 192.29 ± 17.4%; Sin3aNH + LY367385, n = 6, avg. fEPSP slope = 
213.12 ± 7.62%; Sin3aNH + MPEP, n = 7, avg. fEPSP slope = 116.06 ± 10.94%; 
Tukey’s post-hoc test, Sin3aNH + vehicle vs. Sin3aNH + MPEP, p = 0.0002; Sin3aNH 
vehicle vs. Sin3aNH + LY367385, p = 0.999; Sin3aNH + LY367385 vs. Sin3aNH + 
MPEP, p = 0.0002; Fig. 3.11B). These results indicate that LTP in Sin3aNH mice is 
independent of mGluR1α but requires mGluR5, suggesting that increased long Homer1 
levels result in very specific changes in the function of the Group I mGluRs at CA1 
synapses. 
3.4 Discussion 
Inhibition of HDAC activity enhances memory and facilitates neuronal plasticity(Peixoto 
& Abel, 2013). However, the precise molecular mechanisms by which these 
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manipulations ultimately affect synaptic and neuronal function are not understood, and 
the identification of functional effector genes targeted by HDAC inhibition has been 
challenging. Here, we targeted the co-repressor SIN3A, a scaffolding protein that 
coordinates a multi-functional co-repressor complex containing several histone-
modifying enzymes including HDAC1 and HDAC2. Mice carrying a conditional neuronal 
depletion of Sin3a have reduced levels of protein in the hippocampus. We observed that 
chronic reduction of SIN3A is accompanied by enhanced hippocampal synaptic plasticity 
and memory formation, mimicking the effects of acute HDAC inhibitor administration. 
These enhancements in memory and plasticity are accompanied by increased 
expression of several neuronal genes regulated by HDAC2 and SIN3A, including 
Homer1 and Cdk5.  We observed an increase in expression of constitutively expressed 
long isoforms of Homer1, which organize group I mGluRs at the synapse, and increased 
phosphorylation of ERK, a downstream target of group I mGluRs.  Alterations in Homer1 
and mGluR functioning has profound effects on synaptic structure, plasticity, and 
cognition (Ayala et al., 2009; Gerstein et al., 2012; Klugmann et al., 2005; Ménard & 
Quirion, 2012).  
 The upregulation of Homer1 and the observed shift in the requirements for Group 
I mGluR signaling in Sin3aNH L-LTP indicate that the enhancements we observed in 
hippocampus-dependent memory and hippocampal synaptic plasticity may be 
attributable to a change in Homer1/mGluR5 signaling at the synapse, and suggest a 
model by which these changes could occur.  Long isoforms of Homer1 bind to the 
intracellular C-terminal tails of the Group I mGluRs and linking them to the postsynaptic 
density in dendritic spines (Tu et al., 1999; Xiao et al., 1998a). Under baseline conditions 
both mGluR1α and mGluR5 are linked to the postsynaptic density through interactions 
with long Homer1b/c (Fig. 3.8A)., Group I mGluRs are associated with several key 
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signaling pathways associated with memory and plasticity (Ayala et al., 2009; Mao et al., 
2005; Ménard & Quirion, 2012), and under baseline conditions the activation of both 
mGluR1α and mGluR5 are necessary for long-term potentiation (Neyman & Manahan-
Vaughan, 2008) (Fig. 3.12). In Sin3aNH mice, higher levels of long-form Homer1b/c may 
recruit more mGluR5 to the postsynaptic density (Fig. 3.8B). Such an increase in 
synaptic mGluR5 could reduce the requirement for mGluR1α in LTP, and could also 
facilitate LTP enhancement via increases in [Ca2+]i(Ayala et al., 2009; Kotecha et al., 
2003; Mao et al., 2005), downstream signaling through PKC and ERK (Ayala et al., 
2009; Kotecha et al., 2003; Mao et al., 2005), and even NMDA receptor potentiation 
through Src kinase (Kotecha et al., 2003) (Fig. 3.12).  
 Pharmacological inhibition of HDAC enzymes could be an important component 
of future therapies for not only at improving cognition, but also treating cognitive and 
neurodegenerative disorders(Abel & Zukin, 2008; Fischer et al., 2010).  One of the major 
obstacles to developing HDAC inhibitor drugs as neural therapeutic agents is a lack of 
understanding of basic molecular mechanisms driving the synaptic and behavioral 
effects of these compounds. Here, we show that neuronal depletion of the HDAC-
coordinating co-repressor SIN3A alters the expression of HDAC-regulated genes as well 
as Group I mGluR function and downstream signaling through ERK, and these effects 
on mGluR5/Homer1 signaling likely mediate the enhancements in memory and plasticity 
observed in Sin3aNH mice. Indeed, it has recently been demonstrated that increasing 
mGluR signaling via positive allosteric modulators enhances hippocampal long-term 
potentiation, long-term depression, and long-term memory consolidation in 
rodents(Ayala et al., 2009), while disruption of Group I mGluR function has been 
implicated in many cognitive and neurological disorders that may also be influenced by 
histone acetylation (including anxiety disorder, Fragile X syndrome, Parkinson’s disease, 
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and schizophrenia)(Nicoletti, Bockaert, & Collingridge, 2011; Piers et al., 2012; 
Szumlinski, Kalivas, & Worley, 2006). These findings provide evidence linking mGluR 
signaling at the synapse to epigenetic mechanisms regulating gene expression for the 
first time, paving the way for novel therapeutics to treat cognitive deficits. 
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Chapter 3 Figure Legends 
 
Figure 3.1. Sin3a neuronal hypomorphs have reduced levels of SIN3A in the 
hippocampus.   
A. Structure of murine Sin3a locus with exon 4 highlighted.  Recombination via CaMKIIα 
promoter-driven Cre at one or more Sin3aLoxP alleles results in deletion of exon 4 of 
Sin3a.  B. Sin3aNH mice have decreased SIN3A protein levels (arrows) in the 
hippocampus by immunoblot.  C. Quantification of optical density of SIN3A bands 
(arrows in panel c) normalized to β tubulin loading control (controls n = 6, Sin3aNH n = 
5, one way ANOVA, F(1,9) = 32.74, ***p < 0.001). D. The HID domain and four PAH 
domains of SIN3A mediate interactions with co-factors, epigenetic modifiers, and 
transcription factors.  SIN3A-interacting factors have been linked to both activating 
(green) and repressive (red) regulation of gene transcription.  
Figure 3.2. Sin3aNH conditional mutation does not change basal synaptic 
properties at the Schaffer collateral synapses. A. Paired-pulse facilitation was 
unchanged in hippocampal slices from Sin3aNH mice (controls n = 18, Sin3aNH n = 16; 
repeated measures ANOVA: genotype, F(1,32) = 0.364, p = 0.55; genotype × interval 
interaction, F(4,128) = 0.769, p = 0.547).  B. Input-output relationships were not different in 
Sin3aNH mice compared to wild type controls (controls n = 18, Sin3aNH n = 16; 
independent samples t-test on average of regression slopes, t(1,32) = 1.324, p = 0.189). 
C. The maximum amplitude of fEPSP slopes recorded in slices from Sin3aNH mutant 
mice and wild type control animals were not significantly different (controls n = 18, 
Sin3aNH n = 16; independent samples t-test, t(1,32) = 0.11, p = 0.913). D. Baseline 
synaptic response in the absence of stimulation is not altered in Sin3aNH mutants when 
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compared to wild type controls (controls, n = 3, avg. fEPSP slope = 94.32 ± 7.78%; 
Sin3aNH, n = 3, avg. fEPSP slope = 95.12 ± 6.58%; repeated measures ANOVA: 
genotype, F(1,4) = 0.092, p = 0.777). 
Figure 3.3. Neuronal deletion of SIN3A enhances hippocampal LTP.  A. LTP was 
induced by a single 100 Hz, 1 s duration stimuli (indicated by arrow). LTP maintenance 
was significantly enhanced in Sin3aNH mice (controls, n = 6, avg. of fEPSP slope over 
final 20 min = 101.25 ± 2.03 %; Sin3aNH, n = 6, avg. of fEPSP slope over final 20 min = 
151.72 ± 10.88 %; repeated measures ANOVA: genotype, F(1,10) = 7.713, *p = 0.0195). 
B.  In control slices, perfusion with 1.65 µM TSA enhanced 1-train LTP compared to 
vehicle (controls+veh, n = 4, avg. fEPSP slope = 99.71 ± 7.24%; controls+TSA, n = 6, 
avg. fEPSP slope = 155.01 ± 9.47%; repeated measures ANOVA: genotype, 
F(1,16)=10.604, p = 0.005; treatment, F(1,16)= 5.111, p = 0.038; genotype×treatment 
interaction, F(1,16)= 5.151,  p = 0.037; Tukey’s post-hoc, controls+veh vs. controls+TSA, 
*p = 0.026). C.  In Sin3aNH slices, TSA administration did not enhance LTP compared to 
vehicle (Sin3aNH+veh, n = 4, avg. fEPSP slope = 168.82±2.05%; Sin3aNH + TSA, n = 
6, avg. fEPSP slope = 169.34 ± 17.4%; Tukey’s post-hoc, Sin3aNH+veh vs. 
Sin3aNH+TSA, p = 0.999). D. Average fEPSP slopes over final 20 minutes from all 
groups. No significant difference was observed between control + TSA, Sin3aNH+veh, 
and Sin3a+TSA groups; these groups all displayed higher potentiation than control+veh 
slices (repeated measures ANOVA, Tukey’s post-hoc, control+veh vs. Sin3aNH+veh, *p 
= 0.012; control+veh vs. Sin3aNH+TSA, **p = 0.006; control+TSA vs. Sin3aNH+veh, p = 
0.894; control+TSA vs. Sin3aNH+TSA, p = 0.862). 
Figure 3.4. Enhanced LTP in Sin3aNH slices is transcription-dependent. Following 
a 20 minute baseline recording, hippocampal slices from Sin3aNH mutant mice were 
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perfused with the RNA synthesis inhibitor Actinomycin-D (ActD, 25 µM) or vehicle (0.05 
% DMSO) in aCSF for the remainder of the recording period. A single 1 sec, 100 Hz 
tetanus was delivered at 40 minutes (indicated by arrow). LTP in vehicle-treated 
Sin3aNH slices was significantly higher than in ActD treated slices, indicating that 
transcription is necessary for the LTP enhancement observed in Sin3aNH mutant mice 
(Sin3aNH + vehicle, n = 4, avg. fEPSP slope = 168.32 ± 17.74%; Sin3aNH + ActD, n = 
4, avg. fEPSP slope = 110.55 ± 6.23%; repeated measures ANOVA: treatment, F(1,6) = 
9.430, *p = 0.022).  
Figure 3.5. Sin3aNH mice have enhanced long-term memory.   A. Sin3aNH animals 
have enhanced 24 hr long-term memory for contextual fear conditioning (n = 34 control, 
n = 32 Sin3aNH, independent samples Kruskal-Wallis test, effect of genotype: pre-shock 
p < 0.13; 24 hr test **p < 0.008). B. No effect of Sin3a reduction on 1 hr short-term 
memory for contextual fear conditioning (n = 10 control, n = 12 Sin3aNH; two-way 
ANOVA, genotype, F(1,44) = 0.05, p < 0.83; phase, F(1,44) = 94.1, p < 0.001).   C. Cued fear 
long-term memory is not altered in Sin3aNH animals (n = 6 control, n = 7 Sin3aNH; two-
way ANOVA: genotype, F(1,22) = 0.1; p < 0.77; phase, F(1,22) = 21.0, p < 0.001).  D. In the 
elevated zero maze, Sin3aNH mice spend more time in the open arms (n =12 per group; 
independent samples t-test, t(1,22) = 3.342, **p < 0.01), and less time in the closed arms 
(t-test, **p < 0.01) compared to wild-type control animals. 
Figure 3.6. Reduction in SIN3A increases Homer1 expression and affects signaling 
cascades downstream of mGluR.  A. Expression of genes regulated by HDAC2 and 
SIN3A in hippocampus of Sin3aNH mice 1hr after fear conditioning. Levels of Homer1 
(unpaired t-test, n = 7 per group; t(1,12)= -6.448, ***p < 0.001) and Cdk5 (t(1,12) = -2.836, *p 
< 0.02) are increased relative to controls, and the level of Grin2b is decreased (t(1,12) = 
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3.038, * p < 0.02).  B.  Expression of Homer1 exons encoding both short (Homer1a) and 
long (containing exon 10) isoforms is elevated in Sin3aNH mice (n = 7 control, n = 6 
Sin3aNH; unpaired t-test, Exon 1 t(1,11) = -2.877 *p < 0.02; Homer1a t(1,11) = -3.313, **p < 
0.01; Ania-3 t(1,11) = -2.146, p < 0.08;  Exon 10 t(1,11) = -3.251 **p < 0.01). C. 
Representative images of hippocampal area CA1 showing cells stained for somatic ERK 
p42/44 in a Sin3aNH mouse and a control littermate one hour after contextual fear 
conditioning. Scale bar = 0.1 mm.  D. Quantification of pERK-positive neurons is dorsal 
hippocampus following contextual fear conditioning shows a significantly higher number 
of cells positive for ERK p42/44 in CA1, but not CA3 or DG, of Sin3aNH mice compared 
to control littermates (n = 10 per group; t-test, CA1 *p = 0.0296; CA3  p = 0.46; DG p = 
0.0864). 
Figure 3.7 Expression of Homer1 exons and mGluR1/5 transcripts.  A. mRNA 
expression of individual exons of Homer1 in control and Sin3aNH mutant hippocampi 
1hr after training in contextual fear (t-test, *p < 0.05, **p < 0.01).  B. Expression of 
mGluR5 mRNA is reduced in Sin3aNH mutants 1hr after contextual fear training (t-test, 
*p < 0.05).  C.  Exon structure of Homer1 and neuronally expressed Homer1 mRNA 
transcripts.  D.  Gene structure of Homer1 in RefSeq in UCSC genome browser (dark 
purple).  ChIPseq analysis of SIN3A binding and histone H3K27 acetylation Homer1 
locus in CH12 murine B cell lymphoma cell line and melanocyte cells (MEL) from the 
TFBS ChIP-seq conducted by ENCODE/Stanford/Yale (NHGRI ENCODE data; Kundaje 
et al., 2012).  Called peaks are indicated in black and grey bars (significant enrichment 
**p < 0.01 compared to input DNA control) above the signal (blue) for each cell line. 
Figure 3.8.  A model for enhanced synaptic plasticity and mGluR5 function with 
the deletion of Sin3a.  A. In wild type mice, both mGlur1α and mGluR5 are required for 
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the maintenance of hippocampal LTP. Group I mGluRs may be found clustered at 
glutamatergic synapses by interactions with long-form Homer1 proteins, linking them to 
the post-synaptic density and ionic glutamatergic receptors through other scaffolding 
proteins such as Shank, GKAP, and PSD95. While there is debate over the exact 
mechanisms distinct to or shared by mGluR1α and mGluR5 in CA1 pyramidal neurons, 
the Group I mGluRs are associated with several downstream pathways and signaling 
mechanisms involved in both memory and LTP. These include release of Ca2+ from 
internal stores and increase in [Ca2+]i via IP3R signaling; potentiation of NMDA receptor 
currents through Src kinase; and activation of PKC and the ERK signaling cascade. B.  
A possible mechanism underlying memory and LTP enhancement in Sin3aNH mutant 
mice: Neuronal deletion of Sin3a is accompanied by changes in expression of several 
HDAC-regulated genes encoding synaptic proteins, including increased Homer1 and 
Cdk5 expression. Increased levels of long-form Homer1b/c facilitate recruitment and 
clustering of mGluR5 at the postsynaptic density, while increased Cdk5 leads to greater 
levels of phosphorylation of the C-terminal tails of mGluRs, enhancing mGluR5/long-
form Homer1 interaction and contributing further to localization of mGluR5 at the PSD. 
The increase in synaptically-located mGluR5 could contribute to enhanced LTP through 
increased [Ca2+]i and increased signaling via downstream pathways, and reduce the 
necessity of mGluR1α signaling at the synapse. 
Figure 3.9. Phospho-ERK immunostaining in hippocampal sections following 
contextual fear conditioning. Representative images of hippocampal areas CA3 and 
DG in sections from control mice (A, C) and Sin3aNH (B, D) that were immunostained 
for phospho-ERK1/2. Scale bars indicate 0.1 mm. Quantification of phospho-ERK 
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positive cells in these regions found no significant effect of genotype (n=10 for each 
group; CA3 t-test, p = 0.46; DG, t-test, p = 0.0864).  
Figure 3.10. L-LTP is not affected by conditional neuronal Sin3a deletion. Four 
trains of stimulation spaced five minutes apart (indicated by arrows) induces L-LTP of 
similar magnitude in both wild type control slices and slices taken from Sin3aNH mice 
(controls, n = 5,  avg. fEPSP slope = 143.1 ± 9.22%; Sin3aNH, n = 6, avg. fEPSP slope 
= 146.59 ± 19.01%; repeated measures ANOVA: genotype, F(1,9 )= 0.028, p = 0.879). 
Figure 3.11. Reduction in SIN3A affects the role of mGluR signaling in 
hippocampal LTP.  A. In control animals, LTP induced by four spaced trains of 
stimulation is impaired by the administration of the mGluR1α antagonist LY367385 or the 
mGluR5 antagonist (controls + veh, n = 6, avg. fEPSP slope = 182.24 ± 4.67%; controls 
+ LY367385, n = 5, avg. fEPSP slope = 121.82 ± 20.67%; controls + MPEP, n = 5, avg. 
fEPSP slope = 120.96 ± 6.56%; repeated measures ANOVA: genotype, F(1,28) = 17.894, 
p = 0.00023; treatment, F(2,28) = 20.453, p = 0.000003; genotype × treatment interaction, 
F(2,28) = 7.924, p = 0.0019; Tukey’s post-hoc test, controls + vehicle vs. controls + MPEP, 
*p = 0.018; controls + vehicle vs. controls + LY367385, **p = 0.008).  B.  In Sin3aNH 
slices, application of an mGluR5 antagonist impairs spaced 4-train LTP, while 
antagonizing mGluR1α has no effect (Sin3aNH + veh, n = 5, avg. fEPSP slope = 192.29 
± 17.4%; Sin3aNH + LY367385, n=6, avg. fEPSP slope = 213.12 ± 7.62%; Sin3aNH + 
MPEP, n = 7, avg. fEPSP slope = 116.06 ± 10.94%; Tukey’s post-hoc test, Sin3aNH+ 
vehicle vs. Sin3aNH + MPEP, ***p = 0.0002; Sin3aNH vehicle vs. Sin3aNH + LY367385, 
p = 0.999; Sin3aNH + LY367385 vs. Sin3aNH + MPEP, ***p = 0.0002). 
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Figure 3.12. Reduction in SIN3A affects the requirement for type I mGluR signaling 
during plasticity.  Synaptic plasticity engages both major type I mGluRs in the 
hippocampus, leading to influx of calcium from intracellular and extracellular sources, 
activation of downstream calcium-responsive kinase cascades, and transcriptional 
activation.  Both type mGluR1 and mGluR5 activate common downstream calcium 
signaling mechanisms.  Blockade of mGluR1 in control animals leads to reduced overall 
calcium influx, reduced kinase activity, and failure of transcriptional activation necessary 
for late phase plasticity.  In Sin3aNH animals, expanded signaling through mGluR5 is 
able to support signal transduction and engage transcription in the presence of mGluR1 
blockade.  Because mGluR5 is the more abundant type I receptor in the hippocampus, 
blockade of mGluR5 leads to insufficient pathway activation and impaired synaptic 
plasticity in both control and Sin3aNH animals. 
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CHAPTER 4: COGNITIVE DEFICITS IN MICE EXPRESSING CRE RECOMBINASE IN 
FOREBRAIN EXCITATORY NEURONS. 
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Abstract 
Cre recombinase is the predominant site-specific recombinase tool for conditional gene 
deletion approaches in transgenic rodent models.  Phenotypes associated with off-target 
Cre recombinase activity have been described in cultured cells and peripheral tissues, 
but Cre-specific phenotypes have not been identified or explored in the brain.  Here, we 
find sex-specific contextual fear memory deficits in transgenic mice expressing Cre in 
forebrain excitatory neurons.  
4.1 Introduction 
Conditional gene deletion systems have revolutionized genetic research across multiple 
disciplines.  The bacteriophage P1 site-specific recombination system, Cre-loxP, has 
developed into the primary tool for viral and transgene-mediated conditional gene 
deletion in rodents and has been used in multiple other research organisms (Schmidt et 
al. 2000, Sauer 1991, Coppoolse et al. 2003, Siegel and Hartl 1996, Thummel et al. 
2005, Abremski and Hoess 1984).  The double-stranded DNA recombinase Cre is 
required to transition the phage genome from the linear dsDNA contained in the viral 
particle to a circular plasmid in the bacterial host.  Cre binds the terminal loxP 
recognition sites of the linearized genome, and induces a recombination event to yield a 
circular genome and ligated linear end fragments (Abremski and Hoess, 1984).  To 
adapt this system for conditional gene deletion in other organisms, homotypic loxP sites 
sharing the same orientation are inserted into gene loci in positions flanking exon 
sequences (Fig. 1.1A).  Upon binding to Cre, a crossover event is induced such that the 
intervening sequence between the loxP sites is excised into a circular loop, and the cut 
ends of parent strand are ligated (Hoess and Abremski 1984, Fig. 1.1).  Alternately, 
heterotypic sites with opposite orientations can be used to induce inversion of the 
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targeted sequence (Oberdoerffer et al. 2003) Expression of Cre recombinase under a 
cell type-specific promoter allows for tissue restricted deletion events. 
The success of Cre as a research tool hinges on specificity in acting on its intended 
target, but it has long been known that cryptic sequences similar to loxP sequences can 
be found throughout yeast, plant, and mouse genomes, and that these cryptic sites are 
active and undergo Cre-mediated recombination (Sauer 1992, Coppoolse et al. 2003, 
Thyagarajan and Calos 2000, Semprini et al. 2007).  Studies of off-target effects of Cre-
mediated recombination have uncovered increased cell cycle arrest and increased 
incidence of double strand breaks, chromosome fusions, and aneuploidy in cultured 
mouse embryonic fibroblasts (MEFs) (Loonstra et al. 2001).  Genotoxic effects of Cre 
expression have also been observed in mouse models.  Chromosomal aberrations and 
sterility were fully penetrant in transgenic mice expressing Cre in post-meiotic 
spermatids, indicating that DNA damage and chromosome instability require 
recombinase activity, and occur in non-dividing tissues (Schmidt et al. 2000).  In addition 
to genome instability, Cre activity has been linked to changes in the cAMP/protein kinase 
A (PKA) signaling pathway in MEFs.  Increased expression of the PKA inhibitor PKI, 
decreased phosphorylation of PKA targets p40/42 ERK and CREB, and altered 
expression of cAMP/CREB regulated genes Nur77, Nurr1, Il-6, and Dusp1 were 
observed in Cre expressing MEFs (Gangoda et al. 2012).   
Hippocampal learning and memory processes are sensitive to changes in PKA signaling 
and cell division (Abel et al. 1997, Bourtchouladze et al. 1998).  Disruption of adult 
neurogenesis and PKA activity have been linked to deficits in contextual fear memory 
(Saxe et al. 2006, Winocur et al. 2006).  Based on these potential off-target effects of 
Cre, we examined contextual fear memory in mice expressing Cre in forebrain neurons.   
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4.2 Methods 
Mouse lines 
Transgenic mice expressing Cre recombinase under the control of CaMKIIα promoter 
sequence were bred from three lines. CaMKIIα-Cre L7ag#13 (Dragatsis and Zeitlin 
2000), CaMKIIα-Cre transgene R4ag#11, and CaMKIIα-Cre T29-1 (Tsien et al. 1996), 
each with more than 9 generations of backcrossing the CaMKIIα-Cre transgene into 
C57BL/6J.   CaMKIIα-Cre males from each line were bred to C57/BL6j wild-type females 
to produce CaMKIIα-Cre hemizygous mice and non-transgenic wild-type littermates.   
Genotyping was performed using PCR with allele-specific primers. To identify mice 
bearing CaMKII-Cre transgenes, PCR was performed with the following primers: Cre1 
5’-CTG CCA CGA CCA AGT GAC AGC-3’, Cre2 5’-CTT CTC TAC ACC TGC GGT 
GCT-3’, Bglob1 5’-CCA ATC TCC TCA CAC AGG ATA GAG AGG GCA GG-3’, Bglob2 
5’-CCT TGA GGC TGT CCA AGT GAT TCA GGC CAT CG-3’. Thermal cycling 
parameters were as follows: 94° C for 3 min, [94° C  for 45 s, 61° C for 45 s, 72° C for 60 
s] x 30 cycles, 72° C for 10 min. Mice were maintai ned under standard conditions 
consistent with National Institute of Health guidelines for animal care and use, and all 
procedures were approved by the Institutional Animal Care and Use Committee of the 
University of Pennsylvania.  Mice were maintained on a 12 hr light-dark cycle and 
provided with food and water in their home cages ad libitum.  Animals were group 
housed in cages of 2-5 littermates except for fear conditioning experiments.  For fear 
conditioning, animals were moved from group housing to single housing 1 week prior to 
training.  Behavioral testing was conducted on 2- to 6-month old male and female 
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animals during the light portion of the cycle. Experimenters were blind to the genotypes 
of the mice during collection of behavioral data. 
Immunohistochemistry 
 Transcardial perfusions and immunohistochemical stainings were conducted as 
previously described (Havekes et al., 2012). Briefly, coronal sections were incubated 
with rabbit anti-Cre (gift from C. Kellendonck), and developed using avidin-biotin 
horseradish peroxidase complex (ABC kit; Vector Laboratories, 1:500) and stained with 
0.02% diaminobenzidine (DAB).  Staining was initiated with 100uL 0.1% hydrogen 
peroxide, and terminated with multiple rinses in PBS. 
Fear conditioning 
Fear conditioning was conducted as previously described (Hawk et al., 2012).  For 
contextual conditioning, naïve 2- to 6-month old male and female CaMKIIα-Cre mice and 
wild-type siblings were placed in a novel training chamber for 180 s and a single 2 s, 
0.75 mA foot shock was administered after 148 s. Contextual fear testing was conducted 
1 hr or 24 hrs after training, by re-exposing the animals to the trained context for 5 min.  
Freezing behavior during contextual training and testing was scored by computer using 
FreezeScan software (Clever Systems).  For all behavioral tasks, testing order was 
designed so that mice of different sexes were not in the testing room at the same time.  
Testing chambers were thoroughly cleaned between each session to minimize odor 
cues.  Results are presented as group means with SEM. Animals with responses two 
standard deviations above or below the group mean were excluded from the analysis as 
outliers.  Groups were compared across test phases using two-way ANOVA, with 
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significance levels of p < 0.05. Genotype effects within phases were compared using 
unpaired t-tests. 
4.3 Results  
4.3.1 Forebrain expression of Cre recombinase in transgenic mouse lines. 
Expression patterns of CaMKIIα Cre transgenic mouse lines differ among animals with 
the same transgene insert.  CaMKIIα L7 Cre and CaMKIIα R4 Cre lines were created 
using the same gene construct (Dragatsis and Zeitlin, 2000), but are derived from 
different founder animals.  We found differential expression among the L7 and R4 lines 
in brain regions engaged by the contextual fear task (Phillips and LeDoux. 1992).  In the 
L7 line, Cre is expressed more widely throughout the hippocampus, including areas 
CA1, CA3, and the dentate gyrus (DG) (Fig. 4.1A).  In the amygdala, there is 
widespread expression of Cre throughout the BLA in L7 Cre animals (Fig. 4.1B).  In the 
R4 line, Cre is expressed in CA1 and DG in the hippocampus, but is not expressed in 
CA3 (Fig. 4.1C).  In the BLA, Cre is expressed widely in R4 animals (Fig. 4.1D).   In the 
T29-1 line, Cre is expressed in all subregions of the hippocampus in adult animals (Zeng 
et al. 2001).  In the amygdala, Jackson Laboratories uses a Rosa 26 flox β 
galactosidase reporter line to show sparse Cre activity that is not present in all cell types 
(Jackson Laboratories, http://cre.jax.org/Camk2a/Camk2a-creNano.html).  Further 
characterization of Cre expression in the amygdala is needed to determine which cell 
populations actively express the transgene. 
4.3.2  Line-specific contextual fear deficits in CaMKIIα Cre transgenic lines 
Transgenic and viral Cre constructs used in studies of hippocampal function frequently 
contain a CaMKIIα promoter sequence to drive targeted recombination events in 
excitatory pyramidal cells in the hippocampus.   To determine whether expression of Cre 
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recombinase throughout the forebrain affects basal performance in hippocampus-
dependent learning tasks, we bred mice that were hemizygous for a CaMKIIα Cre 
transgene and lacked any targeted floxed alleles.  Thus we have Cre mice and their non-
transgenic wild-type siblings for long-term memory tests in the contextual fear 
conditioning task.  We tested three lines of transgenic CaMKIIα Cre mice: L7, R4, and 
T29-1.  
CaMKIIα L7 Cre mice show mild memory deficits when tested for long-term contextual 
fear memory 24hrs after conditioning.  Baseline freezing levels prior to conditioning is 
not different in L7 Cre animals compared to non-transgenic WT siblings, but L7 animals 
show reduced freezing when they are re-exposed to the conditioned context 24hrs after 
training (t-test: baseline p<0.96, 24hr test *p<0.04.  Fig. 4.2A).  The observed difference 
is small and does not hold up to comparisons of genotypes across the two phases (two-
way ANOVA: genotype F1,116 = 3.19, p<0.08, phase F1,116 = 4.51, p<0.001, 
genotype*phase F1,116 = 2.98, p<0.09).  When the test session is examined more closely 
in one minute bins, L7 animals consistently show reduced  freezing levels across all bins 
(rmANOVA: genotype F1,232 = 4.51, p<0.04, minute F1,232 = 6.75, p<0.001, 
genotype*minute F1,232 = 0.34, p<0.85, Fig. 4.2B).  When we separate animals by sex, 
we find that the Cre group difference in freezing levels is strongly driven by reduced 
freezing levels in male L7 animals (two-way ANOVA: genotype F1,73 = 2.95, p<0.1, 
phase F1,73 = 81.83, p<0.001, genotype*phase F1,73 = 3.49, p<0.07; ttest: baseline 
p<0.91, 24hr test p<0.052.  Fig. 4.2C).  In comparison, female L7 animals freeze at 
levels similar to wild-type females during the 24hr context test (two-way ANOVA: 
genotype F1,86 = 0.66, p<0.43, phase F1,86 = 106.92, p<0.001, genotype*phase F1,86 = 
0.58, p<0.46; ttest: baseline p<0.30, 24hr test p<0.47.  Fig. 4.2D). 
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When the CaMKIIα R4 Cre transgenic line was tested for contextual fear memory, 
severe deficits were observed in Cre transgenic mice.  Prior to conditioning, baseline 
freezing levels in R4 mice is comparable to non-transgenic siblings, but when animals 
are tested for contextual memory, R4 mice exhibit significantly reduced freezing 
behavior (two-way ANOVA: genotype F1,41 = 5.2, p<0.03, phase F1,41 = 116.53, p<0.001, 
genotype*phase F1,41 = 4.24, p<0.05; t-test: baseline p<0.76, 24hr test *p<0.03.  Fig. 
4.3A).  R4 Cre animals show reduced freezing early in the testing period, but this 
difference disappears over time (rmANOVA: genotype F1,23 = 1.17, p<0.3; minute F1,4 = 
2.41, p<0.055; genotype*minute F1,4 = 2.56, p<0.05, Fig. 4.3B).   Interestingly, the 
freezing deficits observed in the R4 Cre line are strikingly sex-dependent.  Male R4 Cre 
animals show robust freezing deficits at the 24hr test compared to wild-type males (two-
way ANOVA: genotype F1,24 = 8.46, p<0.008, phase F1,24 = 116.34, p<0.001, 
genotype*phase F1,24 = 8.43, p<0.008; t-test: baseline p<0.76, 24hr test *p<0.02.  Fig. 
4.3C).  In contrast, contextual fear memory in female R4 cre mice is not impaired (two-
way ANOVA: genotype F1,13 = 0.71, p<0.42; phase F1,13 = X, p<0.001; genotype*phase 
F1,13 = 0.17, p<0.69; t-test: baseline p<0.53, 24hr test p<0.46.  Fig. 4.3D). 
In CaMKIIα T29-1 Cre mice, contextual fear memory was found to be intact.  No 
differences were seen between T29-1 and wild-type mice in baseline freezing levels, nor 
during the contextual memory test (two-way ANOVA: genotype F1,84 = 1.47, p<0.23, 
phase F1,84 = 411.1, p<0.001, genotype*phase F1,84 = 3.3, p<0.08; t-test: baseline 
p<0.39, 24hr test *p<0.12.  Fig. 4.4A).  Freezing levels in T29-1 mice were not 
significantly different from wild-type mice over the five minute test (rmANOVA: genotype 
F1,168 = 2.74, p<0.11; minute F1,168 = 2.14, p<0.08, genotype*minute F1,168 = 0.57, p<0.69, 
Fig. 4.4B).  Male T29-1 mice exhibited slightly enhanced freezing during the test phase 
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(two-way ANOVA: genotype F1,62 = 3.3, p<0.08; phase F1,62 = 389.63, p<0.001; 
genotype*phase F1,62 = 5.65, p<0.03; t-test: baseline p<0.26, 24hr test *p<0.09.  Fig. 
4.4C).  Freezing responses in female T29-1 animals are not different from wild-type 
responses (two-way ANOVA: genotype F1,40 = 0.66, p<0.43, phase F1,40 = 230.59, 
p<0.001, genotype*phase F1,40 = 0.374, p<0.55; t-test: baseline p<0.69, 24hr test 
p<0.48.  Fig. 4.4D). 
4.4 Discussion 
The Cre-loxP system for conditional genetic manipulation can be a useful tool, but care 
should be taken in experimental design to avoid Cre lines with off-target phenotypes that 
compromise interpretation of the results.  Here we showed that Cre expression alone 
impaired performance in the contextual fear task in a line-specific manner.  Despite 
similar transgenic inserts (Dragatsis and Zeitlin 2000, Tsien et al. 1996), the Cre lines in 
this study show slightly different expression patterns that likely reflect a combination of 
copy number and insertion site effects that are specific to each line.    All three 
transgenic lines express Cre in area CA1 of the hippocampus, but patterns of expression 
in hippocampal areas CA3 and DG, and in the cortex differ between lines (Tsien et al. 
1996, Figure 1).  Differential patterning and expression particularly in amygdala nuclei 
and in the hippocampal CA3 subregion, may underlie the line-specific nature of the 
memory deficits.   
Specific molecular mechanisms underlying the effects of Cre recombinase activity on 
cells have not been studied in depth.  Significant effects of Cre expression, such as 
aneuploidy and DNA-damage-induced cell cycle arrest, have been demonstrated in non-
neuronal cells (Loonstra et al. 2001), and may underlie the memory deficits observed in 
L7 and R4 Cre mice.  In all three lines studied, Cre expression is present to various 
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degrees in the dentate gyrus (Fig. 4.1; see also Jackson Laboratories), a site of adult 
neurogenesis.  Experimental manipulations, such as x-irradiation, that induce genomic 
damage and arrest neurogenesis in the hippocampus lead to deficits in hippocampal 
memory, including contextual fear memory (Leuner et al. 2002, Saxe et al. 2006, 
Winocur et al. 2006, Drew et al. 2010).  Titration experiments in non-neuronal cells 
showed that  effects of Cre activity on proliferation are dose-dependent (Loonstra et al. 
2001), suggesting that effects of insertion site and copy number on transgene 
expression levels will likely have a strong influence on whether Cre-specific phenotypes 
emerge. 
In addition to effects on neurogenesis, chromosomal rearrangements and double strand 
breaks in mature neurons may disrupt epigenetic regulatory processes or interrupt 
coding sequences of genes critical for memory formation.  In MEFs, Cre activity led to 
reduced expression of multiple genes linked to memory and plasticity in the 
hippocampus, including Nur77, Nurr1, Rgs2, and Pkib (Gangoda et al. 2012, Hawk and 
Abel. 2011, Han et al. 2006). Differences in DNA accessibility among cell types may also 
influence off-target recombination rates, leading to tissue-specific effects of Cre 
expression. Because Cre is a site-specific recombinase, gene loci situated in 
chromosomal regions with higher incidence of cryptic loxP sequences would be 
predicted to be more vulnerable to recombination events than gene loci in regions with 
fewer cryptic sequences.  Bioinformatic analysis of predicted cryptic loxP sites in the 
murine genome could be used to predict vulnerability of individual gene loci to off-target 
Cre recombination events. 
A candidate molecular signaling pathway likely altered by Cre expression in the brain is 
the cAMP/PKA pathway.  MEFs expressing Cre exhibit increased expression of protein 
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kinase A inhibitor PKIβ, reduced PKA activity, reduced phosphorylation of PKA target 
protein CREB, and altered expression of genes involved in neuronal activity and memory 
(Gangoda et al. 2012).  The specific mechanism by which Cre expression led to changes 
in PKA signaling in the study is not known, but it is dependent on the recombinase 
activity of Cre (Gangoda et al. 2012).  Experimental reduction of PKA activity using 
inactive cAMP analogs or transgenic expression of dominant-negative regulatory 
subunits impairs contextual fear memory at the 24hr time point (Bourtchouladze et al. 
1998).  Cre-mediated reduction of PKA signaling raises serious concerns about studies 
that use Cre transgenic lines or viral delivery of Cre to study memory or circuitry in the 
hippocampus.   Additional studies are needed to uncover and characterize molecular 
mechanisms underlying effects of Cre expression on gene regulation and PKA signaling 
pathways. 
The male-specific cognitive deficits in CaMKIIα Cre L7 and R4 mice are the first example 
of sex differences in off-target effects of Cre expression.  Sex differences in spatial 
memory have been described in humans and rodents (Mizuno and Giese 2010, Driscoll 
et al. 2005), but it is unclear how these mechanisms might be affected by Cre 
expression.  In rodents, sex differences in fear conditioning have been linked to 
alterations in molecular signaling pathways and expression of memory-related genes, 
suggesting that the process of memory formation occurs differently in males and females 
at a molecular level (Gresack et al. 2009, Mizuno et al. 2006, Mizuno et al. 2007).  Sex 
hormones have been shown to increase cAMP levels (Rosner et al. 1999), and regulate 
the expression of PKI genes (Frasor et al. 2006, Zhou et al. 2010), supporting a role for 
sex hormones in mediating the sex-specific effects of Cre expression on memory.  
Enhanced signaling through the estrogen receptor in female animals could potentially 
129 
 
attenuate the effects of Cre expression on PKA signaling by stimulating cAMP 
production, and decreasing expression of PKI.  Future studies of molecular mechanisms 
underlying sex differences in memory formation, and mechanisms underlying effects of 
Cre expression in the brain will provide important insight into the process of memory 
consolidation and highlight important limitations inherent in Cre-mediated conditional 
recombination tools. 
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Chapter 4 Figure Legends 
 
Figure 4.1. Expression pattern of CaMKIIα Cre transgenic lines in the 
hippocampus and amygdala.  A.  Cre is expressed strongly in CA1 and the DG, and 
lightly in CA3 in the dorsal hippocampus of adult CaMKIIα L7 Cre mice.  B.  Cre is 
expressed in the lateral and basolateral nuclei of the amygdala in CaMKIIα L7 Cre mice.  
C.  In adult CaMKIIα R4 Cre mice, Cre is expressed strongly in area CA1 and in the DG 
of the dorsal hippocampus, but it is not expressed in area CA3.  D. CaMKIIα R4 Cre 
mice express Cre in the lateral and basolateral amygdala. 
Figure 4.2. Mild impairment of contextual fear memory in CaMKIIα L7 Cre mice.  A. 
L7 cre mice show reduced freezing when tested for contextual fear 24hrs after 
conditioning (two-way ANOVA: genotype F1,116 = 3.19, p<0.08, phase F1,116 = 4.51, 
p<0.001, genotype*phase F1,116 = 2.98, p<0.09; ttest: baseline p<0.96, 24hr test *p<0.04.  
B. Over the five minute exposure to the conditioned context, L7 Cre mice show a 
general reduction of freezing across the testing period (rmANOVA: genotype F1,232 = 
4.51, p<0.04, minute F1,232 = 6.75, p<0.001, genotype*minute F1,232 = 0.34, p<0.85).  C. 
When separated by sex, male L7 Cre mice exhibit a strong trend toward freezing deficits 
during the test (two-way ANOVA: genotype F1,73 = 2.95, p<0.1, phase F1,73 = 81.83, 
p<0.001, genotype*phase F1,73 = 3.49, p<0.07; ttest: baseline p<0.91, 24hr test 
p<0.052.)  D.  Female L7 Cre mice freeze at levels similar to wild-type mice during both 
baseline and test conditions (two-way ANOVA: genotype F1,86 = 0.66, p<0.43, phase 
F1,86 = 106.92, p<0.001, genotype*phase F1,86 = 0.58, p<0.46; ttest: baseline p<0.30, 
24hr test p<0.47.) 
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Figure 4.3. CaMKIIα R4 Cre male mice exhibit contextual long-term fear memory 
deficits.  A. R4 Cre mice exhibit robust freezing deficits when tested for long-term 
contextual fear memory (two-way ANOVA: genotype F1,41 = 5.2, p<0.03, phase F1,41 = 
116.53, p<0.001, genotype*phase F1,41 = 4.24, p<0.05; t-test: baseline p<0.76, 24hr test 
*p<0.03.)  B. R4 Cre mice show reduced freezing levels early in the contextual test 
phase when compared to wild-type mice (rmANOVA: genotype F1,23 = 1.17, p<0.3; 
minute F1,4 = 2.41, p<0.055; genotype*minute F1,4 = 2.56, p<0.05).  C.  Male R4 Cre 
exhibit significantly reduced freezing levels during the test session (two-way ANOVA: 
genotype F1,24 = 8.46, p<0.008, phase F1,24 = 116.34, p<0.001, genotype*phase F1,24 = 
8.43, p<0.008; t-test: baseline p<0.76, 24hr test *p<0.02).  D.  Freezing levels in female 
R4 Cre mice is not different from wild-types during baseline or test sessions (two-way 
ANOVA: genotype F1,13 = 0.71, p<0.42; phase F1,13 = 34.5, p<0.001; genotype*phase 
F1,13 = 0.17, p<0.69; t-test: baseline p<0.53, 24hr test p<0.46). 
Figure 4.4. Contextual fear memory is intact in CaMKIIα T29-1 Cre mice. A.  In 
baseline and contextual fear test sessions, freezing levels in T29-1 Cre mice are not 
significantly different from wild-type freezing levels (two-way ANOVA: genotype F1,84 = 
1.47, p<0.23, phase F1,84 = 411.1, p<0.001, genotype*phase F1,84 = 3.3, p<0.08; t-test: 
baseline p<0.39, 24hr test p<0.12.)  B.  Over the 5 minute test session, T29-1 Cre mice 
freeze at levels comparable or slightly higher than wild-type animals (rmANOVA: 
genotype F1,168 = 2.74, p<0.11; minute F1,168 = 2.14, p<0.08, genotype*minute F1,168 = 
0.57, p<0.69).  C.  Male T29-1 Cre mice show a small trend to increased freezing during 
the test session compared to wild-type males (two-way ANOVA: genotype F1,62 = 3.3, 
p<0.08; phase F1,62 = 389.63, p<0.001; genotype*phase F1,62 = 5.65, p<0.03; t-test: 
baseline p<0.26, 24hr test p<0.09).  D. Female T29-1 Cre mice exhibit freezing levels 
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that are not different from that of wild-type females during both baseline and test 
sessions (two-way ANOVA: genotype F1,40 = 0.66, p<0.43, phase F1,40 = 230.59, 
p<0.001, genotype*phase F1,40 = 0.374, p<0.55; t-test: baseline p<0.69, 24hr test 
p<0.48). 
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CHAPTER 5: GENERAL DISCUSSION AND FUTURE DIRECTIONS 
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Cognitive deficits are a highly disabling, and poorly understood aspect of many 
neurodevelopmental disorders for which there are no effective treatment options.  
Biochemical and genetic studies aimed at expanding our understanding of the molecular 
basis of cognition are a critical first step to identify targets for therapeutic agents and 
design successful treatment strategies.  In this dissertation, we used two approaches to 
explore the genetic basis of cognitive functioning: first using a single gene knockout 
model to validate a predicted ASD susceptibility gene, and secondly targeting a 
transcriptional regulatory complex that coordinates expression of genes critical for 
memory formation. We also uncovered a significant complication with one of the 
predominant genetic tools for conditional gene deletion in rodents.   
 
5.1 Understanding cognitive deficits in neurodevelopmental disorders using a 
candidate gene approach 
In Chapter 2, we validated Pcdh10 as a key molecule that regulates synaptic structure 
in the amygdala, and found that loss of one allele of Pchd10 led to deficits in social 
behavior and amygdala-dependent learning. Previously, genome-wide association 
studies of families with high incidence of ASD identified a novel copy number variation 
(CNV) affecting a region near multiple genes encoding members of the cadherin and 
protocadherin superfamilies, including Pcdh10 (Morrow et al. 2008). Because the CNV is 
more than 500kb downstream of the nearest protocadherin locus (Pcdh10) and did not 
include promoter or coding regions of the proposed candidate genes, it was unclear 
whether the deletion was likely to alter expression levels at these loci.  Additionally, 
Pcdh10 is a novel ASD candidate gene with limited genetic and molecular studies to 
support a link to the disorder.  To address a possible role for Pcdh10 in the 
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pathophysiology of ASD, functional studies are needed to demonstrate a role for 
PCDH10 in endophenotypes associated with the disorder. 
Because many neurodevelopmental disorders have complicated etiology likely involving 
multiple genetic and environmental factors, identification and validation of candidate 
genes and molecular pathways is critical to gain an understanding of central 
mechanisms.  Studies of PCDH10 function in the brain are limited, but functional studies 
link it to the Fragile X mental retardation protein FMRP (Tsai et al. 2012).  Pcdh10 is a 
regulatory target of FMRP linked to regulation of post-synaptic density stability and 
synapse number, key neuronal processes disrupted in Fragile X disorder (FX) (Tsai et 
al. 2012).  In Chapter 2, we used genetically modified mice to show that loss of a single 
copy of Pcdh10 resulted in cognitive deficits and social withdrawal behaviors, as well as 
alterations in structural and functional properties of synaptic connections that are 
remarkably similar to phenotypes observed in mice lacking FMRP expression. These 
studies provide further evidence that Pcdh10 regulates structural and functional 
properties of synapses, consistent with it being a functional target of FMRP that supports 
consolidation of emotional memory in the amygdala.   
PCDH10 is a newly identified functional target of FMRP, and it is unknown whether it 
plays a role in the pathophysiology of FX.  Knockdown experiments in primary cultured 
neurons from wild-type mice support a role for PCDH10 in dendritic spine elimination 
that is disrupted by aberrant translation elongation factor EF1α in Fmr1 KO mice, leading 
to increased spine density (Tsai et al. 2012).  In Pcdh10+/- mice, increased spine density 
and reduced gamma synchrony in amygdala neurons mirror structural and functional 
changes in Fmr1 KO cortical neurons, hinting at a common mechanism, yet important 
mechanistic differences are predicted in the two mouse lines.  Fmr1 KO mice exhibit 
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increased mGluR5 activity and overactive translation machinery- key functional changes 
proposed to underlie changes in spine density and synaptic plasticity (Tsai et al. 2012, 
Iliff et al. 2012).  In contrast, PCDH10 has yet to be linked to either translational 
regulation or mGluR5 activity.   We could start to address these possibilities by 
measuring protein translation rates in Pcdh10+/- tissue using a protein synthesis reporter 
system such as puromycin labeling.  Additionally, western blot experiments measuring 
activation of signaling molecules downstream of type I mGluRs such as PLC (see Fig. 
3.7) would indicate whether activity of mGluR5 was altered in Pcdh10+/- tissue.  Further 
dissection of synaptic mechanisms underlying synaptic phenotypes in Pcdh10+/- and 
Fmr1 KO neurons is a critical next step in understanding molecular pathways underlying 
changes in spine density in Fmr1 KO mice as well as the role of PCDH10 in spine 
elimination. 
In Chapter 2, we also showed that social deficits in juvenile Pcdh10+/- males could be 
rescued by treatment with the NMDAR partial agonist d-cycloserine (dCS).  
Experimental reduction of NMDAR subunit NR1 levels yields deficits in social approach 
and fear learning, as well as impaired gamma synchrony in mice (Dzirasa et al. 2009, 
Halene et al., 2009).  This array of phenotypes is highly similar to behavioral and 
electrophysiological changes in Pcdh10+/- mice, suggesting that reduced expression of 
NR1 could underlie the social deficts and therapeutic response we observed. To test this 
hypothesis, we are currently measuring synaptic levels of NMDAR subunits in 
subcellular fractions isolated from amygdala tissue of Pcdh10+/- mice.  Preliminary 
results suggest that levels of NR1 protein are reduced in the post-synaptic density of 
Pcdh10+/- mice (A. Bannerjee, unpublished results).   
142 
 
PCDH10 facilitates degradation of PSD95, a synaptic structural protein involved in 
clustering NMDARs and AMPARs at the PSD (Tsai et al. 2012, Yan et al. 2014); 
however, the reduction in NR1 protein levels suggested by our preliminary studies is not 
entirely consistent with the current model of PCDH10 function.  In the Huber model (Tsai 
et al. 2012), knockdown of PCDH10 levels in cultured primary cortical neurons leads to 
stabilization of PSD95 and spine preservation.  Increased synaptic PSD95 is associated 
with increased spine density and increased AMPAR-mediated synaptic transmission (El-
Husseini et al. 2000, Beique and Andrade 2002).   In our mouse, reduced PCDH10 is 
associated with increased spine density but the dCS rescue and NR1 protein levels 
suggest a mechanism involving NDMAR hypofunction.  We did not observe a change in 
amplitude of field responses in the BLA (Fig. 2.10C); suggesting that reduced NMDAR 
function may be accompanied by increased activation of other receptor types, including 
AMPARs.  To unravel this mechanism, more specific dissection of NMDAR/AMPAR 
function is needed.  Whole cell patch clamp recordings designed to distinguish NMDAR 
activity from AMPAR activity will provide a critical functional readout of the relative 
activity of these receptor types, and indicate whether one or both currents are altered in 
Pcdh10+/- neurons.  Additionally, Western blots for synaptic and total levels of PSD95 in 
Pcdh10+/- amygdala tissue will indicate whether reduction of PCDH10 in our mouse 
affects levels of PSD95.  Because the current model of PCDH10 function is based off of 
experiments conducted in cultured cortical neurons harvested from neonatal mice, 
important molecular differences between tissues and developmental stages explain the 
different patterns of electrophysiological and protein changes we observe in 30d old 
mice.  In rodents, expression of NMDAR subunits and functional properties of the 
resulting channels are highly dynamic during the first post-natal week (Monyer et al. 
1994).  Certain experiments in our study were conducted in juvenile mice (social testing, 
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protein levels, electrophysiology), while other experiments were conducted in adult 
animals (cognitive tasks, spine counts).  Additional studies of PSD composition, dendritic 
spine morphology, and electrophysiological properties of Pcdh10+/- neurons from mice of 
different ages will provide important insight into the function of PCDH10 and its 
regulation of structural and functional properties of synapses across development. 
A major theme from Chapter 2 is that exploration of molecular pathways containing 
existing ASD-associated proteins is not only critical for understanding pathological 
processes, but is also a strategy for discovering novel candidates. In a molecular 
pathway that is a critical mechanism underlying ASD phenotypes, major regulatory and 
enzymatic factors should be investigated as potential risk genes by merit of their 
essential role in the pathway.  In the FMRP-PCDH10 pathway, modification of PSD95 by 
the ubiquitin ligase murine double minute 2 (MDM2) is a critical step upstream of its 
degradation. An oncogene best studied for its role in promoting degradation of the tumor 
suppressor p53, MDM2 is only beginning to be explored in the context of neuronal 
function and cognition (Tsai et al. 2012, Richmany et al. 2013).  Existing 
pharmacological tools for inhibiting MDM2-mediated degradation of p53 could potentially 
be used to experimentally stabilize PSD95 (Rew et al. 2012).  Future studies of MDM2 
and its role in synaptic structure and memory formation will provide insight into this novel 
mechanism for regulating a major post-synaptic structural protein. 
 
5.2 Gene silencing is a critical regulatory mechanism during memory formation. 
Gene expression is a tightly regulated process that is a required step in the formation of 
memory traces in the brain.  Loss of activity-dependent gene regulatory factors has been 
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observed in multiple neurodevelopmental and neuropsychiatric disorders with associated 
cognitive dysfunction (Section 1.3).  Studies of histone deacetylases and HDAC inhibitor 
drugs have uncovered strong potential in epigenetic regulation of gene expression as 
promising strategy for cognitive enhancement.  In Chapter 3, we identified Sin3a as a 
gene silencing complex that represses expression of synaptic genes, and acts as a 
negative regulator of memory and synaptic plasticity in the hippocampus.  We showed 
that Sin3a neuronal hypomorph mice exhibit enhancements in long-term contextual fear 
memory, and late-phase LTP.  The memory enhancement was accompanied by 
increased expression of Homer1 a gene that encodes a synaptic scaffolding protein 
involved in regulating signaling through type I mGluRs.  Increased expression of long 
isoforms of HOMER1 and enhanced signaling through mGluR5 have both been linked to 
enhancements in memory consolidation and long-lasting forms of synaptic plasticity 
(Klugmann et al. 2008, Gerstein et al. 2012, Ayala et al. 2009).  In Sin3aNH animals, we 
also see an enhanced role for mGluR5 in maintenance of L-LTP and increased 
activation of mGluR5 downstream target ERK.  Our findings are consistent with a role for 
SIN3A in regulating memory and plasticity via HOMER1/mGluR5 signaling pathways. 
The link we discovered between enhanced synaptic plasticity and changes in synaptic 
mGlur signaling is a unique and significant step forward in our understanding of the role 
of epigenetic modifiers in memory enhancement models.  Previous studies of memory-
related HDACs including HDAC2 and HDAC3 found structural and functional changes in 
synapses, as well as enhanced memory consolidation in hippocampal tasks, but the 
mechanism by which these HDAC proteins regulate synaptic function has remained 
elusive (Guan et al. 2009, McQuown et al. 2011).  Studies of gene targets of HDAC 
inhibitors during memory consolidation have led to the identification of a key transcription 
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factor, yet have yielded little insight into synaptic mechanisms (Vecsey et al. 2007, 
McQuown et al. 2011, Mahan et al. 2012).  Given the level of interest directed toward 
cognitive enhancement, and the strong and consistent nature of memory enhancement 
phenotypes associated with HDAC inhibition, the current lack of mechanistic 
understanding of its molecular underpinnings is disquieting.   
Mechanisms of memory enhancement 
In our study, we take a novel approach by targeting a large co-repressor complex with 
multi-modal functions affecting multiple histone and DNA modifications, an approach that 
strongly deviates from previous studies exclusively focused on histone acetylation.  
Epigenetic modifying enzymes are frequently found in regulatory complexes with other 
modifiers, where carefully coordinated synergistic activity is likely a critical component of 
their function (Section 1.3).  By targeting the scaffold protein at the heart of the complex, 
we are able to explore the function of the entire Sin3a co-repressor complex (Fig. 3.1).  
This approach allowed us to uncover a molecular mechanism not affected by acute 
blockade of HDAC function alone.  We observed elevated levels of long Homer1 
transcripts in Sin3aNH animals 1hr after contextual conditioning; however, levels of long 
Homer1 isoforms are not altered at the same time point in animals treated with the 
HDAC inhibitor TSA ( Fig. A.1).  This is a critical discovery, because if future studies find 
that the memory enhancements observed in Sin3aNH mice do depend on increased 
expression of long Homer1 isoforms, then the enhancements operate via a different 
mechanism from that of acute HDAC inhibitor treatment.  Two possible epigenetic 
mechanisms could explain the memory enhancements in Sin3aNH animals.   
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First, a single one-hour blockade of HDACs may be too brief to fully reverse effects of 
stable silencing machinery, such as the SIN2A complex.  Histone acetylation is known to 
be an important regulator of the Homer1 locus in the hippocampus.  A transient increase 
in acetylated H3 at the common promoter of Homer1 following contextual conditioning is 
associated with induction of only short isoform Homer1a expression, and not long 
isoforms Homer1b/c (Mahan et al.2012).  These findings suggest that long and short 
Homer1 isoforms are regulated by different mechanisms, and that extended HDAC 
inhibitor treatment may be needed to re-organize epigenetic mechanisms that regulate 
long Homer1 isoforms.  The SIN3A complex facilitates deacetylation through the activity 
of three main catalytic partners: HDAC1, HDAC2, and HDAC3.  HDAC2 and HDAC3 
both independently enhance memory and plasticity (McQuown et al. 2011, Guan et al. 
2009), and it is not known which co-repressor(s) mediate these effects.  If changes in 
Homer1/mGLuR5 signaling in Sin3aNH mice are due to loss of HDAC activity, memory 
enhancements in Sin3aNH and HDAC2/3 KO mice likely occur through the same 
mechanism.  Although possible, it is unlikely that multiple groups studying constitutive 
HDAC KO mice failed to uncover this mechanism.  To test for a common mechanism, 
gene expression studies in HDAC2 and HDAC3 KO mice focused on levels of Homer1 
isoforms, followed by functional studies of mGluR5 activity are be needed to determine 
whether Homer1 expression and mGluR5 signaling is altered with long-term loss of 
HDAC recruitment.  
A more parsimonious interpretation of the inability of TSA to affect long Homer1 
expression implicates a novel mechanism of memory enhancement in Sin3aNH mice 
that is not dependent on histone acetylation.  Binding partners of the SIN3A co-repressor 
include modulators of both histone and DNA methylation (Fig. 3.1).   H3K9 
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methyltransferase activity via SIN3A binding partner SETDB1 engages repressive 
machinery including nucleosome compaction via the NuRD complex helicase Mi-2, and 
DNA methylation through recruitment of HP1α/DNMT1 (Section 1.3). The promoter 
region of Homer1 contains a CpG island that overlaps with the predicted peak binding 
site for SIN3A in non-neuronal cells that can function both as a substrate for DNA 
methylation, and a subsequently as a binding site for MeCP2, a methyl-DNA binding 
factor that recruits DNMT1 and the SIN3A and CoREST co-repressors (Fig. 1.5).  This 
intriguing theory suggests that we have discovered a novel mechanism of memory 
enhancement that is separate from effects of HDAC manipulations, and engages histone 
and/or DNA methylation mechanisms.  Additional studies of epigenetic regulation of 
Homer1 locus in both wild-type and Sin3aNH mice are needed to explore open 
questions concerning the role of large complexes such as the SIN3A co-repressor as 
multi-modal regulators of epigenetic landscapes at gene loci.  Immuno-precipitation 
experiments in Sin3aNH and control mice to measure levels of activating (AcH3, 
H3K4me) and repressive (H3K9me) histone marks, as well as DNA methylation at the 
SIN3A binding site on the Homer1 promoter will provide critical insight into the pertinent 
catalytic activities of the SIN3A complex at this locus.   If changes in DNA methylation 
are observed, studies to probe for SETDB1 and MeCP2 localization can be followed up 
by conditional knockdown studies to identify the key factor(s) involved in regulating long 
Homer1 transcription.  Changes in levels of hydroxymethycytosine mediated by SIN3A 
binding partner TET1 are unlikely to be a central mechanism for memory enhancement, 
as contextual memory is not affected in TET1 KO mice (Rudenko et al. 2013). 
Unraveling epigenetic regulation Homer1 locus by SIN3A 
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Future studies of the localization and epigenetic regulatory functions of the SIN3A 
complex under baseline conditions compared to learning conditions are an important 
next step in getting a more complete picture of SIN3A function in the brain.  Our studies 
of gene expression changes in Sin3aNH mice were all conducted in tissue collected 
from trained animals (Fig. 3.6).  Upcoming experiments measuring baseline expression 
of long and short Homer1 isoforms in tissue collected from naïve Sin3aNH and control 
animals will determine whether the increase in long isoforms is related to activity-
dependent processes.  The Homer1 locus contains a single promoter and transcription 
start site from which short (Homer1a and Ania-3) and long (Homer1b/c) isoforms are 
differentially expressed via alternative splicing and poly-adenylation (poly-A) site 
selection (Niibori et al 2007, Flavell et al. 2007, Fig. 3.7).  Long isoform transcripts 
containing exons 7-10 are expressed constitutively, and levels are not altered by 
depolarization events (Bottai et al. 2002, Mahan et al. 2012).  Induction of short isoform 
expression following neuronal activity is thought to occur through an increase in 
transcription levels combined with a switch to internal poly-A sites in the 3’ UTRs of exon 
5 and exon A (Bottai et al. 2002, Figure 3.7).  ChIP seq experiments suggest that 
histone methylation, SIN3A, and SIN3A binding partner MEF2 are important regulators 
of alternate splicing and poly-A site selection (Zhou et al. 2012, Flavell et al. 2008).   
The regulation of isoform-specific expression at the Homer1 locus is not understood, but 
further studies of baseline Homer1 isoform expression in Sin3aNH animals may provide 
insight into this mechanism.  In Sin3aNH animals, we saw increased expression levels of 
both short and long Homer1 isoforms following fear conditioning (Fig. 3.6).  The simplest 
explanation of this result involves a mechanism in which SIN3A acts as a braking 
mechanism slowing the rate of transcriptional activation at the Homer1 locus. Release of 
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this braking mechanism in Sin3aNH animals would lead to increased baseline 
expression of long Homer1 transcripts in Sin3aNH animals.  Higher rates of transcription 
coupled with intact poly-A site selection would yield the higher rates of short isoform 
expression we observed in trained animals.  Alternately we might find that long isoform 
levels are not changed under baseline conditions in Sin3aNH animals.  This outcome 
would indicate impairment poly-A site switching, and loss of isoform-specific expression.  
If this is the case, the results in Fig. 3.6 reflect activity-dependent induction of both long 
and short Homer1 transcripts following contextual conditioning.  Because poly-A site 
selection is a critical process that affects many gene loci involved in neuronal function 
(Flavell et al. 2008), mis-regulation of this process is unlikely to have beneficial effects 
on memory formation.    It is highly unlikely that both transcriptional output and splicing 
are mis-regulated in Sin3aNH animals, leading to increased expression of both long and 
short isoforms at baseline.  Aberrant expression of short isoform Homer1a is associated 
with poor cognitive performance and deficits in synaptic plasticity (Manahan et al. 2012, 
Menard and Quirion 2012, Celiekel et al, 2007, Sala et al. 2003), a pattern that is not 
consistent with the phenotype of Sin3aNH animals. 
Non-epigenetic mechanisms of SIN3A function 
In addition to epigenetic regulatory activities, the SIN3A complex also contains non-
epigenetic activity mediated by its binding partner O-linked N-acetylglucosamine (O-
GlcNAc) transferase (OGT) (Fig. 3.1).  O-glycosylation is a reversible post-translational 
modification that can impact the function of transcriptional regulatory machinery on 
multiple levels.   O-glycosylation of key phosphorylation sites on the RNA polymerase II 
C-terminal domain (CTD) has been linked to retention of Pol II at the TSS (Comer et al. 
2001).  O-glycosylation also reduces transcriptional activation by CREB.  Blocking 
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glycosylation of a key phosphorylation site on CREB (serine 40 to alanine) leads to 
increased transactivation of its target genes and enhances contextual fear memory 
(Rexach et al. 2012).  Loss of SIN3A-mediate recruitment of OGT to the Homer1 
promoter could result in increased transcriptional activation through one or both of these 
mechanisms.  Should ChIP experiments show that OGT is present at the Homer1 locus, 
we could follow up with experiments to determine whether long Homer1 isoforms are up-
regulated in memory-enhanced mice expressing S40A CREB. 
Synaptic changes in Sin3aNH mice 
Another future direction pertaining to Chapter 3 is to explore mechanisms underlying 
synaptic structural and functional effects of increased Homer1 expression.  We showed 
that increased expression of long Homer1 isoforms was accompanied an expanded role 
for mGluR5 in synaptic plasticity, and additional electrophysiological studies indicate that 
signaling through mGluR5 is enhanced (Morgan Bridi, unpublished data). Increased 
expression of Homer1 is sufficient to enhance memory and increase mGluR5 signaling 
during LTP (Klugmann et al. 2008, Gerstein et al. 2012), but the synaptic basis of these 
effects is not understood.  In our model, we have only begun to uncover structural and 
functional changes underlying the memory and plasticity enhancements we observed.  
Experiments measuring levels and localization of synaptic proteins in Sin3aNH are a 
critical next step.  Validation of protein levels changes in HOMER1 proteins and PSD 
localization of mGluR5 are critical next steps needed to support our model.  Due to the 
lack of signaling mechanisms specific to mGluR1/5, activation of synaptic and nuclear 
calcium signaling factors cannot be definitively attributed to activity of mGluR1/5 
receptors, and thus cannot be used to validate our model.  Despite this drawback, 
detailed studies of synaptic protein levels and their activity patterns would provide a 
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valuable window into the molecular changes that support enhanced synaptic plasticity 
and memory in this model.  
Enhancements in memory, plasticity, and ERK signaling are consistent with a 
mechanism whereby enhanced mGluR5 signaling facilitates memory formation, but do 
not definitively demonstrate that the increases in Homer1/ mGluR5 signaling underlie the 
enhancement of plasticity we observed.  Classical approaches to demonstrate necessity 
typically focus on functional blockade, but this is a difficult approach for exploring 
enhanced functioning.  For example, Homer1 and mGluR5 are both critically important 
for memory formation, so knockout or blockade approaches result in general memory 
impairments that do not address our mechanism (Ronesi et al. 2008, Mahan et al. 2012, 
Gerstein et al. 2012, Schulz et al. 2001).  What we need is a subtle approach to reduce 
the excess Homer1/mGluR5 signaling and achieve a ‘down-rescue’ of the enhanced 
plasticity in a way that doesn’t impair plasticity in our control animals.  Carefully 
controlled titration experiments involving viral knockdown of long Homer1 isoforms or 
using a soluble peptide to uncouple Homer1-mGluR5 interactions would be the best 
approach to address this important question. 
5.3 Important considerations for genetic models 
A key advantage to using rodent genetic models in neuroscience research is the ability 
to intricately dissect molecular mechanisms underlying cellular, network, and behavioral 
phenotypes.  Despite continual development of increasingly powerful tools, two areas 
have been consistently overlooked in studies of genetic models of neurodevelopmental 
disorders: sex differences and limitations of the aforementioned tools.  In Chapter 2 and 
Chapter 4, we found male-specific impairment of memory formation in mice lacking the 
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autosomal gene Pcdh10 and also in mice expressing Cre recombinase in forebrain 
neurons.  
In Chapter 2, we observed impairments in social behavior and emotional memory in 
male but not female mice haploinsufficient for Pcdh10.   Because of the significant and 
poorly understood predominance of ASD incidence in male children, behavioral and 
cognitive tasks were conducted in both male and female Pcdh10+/- mice.  Oddly, multiple 
studies of ASD model mice focus exclusively on male animals, and do not consider sex 
differences (Penagarikano et al. 2011, Jamain et al. 2008, Tsai et al. 2012, Peca et al. 
2011).  Because we observed sex differences in behavioral responses, we are able to 
explore the biochemical effects experimentally in our mice.  Sex differences are 
fundamentally related to either sex chromosome complement or activational changes 
following exposure to steroid sex hormones during gestation and post-puberty.  Social 
changes in juvenile Pcdh10+/- males prior to puberty show reduced social interactions, 
indicating that sex-differences in social functioning emerge early in life.  A pattern of 
early-onset social differences has also been found in studies of toddlers with ASD, 
suggesting a possible mechanistic role for sex chromosomes or early exposure to sex 
hormones before puberty (Landa et al. 2007, Werling and Geschwind 2013, Baron-
Cohen et al. 2011).   
Prior to onset of puberty, sexual dimorphism can occur through both chromosomal and 
hormonal mechanisms (Arnold and Chen, 2009).  The Y chromosome is dominantly 
comprised of a ‘male-specific’ region that is not engaged in crossover events with the X 
chromosome, and contains multiple genes encoding transcription and translation 
regulatory proteins (Skaletsky et al. 2003).  Several of these Y-specific genes, including 
the transcription factor Sry are expressed in the brain, providing a possible mechanism 
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by which expression of transcripts and proteins in the brain may be differentially 
regulated in males (Xu et al., 2002 and 2006; Skaletsky et al., 2003).  Expression of Sry 
in the substantia nigra of male rodents is correlated with levels of dopamine production, 
supporting a role for the Y chromosome in sexual dimorphism in motor and reward 
functioning (Dewing et al. 2006).  Additionally, homologous sex-linked genes show 
differential expression in male and female mice, with 13 X-linked genes identified by 
RNA sequencing as incompletely inactivated in XX female mice (Fisher et al., 1990; 
Yang et al., 2010).  Sex-dependent changes in gene expression in the brain have been 
described in mice at very early time points prior to differentiation of the gonad, providing 
evidence for the presence of chromosomal or non-gonadal gene regulatory mechanisms 
(Dewing et al. 2003).  In addition to chromosome complement, exposure to sex steroid 
hormones during the late pre-natal and early post-natal period induces organizational 
changes in brain structure and function in rodents (de Vries et al. 2014).  Sex-specific 
volumetric changes in the brain have been described for cortical, hypothalamic, and 
extended amygdala regions in pre-pubertal children, and volumetric changes in the 
extended amygdala have been linked to developmental testosterone exposure in 
rodents (Lombardo et al., 2012; del Abril et al.,1987).  Additionally, organizational effects 
of neonatal testosterone exposure have been linked to sex differences in the pattern of 
estrogen receptor and tyrosine hydroxylase expression in the rodent brain (MacLusky et 
al. 1997; King et al. 2000).  These studies provide strong evidence for effects of 
chromosome complement and early sex hormone exposure on neuronal gene 
expression, amygdala volume, and behavioral changes in tasks that engage midbrain 
dopamine circuits, such as social interaction (Gunaydin et al. 2014).  
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In our haploinsufficiency model, our Pcdh10+/- animals carry a single copy of the intact 
Pcdh10 locus that could be subject to sex-dependent compensatory regulation.  
Quantitative PCR experiments to measure expression levels of Pcdh10 in male and 
female Pcdh10+/- juveniles and adults are an important first step to determine whether 
levels of PCDH10 are altered in a sex-dependent manner.  Future studies to explore 
emergence of fear memory deficits in Pcdh10+/- mice combined with experimental 
manipulation of sex chromosome complement and exposure to sex hormones will 
provide important insight into molecular mechanisms underlying the sex-dependent 
nature of these deficits.  To determine whether sex chromosome complement affects 
sex dependence of social and memory deficits, we are currently behaviorally 
characterizing gonadally female XY- Pcdh10+/- mice carrying a mutated copy of the Y 
chromosome lacking the male organizing locus Sry (Arnold and Chen 2009).  
Additionally, neonatal castration of XX mice carrying a Sry transgene would reveal 
organizational effects of Sry expression in the absence of testosterone exposure.  To 
explore effects of hormone exposure early in life, experiments to exogenously 
manipulate sex hormone effects through gonadectomy with or without sex hormone 
replacement are also being conducted in Pcdh10+/- male and female animals. 
In Chapter 4, we found unexpected sexually dimorphic fear memory deficits in mice 
expressing Cre recombinase.  Cognitive deficits have not previously been described in 
mice only expressing Cre recombinase, and the mechanisms underlying this effect are 
unclear.  Studies of cultured embryonic fibroblasts found reduced cAMP/PKA signaling 
(Gangoda et al. 2012), but it is not clear whether these changes reflect increased 
susceptibility at the PKI locus to deleterious effects of Cre, or whether these changes 
reflect line-specific differences such as a locus-specific effect of the transgene insertion 
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site.  Bioinformatics approaches to identify genomic regions with high incidence of 
cryptic loxP sequences would provide useful information that could be used to predict 
gene loci with increased susceptibility to Cre effects, but further efforts to mechanistically 
explore Cre effects in the brain cross over into the realm of morbid curiosity.  Efforts 
toward improving the tool to reduce deleterious effects are more likely to benefit the field.  
LoxP flanked Cre transgenes have been put forward as one promising method to reduce 
the duration of Cre expression and thereby reduce off-target effects (Silver and 
Livingston, 2001).  Sex differences observed in the R4 Cre mice are puzzling, but 
experiments to uncover sex differences in memory formation would be more useful 
outside of variable background effects of Cre expression.  Studies of sex differences in 
memory processes in wild-type mice, or in genetic models with sex differences in 
memory formation, such as Pcdh10+/- mice, will provide novel insights into mechanisms 
of memory consolidation. 
5.4  Concluding remarks 
In this dissertation, I explored genetic and epigenetic regulation of synaptic structure and 
function, and how these factors impact memory consolidation.  We explored 
mechanisms underlying memory impairment in Chapter 2, as well as memory 
enhancement in Chapter 3. In both these studies, we traced the memory phenotype 
back to effects on glutamatergic signaling at the post-synaptic density.  PCDH10 is a 
synaptic protein that has a direct role in the PSD regulating the stability of key structural 
protein PSD95, and through PSD95, it modulates the localization and function of a wide 
array of glutamatergic receptors and calcium signaling pathways.  Mice haploinsufficient 
for Pcdh10 show behavioral and electrophysiological changes highly suggestive of 
reduced NMDAR function (Fig. 2.10, 2.11).  In Sin3aNH animals, effects of reduced 
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SIN3A indirectly modulate synaptic function through epigenetic regulation of synaptic 
structural protein HOMER1.  HOMER1 is a strong modulator of glutamatergic signaling, 
particularly through type I mGluRs (Fig. 3.8, 3.12), and the increased expression of long 
isoforms we observed is associated with enhanced mGluR5 signaling.  At first glance, it 
appears that the directionality of changes we see in memory neatly align with effects on 
glutamatergic signaling- impaired signaling in mice with memory deficits and increased 
signaling in mice with memory enhancement.  However, closer inspection of pathological 
glutamatergic signaling in Fragile X syndrome reveals an important caveat. 
Overactive glutamatergic signaling through metabotropic receptors leads to cognitive 
and synaptic deficits in Fragile X, indicating that the positive relationship between mGluR 
signaling and cognition observed in Sin3aNH has a limited scope.  Cognitive impairment 
is found both with reduced mGluR signaling observed in schizophrenia and with 
overabundant mGluR signaling in Fragile X, yielding the classic inverted U-shaped 
relationship (Fig. 5.1).  In Sin3aNH animals and animals treated with positive allosteric 
modulators of mGluR5, there is an expansion of mGluR5 signaling that bolsters memory 
formation without over-reaching into maladaptive responses.  This mechanism of 
memory enhancement could be a powerful tool for overcoming cognitive deficits, but it is 
not a magic bullet.  Molecular changes underlying the enhanced synaptic plasticity in 
Sin3aNH animals show many of the same directional changes as synaptic changes 
observed in Fragile X models (Fig. 5.2), suggesting that in Fmr1 KO mice, reducing 
expression of SIN3A would be damaging rather than therapeutic.  Similarly, reducing 
SIN3A levels in Pcdh10 haploinsufficient mice may also prove detrimental if the memory 
and dendritic spine deficits we observed (Chapter 2) are mechanistically similar to those 
of Fmr1 KO mice.   On the other hand, reduced signaling through type I mGluRs has 
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been observed in schizophrenia models, including Nrg1 mutant mice.  Therapeutic 
approaches to enhance mGluR signaling are promising therapeutic options for the 
treatment of negative symptoms in schizophrenia. 
These studies highlight important challenges in identifying therapeutic targets for 
neurodevelopmental and neuropsychiatric disorders, and underscore the need for 
detailed studies addressing molecular mechanisms of synaptic function.  Cognition 
requires a delicate balance of signaling through a wide array of receptors and signaling 
pathways, therefore therapeutic approaches must therefore be specifically targeted to 
affected pathways.  Careful dissection of structural and signaling processes at the 
synapse is a critical component both in pathological and therapeutic models.  It is 
through a detailed and careful exploration of the molecular basis of memory formation in 
synapses that we will gain insight into how to properly develop effective therapeutics to 
improve cognitive functioning using epigenetic or neuropharmacologic strategies. 
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Chapter 5 Figure Legends 
 
Figure 5.1.  Inverted U-shaped relationship between cognition and mGluR 
signaling. Signaling through metabotropic glutamate receptors is critical for cognitive 
processes.  Neurodevelopmental and neuropsychiatric disorders such as schizophrenia 
and Fragile X syndrome are associated with deficient or excess mGluR signaling, 
respectively.  In Sin3aNH mice, enhanced mGluR5 signaling likely reaches a therapeutic 
threshold above typical levels, but remains below pathological levels observed in Fragile 
X. 
Figure 5.2.   Post-synaptic mGluR5 and NMDAR signaling in mouse models.  A. 
Calcium signaling and ERK activity downstream of mGluR5 and the NMDAR activates 
transcription and translation mechanisms required for long-term memory.  B. In Sin3aNH 
mice, increased signaling through mGluR5 increases calcium signaling, leading to 
increased phosphorylation of ERK, elevated transcriptional activation, and enhanced 
memory.  C.  In Fmr1 KO mice, increased signaling through mGluR5 leads to increased 
pERK and increased translation.  Over-active transcription leads to reduced post-
synaptic responses mediated by AMPAR and voltage gated calcium channels, and 
impaired memory.  D.  In Pcdh10+/- mice, NMDAR function is decreased, but the 
amplitude of post-synaptic responses is not altered.  Amygdala-dependent memory is 
impaired.  (red = increased, blue = reduced, ? = not determined) 
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APPENDIX 
  
163 
 
In addition to the main directions of my research, expanded my studies into other 
directions that greatly enhanced my understanding of gene regulation during memory 
consolidation, as well as increased my knowledge of social behavior in mouse models of 
autism.  Here, I will briefly describe additional studies that are ongoing, part of 
manuscripts in preparation, or already published. 
 
A1. Short-term regulation of Homer1 expression in the hippocampus by the HDAC 
inhibitor Trichostatin A (TSA).   
Introduction 
Histone acetylation is associated with transcriptional activation, and both histone 
acetylation and expression of acetylation-regulated genes are increased during memory 
consolidation (Levenson et al. 2004, Mahan et al. 2012, Maze et al. 2013). 
Pharmacological blockade of HDAC function is a well-established strategy for memory 
enhancement in rodents (Vecsey et al.2007, Alarcon et al. 2004, Levenson et al. 2004, 
McQuown et al. 2011).  Previous work from our lab and others has shown that 
administration of the histone deacetylase inhibitor TSA enhances hippocampal memory, 
synaptic plasticity, and increases memory-related gene expression (Vecsey et al. 2007, 
Levenson et al. 2004, Hawk et al. 2011; Fig. 3.5).  One memory-related gene with 
increased expression following HDAC inhibitor treatment is Homer1 (Mahan et al. 2012).  
Interestingly, we see increased expression of Homer1 in Sin3aNH mice following 
contextual conditioning (Fig. 3.7), affecting both long and short splice variants (Fig. 3.8).  
Because previous studies only investigated expression of short isoform Homer1a 
following HDAC inhibitor treatment, we examined expression of long Homer1 isoforms 
following acute TSA treatment. 
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Methods 
Mice were maintained under standard conditions consistent with National Institute of 
Health guidelines for animal care and use, and all procedures were approved by the 
Institutional Animal Care and Use Committee of the University of Pennsylvania.  Mice 
were maintained on a 12 hr light-dark cycle and provided with food and water in their 
home cages ad libitum. Adult male C57BL/6 mice were fitted with bilateral hippocampal 
guide cannulae as previously described (Hawk et al. 2012).  Singly housed mice were 
handled for three days prior to training in contextual fear conditioning as described in 
Section 3.2.  Immediately after training, mice were injected bilateral injections of 1.0uL 
Trichostatin A dissolved in 50% ethanol, or an equal volume of 50% ethanol (vehicle) as 
previously described (Hawk et al. 2012).  One hour after training, hippocampi were 
collected, and RNA was isolated as described in Section 3.2.  Quantitative PCR was 
performed using Taqman assays targeting exons 3-4 or exons 7-8 of Homer1 (Applied 
Biosystems) were used to amplify target isoforms.  ∆∆Ct values were calculated as 
described in Section 3.2.   
 
Results 
Expression levels of long Homer1 isoforms were differentially affected by acute post-
conditioning treatment with TSA.  Expression of transcripts containing common exons 
shared by both long and short Homer1 isoforms is increased in TSA treated animals 
compared to vehicle treated animals.  In contrast, levels of transcripts containing exons 
specific to long Homer1 isoforms is not altered by acute treatment with TSA.   These 
results are consistent with a role for histone acetylation in the regulation of short 
isoforms of Homer1 during memory formation, but not long isoforms. 
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Discussion 
In this experiment, we found that regulation of Homer1 isoforms is differentially impacted 
by acute treatment with the HDAC inhibitor TSA.  Activity-regulated short isoform 
Homer1a is up-regulated by TSA treatment, but levels of long Homer1 transcripts 
containing the common final exon 10 does not change.  These results suggest that short 
and long Homer1 isoforms are regulated by different epigenetic mechanisms following 
fear conditioning, and that expression of long Homer1 isoforms is not dependent on 
changes in histone acetylation at this time point. 
  
Contributions 
J.D. Hawk and H. Schoch designed the experiment.  J.D. Hawk trained the animals and 
collected the tissue.  H. Schoch performed the gene expression assay. 
 
 
A2. Social behavior not altered in genetic models of autism 
 
Reciprocal social interaction is one of the core features of autism spectrum disorders.  
Individuals with ASD show atypical frequency and quality of social interactions that 
emerges early in development and extend into adulthood (Landa et al. 2007, Nacewicz 
et al. 2006).  ASD is a highly heritable disorder, and genomic studies have identified 
many genetic polymorphisms and copy-number variants (CNVs) associated with the 
disorder (Michelson et al. 2012, Sanders et al. 2012).  Two of the more common 
polymorphisms linked to syndromic forms of ASD are the 16p11.2 microdeletion 
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(Fernandez et al. 2010) and variants in the gene contactin associated protein-like 2 
(CNTNAP2) (Burbach and van der Zwaag 2008, Alarcon et al, 2008, Arking et al. 2008).  
Social deficits have been described in CNTNAP2 deficient mice (Penagarikano et al. 
2011), but a lack of social phenotypes has been described in mouse models carrying a 
single copy deletion affecting the conserved murine 16p11.2 region (Horev et al. 2011, 
Portmann et al. 2014).  Here we investigate social approach behavior in mouse models 
of 16p11.2 microdeletion and CNTNAP2 deficiency. 
 
Methods 
Mice were maintained under standard conditions consistent with National Institute of 
Health guidelines for animal care and use, and all procedures were approved by the 
Institutional Animal Care and Use Committee of the University of Pennsylvania.  Mice 
were maintained on a 12 hr light-dark cycle and provided with food and water in their 
home cages ad libitum. Mice heterozygous for deletion of the murine conserved locus 
corresponding to the 16p11.2 human microdeletion (16p11.2 del) (Horev et al. 2011) 
were obtained from Jackson Laboratories, and bred in house on a mixed B6/129 genetic 
background.  Adult mice 63-77 days of age were tested in social choice.  CNTNAP2 
knockout mice (Pengarikano et al. 2011) were obtained from Jackson Laboratories, and 
bred in house on a B6 background.  Juvenile mice aged 28-32 days old were tested in 
social choice.  Social testing was conducted as described in Section 2.2.  Social 
behavior was scored using Top Scan automatic behavior analysis software, and average 
time spent sniffing social and non-social cylinders was reported for mice of each sex and 
genotype combination.  Social preference scores were computed for each phase as the 
fraction of time spent sniffing social cylinder divided by total time spent sniffing both 
cylinders. 
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Results 
No differences in social approach behavior were observed adult 16p11.2 del males or 
juvenile CNTNAP2 knockout mice.  Male 16p11.2 del mice spend similar amounts of 
time sniffing the social cylinder during Phase 2 when the stimulus mouse is present (Fig. 
A.2A).  Compared to wild-type females, female 16p11.2 del mice show decreased time 
spent exploring the empty social cylinder and empty non-social cylinder during Phase 1 
prior to addition of novel object and novel mouse, and also spend less time sniffing the 
social cylinder containing the novel mouse during Phase 2 (Fig. A.2B).  However, when 
we normalize for differences in overall sniffing and calculate the ratio of time spent 
interacting with the social cylinder vs non-social cylinders, all groups show significant 
preference for the social cylinder (Fig. A.2C).  This result suggests that the differences 
in total sniffing observed in Phase 1 and Phase2 in female mice reflects a decreased 
baseline level of exploratory behavior in the deleted animals, and not a difference in 
sociability.  Male and female CNTNAP2 KO mice show robust increases in time spent 
sniffing the social cylinder in Phase 2 that are not different from wild-type mice (Fig. 
A.3). No genotype differences were found in male or female animals.  
 
Discussion 
We observed no significant differences in sociability in male or female animals in either 
16p11.2del mice or CNTNAP2 mice.  A reduced level of overall sniffing time was found 
in 16p11.2 del females compared to wild-type females, but no change was observed in 
preference for the social cylinder.  We did not observe changes in sociability in CNTNAP 
KO males, a finding that contrasts with previous reports of social interaction deficits in 
male KO animals (Pengarikano et al. 2011).  Lack of deficits in juvenile male animals 
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could indicate a developmental change in sociability in KO males, such that social 
deficits emerge in adulthood.  Additional studies of sociability in both mouse lines across 
development are in progress, and will provide critical information about the role of these 
CNVs in the developmental trajectory of social approach behavior in mice.  
 
Author Contributions 
This section was written by H Schoch. Experiments were planned by H. Schoch. 
Experiments were carried out by H. Schoch, M. Zhang, and O. Perez.   
 
Experiments in section A2 are part of a manuscript in preparation. 
 
A3. Object-Location Training Elicits an Overlapping but Temporally Distinct 
Transcriptional Profile from Contextual Fear Conditioning 
  
Abstract 
Hippocampus-dependent learning is known to induce changes in gene expression, but 
information on gene expression differences between different learning paradigms that 
require the hippocampus is limited. The bulk of studies investigating RNA expression 
after learning use the contextual fear conditioning task, which couples a novel 
environment with a footshock. Although contextual fear conditioning has been useful in 
discovering gene targets, gene expression after spatial memory tasks has received less 
attention. In this study, we used the object-location memory task and studied gene 
expression at two time points after learning in a high-throughput manner using a 
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microfluidic qPCR approach. We found that expression of the classic immediate-early 
genes changes after object-location training in a fashion similar to that observed after 
contextual fear conditioning. However, the temporal dynamics of gene expression are 
different between the two tasks, with object-location memory producing gene expression 
changes that last at least 2 hours. Our findings indicate that different training paradigms 
may give rise to distinct temporal dynamics of gene expression after learning. 
 
Introduction 
Long-term memory is critical to our lives, yet the molecular mechanisms that create and 
stabilize memories are still poorly understood. The hippocampus, which encodes 
contextual information, has been heavily studied in an effort to better understand these 
mechanisms. Transcription is required to convert labile short-term memories into stable 
long-term memories during the period of memory consolidation (Agranoff et al., 1967; 
Igaz et al., 2002). The expression of many genes is regulated within the first hour after 
learning in the hippocampus (Hawk et al., 2012; Keeley et al., 2006; Lemberger et al., 
2008; Levenson et al., 2004; Lonergan et al., 2010; Ramamoorthi et al., 2011). 
Epigenetic mechanisms, such as histone acetylation, can modulate this transcription to 
enhance or dampen long-term memory formation (Alarcon et al., 2004; Guan et al., 
2009; Korzus et al., 2004; Levenson et al., 2004; McQuown et al., 2011; Vecsey et al., 
2007; Wood et al., 2006; Wood et al., 2005). 
Most research into transcriptional regulation in the hippocampus has used contextual 
fear conditioning as the paradigm to test learning and memory (Barnes et al., 2012; 
Keeley et al., 2006; Levenson et al., 2004; Mei et al., 2005). This is primarily because 
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contextual fear conditioning produces a robust memory that has a well-defined time of 
acquisition due to the requirement of only a single training session (Abel and Lattal, 
2001). Although this task has proven useful for dissecting the phases of memory and 
mapping the transcriptional landscape after learning, it also introduces a footshock that 
can be stressful to the animal. It is therefore important to study gene expression in other 
memory tasks that are more similar to the learning events that occur in daily life. 
Spatial learning requires the hippocampus and can be measured using the Morris water 
maze, Barnes maze, or object-location memory (OLM) tasks that do not require a 
footshock. These spatial tasks are also known to regulate transcription in the 
hippocampus, including many of the same genes and processes required for contextual 
fear memory (Bousiges et al., 2010; Cavallaro et al., 2002; Florian et al., 2006; Fordyce 
et al., 1994; Haettig et al., 2011; Hawk et al., 2011; Klur et al., 2009; McNulty et al., 
2012; Pittenger et al., 2002; Vogel-Ciernia et al., 2013). There is evidence that 
contextual and spatial learning in the hippocampus can utilize different molecular 
pathways (Mizuno and Giese, 2005), so gene expression may also differ after these two 
tasks. Like contextual fear memory, OLM is a hippocampus-dependent task (Oliveira et 
al., 2010). However, the targets and temporal resolution of the gene expression changes 
after OLM have not been thoroughly studied. The goal of this study was to investigate 
the transcriptional profile that occurs within the first transcriptional wave after OLM 
learning (Bourtchouladze et al., 1998; Igaz et al., 2002) and compare this transcriptional 
profile to that of contextual fear conditioning. Gene expression changes within this 
window after fear conditioning are typically highest 30 minutes after training and return to 
baseline by 2 hours (Hawk et al., 2012; Keeley et al. 2006; Peixoto et al., 2013). Using a 
Fluidigm HD microfluidic high-throughput qPCR system, we examined expression of 96 
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different candidate genes at both 30 minutes and 2 hours after OLM training in a single 
experiment. We found that the most commonly studied genes after fear conditioning 
show a similar profile after OLM. However, OLM produces long-lasting expression 
changes in a number of genes that are not observed after fear conditioning. 
 
Methods 
Subjects  
Forty-two C57BL/6J mice were maintained under standard conditions with food and 
water available ad libitum. Adult male mice 3 months of age were kept on a 12-hr 
light/12-hr dark cycle with lights on at 7AM. All behavioral and biochemical experiments 
were performed during the light cycle with training starting at approximately 7AM (ZT0). 
All procedures were approved by the University of Pennsylvania Institutional Animal 
Care and Use Committee. 
 
Behavior  
Object-location memory (OLM) was carried out as previously described (Hawk et al., 
2011; Oliveira et al., 2010). Briefly, naïve three month old male C57Bl/6J mice were 
singly housed for a week and handled for 2 min/day for five consecutive days prior to 
tissue collection. One animal per behavioral group was trained and dissected each day 
for 10 total days to allow all animals to be dissected at the same circadian time. 
Exploration was normal in all mice used in this experiment (data not shown). One animal 
per training session was tested in a 24hr retrieval test the following day to ensure the 
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training proceeded correctly. Half of the handled animals received OLM training, and half 
of the animals were left undisturbed on training day and were sacrificed at the same 
circadian time points as trained animals. On the day of training, OLM mice were given a 
single block of four 6 min trials with an inter-trial interval of 3 min. The animals were 
habituated to an empty arena with a black and white striped spatial cue on one wall in 
the first trial, followed by three trials of object exposure. Each mouse was exposed to 
three distinct objects: a rectangular metal tower, a glass bottle, and a white plastic 
cylinder that were arranged in a V-shaped spatial pattern in the arena. Objects were 
positioned in the arena with at least two inches of spacing around each object to allow 
free exploration of all objects. During the ITI, animals were gently removed from the 
arenas, and the arenas and objects were cleaned with 70% ethanol. Objects were not 
moved during the ITI. Immediately following the final trial, animals were gently placed in 
their home cage, and returned to the colony room until tissue collection. 
Fear conditioning was performed as previously described (Hawk et al., 2012; Vecsey et 
al., 2007) with handling for 3 days prior to conditioning. Briefly, the conditioning protocol 
entailed a single 2-sec, 1.5mA footshock terminating at 2.5 minutes after placement of 
the mouse in the novel chamber. Mice were left in the chamber for an additional 30 
seconds and then returned to their homecage.  
 
RNA isolation 
Hippocampi were dissected 30 minutes and 2 hours after the last training session into 
RNAlater (Qiagen, Valencia, CA) and frozen on dry ice. Tissue was homogenized using 
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a TissueLyser system and RNA was extracted using the miRNeasy kit (Qiagen) 
according to the manufacturer’s instructions. 
 
cDNA synthesis and high-throughput qPCR 
RNA concentration was determined using a NanoDrop spectrophotometer (Thermo 
Scientific, Waltham, MA) and 1µg RNA was used in each RETROscript (Ambion, Austin, 
TX) cDNA synthesis reaction with random decamers, 10x RT Buffer and no heat 
denaturation according to the manufacturer’s protocol. Concentrated cDNA was used in 
a specific target reaction following the manufacturer’s recommendations (Fluidigm Corp. 
South San Francisco, CA). Briefly, Taqman assays for all 96 probes were pooled to a 
concentration of 0.2X (1:100) and 1.25ul of the pooled assay mix was combined with 
2.5ul 2X Taqman Preamp Master Mix (Life technologies, Carlsbad, CA) and 1.25µl 
cDNA. The preamplification reaction was cycled using the following protocol in a 7500 
Fast Real-Time PCR system: 10 min at 95C, then 14 cycles of 95C for 15s followed by 
60C for 4min. Preamplified samples were diluted 1:5 using 1X TE. Samples were then 
delivered to the Molecular Profiling Core at the University of Pennsylvania, where they 
were run on a 96.96 Dynamic Array IFC on the Biomark HD machine (Fluidigm Corp). 
For validation and the 120 minute fear conditioning experiment, cDNA reactions 
were diluted to 2 ng/ul in water, and real-time RT-PCR reactions were prepared in 384-
well optical reaction plates with optical adhesive covers (Life technologies). Each 
reaction was composed of 2.25µl cDNA (2 ng/ul), 2.5µl 2x Taqman Fast Universal 
Master Mix (Life Technologies), and 0.25µl of Taqman probe. Reactions were performed 
in triplicate on the Viia7 Real-Time PCR system (Life Technologies, Carlsbad, CA). 
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Data analysis 
High-throughput qPCR was analyzed using the Fluidigm Real Time PCR Analysis 
program and Microsoft Excel. Genes with at least one sample having an average Ct ≥20 
were discarded as being non-expressed or failed reactions. This included Dnmt3b, 
Erbb2, Esrrg, Fosb, Hdac1, Hdac4, Jun, Nr6a1, Pparg, and Trdmt1, which brought the 
total number of genes tested to 86. Relative quantification of gene expression between 
groups was performed using the ∆∆Ct method as described previously (Vecsey et al., 
2007). The difference between each Ct and the average Ct for that gene was subtracted 
from the average of three housekeeper genes treated in the same manner. A p-value of 
0.01 was used for significance to control for the number of t-tests performed. This p-
value cutoff was chosen because we selected genes for analysis that we expected to 
change, and thus Bonferroni correction is too strict. This 1% chance of a type I error 
corresponds to one false positive per 100 t-tests. Because 86 t-tests were performed, 
this p-value would suggest less than 1 false positive in the data, limiting the amount of 
type I errors introduced by multiple testing.  
 
Results 
Immediate Early Genes Are Regulated 30 minutes after OLM training 
We chose sixteen representative genes that have been studied 30 minutes after fear 
conditioning to examine expression profiles 30 minutes after OLM training. The genes 
were chosen for well-studied expression changes (Arc, Bdnf4, Egr1, Fos, Homer1), 
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genes our lab has previously studied [Fosl2 (Hawk et al., 2012), Gadd45 family (Leach 
et al., 2012)], or from microarray data (Btg2, Cpeb3, Histh2hab, Sik1, Sox18, Tob1, 
Tob2 (Peixoto et al., 2013)). cDNA samples underwent specific target amplification and 
were run on a 96.96 Fluidigm Biomark HD plate in triplicate (96 genes, 32 samples). Ten 
genes were excluded due to too low expression or a failed reaction, bringing the total 
number of genes tested to 86 (See Methods for genes). In all cases, immediate early 
gene (IEG) expression after OLM mirrored expression after fear conditioning (Figure 
A.4). Previously studied genes including Arc, Bdnf4, Egr1, Fos and Homer1 were 
upregulated as anticipated (Arc 272% p=4.7x10-8; Bdnf4 53% p=3.3x10-7; Egr1 225% 
p=4.4x10-8; Fos 410% p=1.2x10-10; Homer1 31% p=1.4x10-4) (Keeley et al., 2006; 
Lonergan et al., 2010; Mahan et al., 2012; Mizuno et al., 2012). The probe against 
Homer1 recognizes both Homer1a and Homer1c, but research from our lab and others 
suggests that this effect is primarily due to Homer1a (Mahan et al., 2012). Further 
investigation is required to investigate specific Homer1 isoforms regulated by OLM. 
Genes that our lab discovered to be regulated after contextual fear conditioning using 
microarrays (Peixoto et al., 2013), including Btg2 (27% p=8.9x10-6), Hist2h2ab (-26% 
p=8.8x10-4), Sik1 (70% p=1.3x10-5), Sox18 (-21% p=0.002), and Tob2 (30% p=0.004) 
showed similar changes after OLM. The genes Gadd45b and Gadd45g showed 
increased expression (32% p=0.004, 32% p=0.001) while Gadd45a did not (p=0.20), as 
has been reported previously by our lab and others (Leach et al., 2012; Sultan et al., 
2012). This observation suggests that the most commonly studied genes after contextual 
fear conditioning are similarly regulated after spatial behavioral tasks such as object-
location memory. 
Nuclear Hormone Receptors Display a Limited Response to OLM 
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A subset of nuclear hormone receptors are known to be regulated 30 minutes after fear 
conditioning, including the Nr4a family of orphan nuclear receptors (Hawk et al., 2012). 
We tested all 37 nuclear hormone receptors that are expressed in the hippocampus for 
changes after OLM training (Figure A.5). The Nr4a family of nuclear receptors (Nr4a1, 
Nr4a2, Nr4a3), which are known to be necessary for long-term fear memory (Hawk et 
al., 2012; McNulty et al., 2012; McQuown et al., 2011), all displayed increased 
expression at 30 minutes after OLM. Rev-ErbA (NR1D1), COUP-TFII (NR2F2), and 
retinoid X receptor gamma (Rxrg) all showed decreased expression at 30 minutes. No 
other nuclear receptors were observed to respond to spatial learning at this time point or 
at 120 minutes after OLM (data not shown). This contrasts with the large number of 
nuclear receptors that our lab observed to change after fear conditioning training in our 
previous study (Hawk et al., 2012), which included increased expression of 13 nuclear 
receptor genes between 30 and 120 minutes after training. These results may indicate 
transcriptional regulation of this class of genes depends on the training paradigm. 
 
Regulators of Transcription Show Limited Changes in Response to OLM 
Histone acetylation is known to be a crucial regulator of transcription during memory 
consolidation (Alarcon et al., 2004; Barrett et al., 2011; Haettig et al., 2011; Korzus et al., 
2004; Levenson et al., 2004; McQuown et al., 2011; Vecsey et al., 2007; Wood et al., 
2006; Wood et al., 2005). To test whether expression levels of histone acetylation 
modifying enzymes are regulated by OLM, we tested all histone deacetylases (HDACs, 
Figure A.6A) and 16 histone acetyltransferases (HATs, Figure A.6B) representing each 
class of enzyme, including the HATs CBP and p300 that have been shown to be 
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essential for memory formation. The probes against Hdac1 and Hdac4 did not amplify 
and were discarded. None of the HATs tested showed a gene expression change, in 
contrast to previous reports showing changes in expression of CBP, p300 and PCAF 
after the Morris Water Maze (Bousiges et al., 2010). However, Hdac7 displayed reduced 
expression after OLM. HDAC7 is a class IIa HDAC that has not been previously linked to 
memory formation. This may suggest a novel role for HDAC7 in hippocampus-
dependent memory formation. In addition to the regulators of histone acetylation, we 
chose ten genes that are known to regulate transcription in other ways. None of these 
genes showed any changes in transcription at 30 minutes after OLM training (Figure 
A.7). 
OLM Induces Longer Lasting Gene Expression Changes than Fear Conditioning 
In addition to the 30 minute timepoint that has shown such robust changes after fear 
conditioning, we also tested hippocampal samples taken 2 hours after OLM training to 
investigate the persistence of these transcriptional changes. Interestingly, a number of 
genes that are upregulated at 30 minutes remain elevated 2 hours after OLM training. 
This includes highly induced genes that appear to be slowly returning to baseline, such 
as Egr1 and Fos, but also genes that maintain a similar level of induction as observed at 
30 minutes such as Bdnf4, Fosl2, Homer1, Nr4a2 and Nr4a3 (Figure A.8A). Sin3a was 
not changed at 30 minutes, but shows a selective change at 2 hours. The gene 
expression profiles at 30 minutes and 2 hours for Arc, Egr1, Fos, Nr4a1, and Nr4a2 were 
confirmed by standard 384-well qPCR (data not shown). To test whether these same 
genes show transcriptional changes after fear conditioning, we prepared cDNA from 
samples that were collected 2 hours after fear conditioning. None of the genes 
determined to change 2 hours after OLM showed a significant change 2 hours after fear 
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conditioning (Figure A.8B), indicating a long-lasting gene expression response specific 
to OLM. 
 
Discussion 
In this study, we investigated the transcriptional changes that occur in response to OLM 
training using powerful high-throughput qPCR technology and compared these changes 
to fear conditioning. In a single run, we were able to study 96 different genes in 2 
different time points after OLM training with n=8 mice per group using microfluidic high-
throughput qPCR. This type of throughput, flexibility, and consistency is not possible with 
any other qPCR technology. In addition to requiring more pipetting steps, standard 
qPCR would have required the same housekeepers to be run on each individual plate 
and limited the number of targets that could be tested. Using a high-throughput 
approach allowed us to reliably determine that gene expression changes after OLM last 
longer than similar expression changes after contextual fear. 
 Our study discovered that commonly studied IEGs, such as Fos and Arc, show 
similar expression differences after fear conditioning and after OLM, indicating overlap 
between contextual and spatial learning. In a previous study from our lab (Hawk et al., 
2012), we found that a number of nuclear receptors exhibit increased expression after 
contextual fear conditioning. Our current findings suggest a more limited regulation of 
this class of genes after OLM. It is unclear whether the wider regulation after fear 
conditioning is in response to the footshock or whether the timecourse of expression 
after OLM is different. As seen after fear conditioning, all 3 members of the Nr4a family 
of orphan nuclear receptors were upregulated after OLM. However, while Nr4a1 
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returned to baseline by 2 hours, Nr4a2 and Nr4a3 did not, suggesting that different 
processes may regulate Nr4a1 than the other two family members. Future studies will 
aim to determine how expression increases of Nr4a2 and Nr4a3 are maintained after 
OLM training. 
 It is interesting to note that Hdac7 and Sin3a are regulated by OLM while HATs 
are not. This may suggest that relieving the negative repression of histone acetylation is 
a crucial step for long-term memory formation. Although class I HDACs have been 
heavily implicated in learning and memory (Bahari-Javan et al., 2012; Guan et al., 2009; 
Hawk et al., 2011; McQuown et al., 2011), class IIa HDACs have received less attention. 
A study by Agis-Balboa et al. demonstrated that loss of the class IIa member HDAC5 
impairs spatial memory (Agis-Balboa et al., 2013), but those experiments used a 
complete knockout mouse line that has the potential for developmental or 
extrahippocampal effects. Our study is the first to observe changes in Hdac7 in response 
to learning in the hippocampus. 
 The most intriguing finding of this study was the long-lasting regulation of gene 
expression 2 hours after OLM, something that is not seen after fear conditioning. It might 
be expected that the fear of a footshock would produce a stronger transcriptional 
response in the hippocampus than would the spatial rearrangement of objects. There 
are a number of potential causes for this disparity, although the most likely explanation is 
that the multiple training sessions required for OLM induce a stronger response than the 
single shock training used by our lab for fear conditioning. It would be interesting to test 
whether a multiple shock fear conditioning protocol induces longer lasting gene 
expression changes. Also, there could be an association between the novel context and 
the novel objects formed during OLM training that is not present in fear conditioning. 
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Testing mice in the context only, introducing novel objects, or altering the number of 
training trials could determine whether these changes are sufficient to elicit gene 
expression changes. Further, different molecular mechanisms may regulate contextual 
and spatial learning (Mizuno and Giese, 2005). Future studies can test for changes at 
the protein level, although mRNA and protein levels generally agree after learning 
(Stanciu et al., 2001; Steward et al., 1998). Additional investigation into later time points 
after OLM training will be required to see if gene expression changes that occur well 
after fear conditioning (Mizuno et al., 2012) also exist after OLM. It is interesting that not 
all genes with increased expression at the 30 minute timepoint remain elevated for 2 
hours after OLM. Future studies will determine whether specific epigenetic modifications 
regulate this longer term maintenance of gene expression at particular genes.  
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Appendix Figure Legends 
Figure A.1. Differential expression of Homer1 isoforms by acute post-training 
treatment of TSA.  Expression of Homer1 transcripts containing exons common to both 
short and long isoforms is elevated in trained animals that received infusions of TSA, but 
levels of long Homer1 isoforms containing exons 7-8 are not changed. Graph shows 
means with error bars denoting SEM (t-tests: * indicates p<0.05.) 
Figure A.2. Cylinder sniffing is reduced in female 16p11.2 del mice, but social 
preference is intact.  A. Sniffing of social and non-social cylinders in not different in 
adult male 16p11.2 del mice.  B.  Female 16p11.2 del animals show reduced sniffing 
behavior during both phases of social choice testing.  C.  No difference in preference 
scores for sniffing the social cylinder in males or females of either genotype. All graphs 
show means with error bars denoting SEM (t-tests: * indicates p<0.05.). 
Figure A.3. Sociability is not altered in juvenile CNTNAP2 knockout mice.  A. No 
differences in exploration of social cylinder during phase 2 in male CNTNAP2 KO mice.  
B. No differences in sniffing of social or non-social cylinders in female CNTNAP2 KO 
mice.  Graphs show means with error bars denoting SEM (t-tests: * indicates p<0.05.). 
Figure A.4. Classic IEGs Show Expected Expression Changes after OLM Training. 
16 genes that are known to be induced 30 minutes after contextual fear conditioning 
were studied 30 minutes after OLM training. Each gene tested displayed the expression 
change that would be expected after contextual fear conditioning, indicating these genes 
may represent a common transcriptional response to learning. All error bars denote 
s.e.m. and * indicates p<0.01. 
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Figure A.5. Limited Expression Changes of Nuclear Receptors after OLM training. 
Because of the known involvement of the Nr4a nuclear receptor family in memory, we 
tested expression of all nuclear receptors expressed in the hippocampus 30 minutes 
after OLM training. The Nr4a family displayed increased expression after OLM, while 
NR1D1, NR2F2, and RXRg had reduced expression. All error bars denote s.e.m. and * 
indicates p<0.01. 
Figure  A.6. Modifiers of Histone Acetylation Display Limited Regulation after OLM 
Training. Histone modifying enzymes were tested for expression changes 30 minutes 
after OLM training. A. Hdac7, a class IIa HDAC, was the only family member found to 
change expression after OLM. B. No HATs were observed to change expression after 
OLM. All error bars denote s.e.m. and * indicates p<0.01. 
Figure A.7. No Changes in Other Transcriptional Regulators after OLM Training. 
Other genes that can regulate gene expression, including DNMTs, were tested 30 
minutes after OLM training. No differences in any gene were observed. All error bars 
denote s.e.m. and * indicates p<0.01. 
Figure A.8. OLM Training Induces Long-Lasting Changes in Gene Expression Not 
Seen after Fear Conditioning. A. Every gene was also tested 2 hours after OLM 
training to observe the maintenance of transcription. Genes shown in this figure are 
those that were changed at 2 hours after OLM, all other genes were unchanged. Sin3a 
was the only gene uniquely regulated at the 2 hour time point.  B. These same genes do 
not show gene expression changes 2 hours after contextual fear conditioning. All error 
bars denote s.e.m. and * indicates p<0.01. 
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This was a triumph! 
I'm making a note here: 
Huge success! 
 
It's hard to overstate 
my satisfaction. 
 
Aperture Science: 
We do what we must 
because we can 
For the good of all of us. 
Except the ones who are dead. 
 
But there's no sense crying 
over every mistake. 
You just keep on trying 
'til you run out of cake. 
And the science gets done. 
And you make a neat gun 
for the people who are 
still alive… 
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